Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.8015874241384499,-2.0669237002342378,0.0,0.01610304321084922,0.013,9/12,9.70%,PDE7B;PDE3A;PDE8B;PDE8A;PDE4D;PDE3B;PDE4A;PDE4B;PDE2A
prerank,amino acid:sodium symporter activity (GO:0005283),-0.8106749727479537,-2.020716048589829,0.0,0.01409016280949307,0.025,6/11,8.32%,SLC1A3;SLC6A13;SLC6A12;SLC1A2;SLC1A1;SLC6A1
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6341385166612518,-1.974509199854574,0.0,0.021470724281132298,0.057,20/29,22.48%,GRIK2;GRID2;GABRG3;GRIA2;GABRB1;GRIK3;GABRG2;GABRG1;GRIK4;GRIK1;GABRA3;GLRA3;GLRA2;GABRB2;GABRA1;GABRE;GRIA4;GRIK5;CHRNB1;GABRB3
prerank,phosphatidate phosphatase activity (GO:0008195),0.8647606484177781,1.898368926762839,0.0,0.5844978523753357,0.364,1/13,0.01%,PLPPR2
prerank,cAMP binding (GO:0030552),-0.7661582129730395,-1.8676969668275405,0.0,0.06768310349560062,0.209,7/11,9.70%,RAPGEF2;PDE4D;PDE4A;PDE10A;PDE4B;CNBD2;PDE2A
prerank,lipid phosphatase activity (GO:0042577),0.8482777121245203,1.8675563520507006,0.001597444089456869,0.48425547325635737,0.542,1/14,0.01%,PLPPR2
prerank,platelet-derived growth factor binding (GO:0048407),-0.7515840960133853,-1.867176612024425,0.0,0.055152922997158585,0.212,6/11,4.82%,PDGFRB;COL1A2;COL1A1;COL5A1;PDGFRA;COL4A1
prerank,C-C chemokine receptor activity (GO:0016493),0.7720057283662822,1.8431356043118168,0.0029455081001472753,0.4538336567078118,0.621,8/21,6.25%,CCR4;CXCR4;CCR10;ACKR2;ACKR4;ACKR3;CCRL2;GPR75
prerank,tropomyosin binding (GO:0005523),0.8067062061832603,1.8292967041588797,0.006201550387596899,0.404959262908509,0.682,6/16,5.16%,CALD1;NEBL;TMOD3;S100A6;TMOD2;LMOD3
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.7059138985485797,-1.8214466125021882,0.005420054200542005,0.08168939628837053,0.347,10/13,19.90%,GABRG3;GLRA1;GABRG2;GABRG1;GABRA3;GLRA3;GLRA2;GABRA1;GABRE;GLRB
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.7298004244690918,-1.7992002074992863,0.010256410256410256,0.09158605826170495,0.439,4/11,10.70%,SASH1;DAB2IP;ROR2;TRAF6
prerank,chemokine receptor activity (GO:0004950),0.7325324372568219,1.795595448918267,0.0072254335260115606,0.4817618817359848,0.816,8/24,6.25%,CCR4;CXCR4;CCR10;ACKR2;ACKR4;ACKR3;CCRL2;GPR75
prerank,outward rectifier potassium channel activity (GO:0015271),-0.7309350788719715,-1.7886833955475026,0.005,0.09120864318645067,0.483,4/11,5.04%,KCNK2;KCNT2;KCND2;PKD2
prerank,retinoic acid binding (GO:0001972),-0.7085900749674281,-1.7846261123558076,0.0025252525252525255,0.08498828361281534,0.495,2/12,4.96%,NR2F2;CYP26B1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.6708254924278028,-1.7709792749469462,0.0,0.0882648055994673,0.538,5/14,10.07%,SLC7A11;SLC1A3;SLC1A2;SLC1A1;SLC17A6
prerank,androgen receptor binding (GO:0050681),0.7225723554990617,1.766924388382029,0.00847457627118644,0.5426055148330761,0.893,14/25,20.29%,PRKCB;DAXX;DDX5;EP300;TGFB1I1;KDM3A;SMARCA4;KDM4C;FOXP1;KDM1A;PRPF6;PARK7;ZBTB7A;PRMT2
prerank,serine-type peptidase activity (GO:0008236),0.5932895624437309,1.7653168030661806,0.0022396416573348264,0.47378238887079255,0.898,12/96,6.21%,DPP4;KLK11;KLK10;PIK3IP1;MMP9;HPN;HP;HPR;PRSS12;PRSS36;GZMM;NAALAD2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6102767093848683,-1.7522929961771898,0.003125,0.1000950526856196,0.618,13/19,22.22%,GRIK2;GRID2;GABRG3;GRIK3;GABRG2;GABRG1;GRIK4;GRIK1;GABRA3;GABRA1;GABRE;GRIK5;CHRNB1
prerank,C-C chemokine binding (GO:0019957),0.7236691946574324,1.7418016013047943,0.011834319526627219,0.5202878707257413,0.947,7/22,6.03%,CCR4;CXCR4;CCR10;ACKR2;ACKR4;ACKR3;CCRL2
prerank,calcium:sodium antiporter activity (GO:0005432),-0.7219596109349053,-1.736318812418422,0.012755102040816327,0.10903102174012494,0.678,4/10,7.99%,SLC24A3;SLC8A1;SLC8A3;SLC24A2
prerank,disordered domain specific binding (GO:0097718),0.7120656464966695,1.727568137139236,0.012605042016806723,0.5246516558863934,0.968,2/23,1.24%,FN1;NCOA3
prerank,serine-type endopeptidase activity (GO:0004252),0.5936223166346252,1.725953788606781,0.0023094688221709007,0.48126316343191033,0.972,9/80,6.05%,DPP4;PIK3IP1;MMP9;HPN;HP;HPR;PRSS12;PRSS36;GZMM
prerank,death domain binding (GO:0070513),0.811164498700569,1.7218553659508644,0.012738853503184714,0.4526548679890902,0.975,1/11,0.02%,DAPL1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5320086288791256,-1.7216184494756068,0.014388489208633094,0.11775350347933493,0.735,13/28,22.22%,GRIK2;GRID2;GABRG3;GRIK3;GABRG2;GABRG1;GRIK4;GRIK1;GABRA3;GABRA1;GABRE;GRIK5;CHRNB1
prerank,potassium:proton antiporter activity (GO:0015386),0.8422787349837129,1.7170384465796975,0.010273972602739725,0.4303938964163094,0.979,2/10,0.16%,SLC9A2;SLC9A4
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.7346041357770361,1.7169647584078613,0.015313935681470138,0.3973633995079894,0.979,6/18,6.89%,BAIAP2L1;PDLIM5;STXBP6;TMOD3;S100A11;ANXA2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.8162482772056785,1.690263000200312,0.023622047244094488,0.465446668645547,0.994,3/10,2.16%,CXADR;DSG2;CD200
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.671759534933033,-1.6898607431252055,0.016129032258064516,0.14924070404340617,0.833,9/12,22.48%,GABRG3;GABRB1;GABRG2;GABRG1;GABRA3;GABRB2;GABRA1;GABRE;GABRB3
prerank,metal ion:proton antiporter activity (GO:0051139),0.7728454991569129,1.685096385361448,0.014173228346456693,0.45523006795922044,0.994,2/13,0.16%,SLC9A2;SLC9A4
prerank,sodium:proton antiporter activity (GO:0015385),0.8070374021199958,1.6848095677890838,0.013377926421404682,0.4275262661678809,0.994,2/11,0.16%,SLC9A2;SLC9A4
prerank,ligand-gated ion channel activity (GO:0015276),-0.5145293709968843,-1.678321135246075,0.00749063670411985,0.15499179090442375,0.864,16/30,25.15%,GRIK2;GRID2;GRIN2A;GRIA3;GRIA2;GRIN2B;GABRB1;GRIK3;GRIK4;GRIK1;ANXA6;GRIA4;GRIK5;CHRNB1;GRIN3A;CHRNA4
prerank,cytokine activity (GO:0005125),0.5432496926430027,1.6733553783150534,0.0,0.44039759886862767,0.997,19/131,8.03%,WNT16;TNFRSF11B;CRLF1;WNT1;CCL5;WNT10A;IL15;GDF15;WNT11;IL16;BMP5;WNT6;CLCF1;TIMP1;EPO;BMP4;TGFB2;SLURP1;WNT5B
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.7826547026360391,1.6657845025957867,0.017973856209150325,0.4433051591773497,0.997,2/12,0.16%,SLC9A2;SLC9A4
prerank,cell adhesion mediator activity (GO:0098631),-0.5398543241774794,-1.6640787289078887,0.00641025641025641,0.1669432682874759,0.901,11/24,10.40%,CD47;ESAM;PALLD;EMB;LRRC4C;NEXN;DSCAML1;BSG;CNTN6;NTNG1;ROBO4
prerank,cholesterol transfer activity (GO:0120020),-0.5925817837291475,-1.663478978259698,0.02735562310030395,0.15812951623594954,0.901,5/16,10.43%,ABCA1;PLTP;GRAMD1C;MTTP;GRAMD1B
prerank,ligand-gated channel activity (GO:0022834),-0.5183021404385779,-1.6547185339602093,0.0076045627376425855,0.1613099988309028,0.917,16/29,25.15%,GRIK2;GRID2;GRIN2A;GRIA3;GRIA2;GRIN2B;GABRB1;GRIK3;GRIK4;GRIK1;ANXA6;GRIA4;GRIK5;CHRNB1;GRIN3A;CHRNA4
prerank,5'-nucleotidase activity (GO:0008253),0.7680160129669794,1.6536278617143465,0.02735562310030395,0.46585539266918696,0.999,4/13,7.01%,NT5E;NT5C1A;NT5C3A;NT5C2
prerank,sterol transfer activity (GO:0120015),-0.5842475397208935,-1.6498736437685686,0.024922118380062305,0.16023587405532533,0.931,5/17,10.43%,ABCA1;PLTP;GRAMD1C;MTTP;GRAMD1B
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.6326296845193671,-1.6460811579529049,0.0326975476839237,0.15730660336598334,0.94,6/12,9.42%,IGF1;PIK3R1;INSR;GNAS;IGF2;ARRB1
prerank,dipeptidyl-peptidase activity (GO:0008239),0.7795869411122632,1.6436294341785291,0.02901023890784983,0.47832072543787063,1.0,3/10,6.21%,DPP4;DPP7;NAALAD2
prerank,nucleotidase activity (GO:0008252),0.7330838949897356,1.6154192152576423,0.022590361445783132,0.5634091926601845,1.0,4/15,7.01%,NT5E;NT5C1A;NT5C3A;NT5C2
prerank,glutamate receptor activity (GO:0008066),-0.5762729825364883,-1.6145527712443828,0.00906344410876133,0.1948659931408123,0.964,10/19,11.28%,GRIK2;GRID2;GRM3;GRM7;GRIA2;GRM8;GRM5;GRIK3;GRIK4;GRIK1
prerank,GABA-A receptor activity (GO:0004890),-0.5817280931252053,-1.6051925443019306,0.032467532467532464,0.20096780916267226,0.972,9/18,22.48%,GABRG3;GABRB1;GABRG2;GABRG1;GABRA3;GABRB2;GABRA1;GABRE;GABRB3
prerank,frizzled binding (GO:0005109),0.6176770385685357,1.5999007778221046,0.026595744680851064,0.603041105681379,1.0,8/34,8.03%,WNT16;WNT1;WNT10A;WNT11;RNF43;WNT6;DVL3;WNT5B
prerank,protein kinase C binding (GO:0005080),0.5883318338273782,1.5858593998100752,0.026415094339622643,0.6380558615520339,1.0,10/43,10.45%,PRKCB;PDLIM5;GRK5;HDAC5;CAVIN2;HSPB1;ADCY6;PARD6B;DACT2;NELL2
prerank,glycine binding (GO:0016594),-0.6245525575136769,-1.5857405419756003,0.04521276595744681,0.22216073473228667,0.983,10/11,34.74%,GRIN2B;GLRA1;GLRA3;GLRA2;SRR;GLRB;GRIN3A;GRIN1;GLDC;GNMT
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.42622383313445916,-1.571340202107247,0.00641025641025641,0.23508765687505398,0.992,28/60,13.47%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;AXL;ACVRL1;TIE1;KDR;PDGFRA;BMPR1B;ACVR1B;EPHB2;EPHB4;NTRK2;ERBB4;ACVR2A;ROR2;FGFR2;KIT;RYK;IGF1R;FGFR4;FLT4;EPHA5;RET
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.6560278943694713,-1.5659035713524987,0.027918781725888325,0.23474211240615453,0.994,6/10,18.97%,GABRG3;GABRG2;GABRG1;GABRA3;GABRA1;GABRE
prerank,receptor antagonist activity (GO:0048019),0.6745497898711297,1.5575048166122216,0.042488619119878605,0.7468722202102642,1.0,4/17,6.81%,CCL5;ADH7;IGSF1;PXDN
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.58968342385256,1.5484027109370924,0.05019815059445178,0.7604057725884997,1.0,21/37,21.07%,EPRS1;QARS1;VARS1;VARS2;FARS2;HARS1;CARS2;NARS2;LARS2;AARS1;TARS1;YARS1;HARS2;SARS1;SARS2;TARS3;FARSA;FARSB;DARS2;NARS1;YARS2
prerank,potassium ion antiporter activity (GO:0022821),0.6945497719948575,1.5478396901544333,0.046875,0.7341900694906257,1.0,2/15,0.16%,SLC9A2;SLC9A4
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.6097556006513422,-1.5447259323292573,0.04851752021563342,0.2621002537996637,0.998,5/13,3.96%,PDGFRB;PDGFD;PTPRJ;IL1R1;PDGFRA
prerank,ankyrin binding (GO:0030506),0.6515158476974253,1.5347780007085103,0.05847076461769116,0.7733827922814848,1.0,1/19,0.06%,CDH1
prerank,chemorepellent activity (GO:0045499),0.6140861904147127,1.5306056297339816,0.059322033898305086,0.7665656560985402,1.0,3/25,2.82%,DPP4;SEMA3D;SEMA3B
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5471045739491424,-1.5281847947038942,0.03903903903903904,0.28191508287882566,0.999,8/17,11.28%,GRIK2;GRIN2A;GRIA3;GRIA2;GRIN2B;GRIK3;GRIK4;GRIK1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.6211443410612956,1.5196348349759652,0.06950354609929078,0.795335314718563,1.0,2/27,0.16%,SLC9A2;SLC9A4
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.5595085676541105,-1.5194574828848515,0.04632152588555858,0.28899211476613335,0.999,5/15,10.07%,SLC1A3;SLC1A5;SLC1A2;SLC1A1;SLC17A6
prerank,enoyl-CoA hydratase activity (GO:0004300),0.7347989534725041,1.5161999144065827,0.06115702479338843,0.7865785091863305,1.0,6/10,17.64%,ECHDC1;EHHADH;HADHA;AUH;HADHB;ECHS1
prerank,protein phosphatase 2A binding (GO:0051721),-0.49076920438316907,-1.511216958923734,0.05211726384364821,0.2939846531015167,0.999,13/23,23.73%,CTTNBP2NL;MFHAS1;FOXO1;DAB2IP;TP53;PPME1;BOD1L1;MASTL;STRN;BOD1;SPHK1;ADCY8;GRIN3A
prerank,G protein-coupled receptor binding (GO:0001664),0.49455707498105633,1.5059302934864465,0.016375545851528384,0.8104333318083207,1.0,23/132,12.95%,WNT16;ITGB4;AGTR1;WNT1;CCL5;WNT10A;PENK;WNT11;ARHGEF12;RNF43;HOMER2;HOMER3;WNT6;CCRL2;DVL3;WNT5B;USP20;GRK2;GNAO1;GNAQ;GNA13;WNT3;SFRP1
prerank,carboxypeptidase activity (GO:0004180),0.5816025860158226,1.5030576500376969,0.060526315789473685,0.7984168349292994,1.0,9/35,7.99%,CPB1;CPA4;CPA3;MINDY2;AGTPBP1;CTSZ;NAALAD2;CPE;AGBL1
prerank,exopeptidase activity (GO:0008238),0.551322547180539,1.5017342310458452,0.054292929292929296,0.7800256529243089,1.0,6/50,7.26%,DPP4;CPB1;DPP7;CTSZ;NAALAD2;CPE
prerank,protease binding (GO:0002020),0.5011436638012842,1.5001601685796657,0.030474040632054177,0.7641831236963018,1.0,14/99,10.93%,FN1;DPP4;LDLR;TIMP4;SERPINC1;TIMP1;TIMP2;LCOR;ANXA2;DVL3;ADAMTSL4;CARD16;POLG;ATP9A
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6727275855316638,1.498637336210677,0.07413249211356467,0.7491888854751437,1.0,4/15,6.03%,CCR4;ACKR2;ACKR4;CCRL2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.552485345913145,-1.4839874041909162,0.049723756906077346,0.33762713932080535,1.0,6/15,15.49%,HS6ST2;HS3ST3A1;NDST3;HS6ST3;HS3ST3B1;HS3ST1
prerank,receptor ligand activity (GO:0048018),0.46860615570461794,1.474831080663807,0.00511770726714432,0.8394537320472089,1.0,31/245,8.83%,DPP4;WNT16;SEMA3D;TNFRSF11B;CRLF1;WNT1;CCL5;EDA;WNT10A;NBL1;IL15;GDF15;WNT11;IL16;SEMA3B;NGF;TNFSF13;GDNF;BMP5;WNT6;CLCF1;TIMP1;EPO;BMP4;OSGIN2;TGFB2;SLURP1;WNT5B;FGF22;LGALS3;VEGFB
prerank,NAD binding (GO:0051287),-0.471126081329452,-1.4717121644816602,0.045454545454545456,0.3519943437339259,1.0,11/26,28.32%,ALDH1A1;ZC3HAV1;ME1;HPGD;SIRT2;ALDH2;SORD;CRYZ;BDH2;NNT;SIRT6
prerank,Wnt-activated receptor activity (GO:0042813),-0.5564565305434932,-1.4713367016187742,0.08746355685131195,0.3418122531552916,1.0,7/15,11.25%,ROR1;FZD6;FZD4;LRP5;TSPAN12;RYK;FZD1
prerank,MAP kinase kinase activity (GO:0004708),-0.5383676744631685,-1.4709935789842175,0.07079646017699115,0.3320947680358659,1.0,8/15,21.12%,PAK3;MAPK10;MAP2K6;LRRK2;MAP2K4;MAP2K1;MAP3K9;MAPK14
prerank,ATP hydrolysis activity (GO:0140603),0.5506513494514655,1.4652999758048213,0.08010335917312661,0.865505398411702,1.0,14/41,20.73%,CFTR;CLU;ABCD1;SHOC1;TOR1A;VPS4B;CHD3;HSP90AA1;DHX9;MYO1E;KIF20B;ABCB6;MYO18A;ABCA4
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.6085558443887829,-1.4601005662419921,0.07672634271099744,0.34438015572613945,1.0,3/10,5.31%,MECOM;SETD5;PRDM16
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6068552316719551,-1.4527219716043822,0.07556675062972293,0.3490909724637671,1.0,3/10,4.78%,GNAS;SHANK3;SHISA6
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.7010845765428462,1.4507775921199686,0.0759493670886076,0.9185078744462961,1.0,1/11,0.43%,NUDT4
prerank,potassium channel activity (GO:0005267),-0.36124119137812777,-1.4487933283722352,0.01639344262295082,0.34722186923393633,1.0,28/89,22.91%,KCNK2;KCNT2;GRIK2;KCND2;KCNK5;KCNN2;ABCC9;PKD2;KCNQ4;GRIK3;HCN2;GRIK4;GRIK1;CCDC51;KCNC1;TMEM38B;KCNMA1;KCNMB4;KCNK13;KCNH5;KCNQ3;HCN1;KCNK3;GRIK5;KCNB2;KCNK12;KCND1;KCNC3
prerank,chemokine binding (GO:0019956),0.569917834086302,1.4481613440090282,0.06460674157303371,0.9091506806790247,1.0,7/30,6.03%,CCR4;CXCR4;CCR10;ACKR2;ACKR4;ACKR3;CCRL2
prerank,growth factor receptor binding (GO:0070851),-0.35289414069889946,-1.4451918924481317,0.008928571428571428,0.34545379861112346,1.0,19/95,13.05%,PDGFRB;PDGFD;HIP1;PTPRJ;TGFA;IL1R1;VEGFC;GLMN;PDGFRA;KL;FGF2;IL6R;ERBB4;JAK2;PLSCR1;LINGO1;IL6ST;GRB2;CNOT9
prerank,GABA receptor activity (GO:0016917),-0.49971424335667725,-1.4418227143671303,0.07407407407407407,0.3427458588677628,1.0,10/21,22.48%,GABRG3;GABRB1;GABRG2;GABRG1;GPR156;GABRA3;GABRB2;GABRA1;GABRE;GABRB3
prerank,pre-mRNA binding (GO:0036002),0.5762261035813457,1.4398220746321693,0.08469945355191257,0.929835342031736,1.0,4/28,5.33%,CELF2;DDX5;CELF1;TARBP2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.5384146487590449,1.4359729315780387,0.066167290886392,0.9282242386323537,1.0,12/46,12.45%,B3GALT1;OGT;HEXA;B4GAT1;MGAT3;GCNT2;LARGE1;MGAT1;EXT1;HEXB;PIGA;MGAT4C
prerank,insulin-like growth factor I binding (GO:0031994),0.6500591631416397,1.4292546889972213,0.11074918566775244,0.9407727094099034,1.0,2/13,0.77%,ITGB4;IGFBP6
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.6834937204188395,1.4291782916758935,0.105,0.9191494325094323,1.0,2/12,2.20%,B3GALT1;B4GAT1
prerank,nucleotide diphosphatase activity (GO:0004551),0.6528635136552323,1.4282671276377679,0.09171597633136094,0.9032468557204176,1.0,2/14,2.13%,NUDT4;FHIT
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5220033793566308,1.4266924143430764,0.05771643663739021,0.8910655352044319,1.0,13/48,13.39%,TRPM3;ATP6V1B1;NALCN;TRPM8;CALHM5;TMEM165;TRPM6;SLC12A4;TRPM4;AQP1;SLC41A1;PKD2L1;TRPM2
prerank,ferrous iron binding (GO:0008198),0.609704744000911,1.418162967445161,0.10682492581602374,0.914519269245517,1.0,4/21,11.07%,EGLN3;HEPH;EGLN2;CDO1
prerank,neuropeptide binding (GO:0042923),-0.49603142604362965,-1.4127067484556346,0.10263929618768329,0.39524713111757487,1.0,12/18,44.00%,GPR37;SORL1;OPRM1;OPRK1;NMUR2;GPR149;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.6253519050743573,1.4125742914441264,0.12102874432677761,0.922543974315889,1.0,5/14,11.18%,MINDY2;MINDY3;OTUD7B;DESI2;MINDY4
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.6615240388458651,1.4102032227981174,0.10929853181076672,0.9148363890366947,1.0,1/12,1.15%,OPN1SW
prerank,neuropeptide receptor activity (GO:0008188),0.5584162463756568,1.4090634970414315,0.0942622950819672,0.9013162884821031,1.0,2/29,1.41%,SORCS2;GAL
prerank,R-SMAD binding (GO:0070412),0.608609633205836,1.4055388396125983,0.11377245508982035,0.8999471540685501,1.0,7/18,11.31%,SMAD6;DDX5;TRIM33;FOS;PPM1A;JUN;LDLRAD4
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4964850579512288,1.401561549213751,0.057210965435041714,0.9021325181194241,1.0,12/70,12.45%,B3GALT1;B4GALNT2;OGT;HEXA;B4GAT1;GCNT2;LARGE1;CHPF;EXT1;HEXB;CHPF2;MGAT4C
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5012819746186328,-1.4015283314589955,0.09785932721712538,0.4108288899167908,1.0,6/18,8.61%,LTBP1;ENG;ACVRL1;BMPR1B;ACVR1B;ACVR2A
prerank,chloride transmembrane transporter activity (GO:0015108),0.6250319132810108,1.3988105430578706,0.11179173047473201,0.898652020995815,1.0,1/16,0.12%,CFTR
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.37239701581126405,-1.397273576098937,0.049689440993788817,0.4101121081153322,1.0,25/60,13.47%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;AXL;TIE1;KDR;PDGFRA;IGF2R;EPHB2;EPHB4;NTRK2;ERBB4;ROR2;FGFR2;KIT;RYK;IGF1R;FGFR4;FLT4;EPHA5;RET
prerank,chloride channel inhibitor activity (GO:0019869),0.6758019131078282,1.3972060095860557,0.12624584717607973,0.8892617850614771,1.0,1/10,0.12%,CFTR
prerank,Hsp70 protein binding (GO:0030544),-0.4136402896293389,-1.3971067100247774,0.09055118110236221,0.4005392370079535,1.0,7/31,8.28%,PACRG;SACS;TSC1;DNAJC18;GPR37;DNAJA1;DNAJB12
prerank,NF-kappaB binding (GO:0051059),0.5753119321182858,1.3931130381977543,0.10906515580736544,0.8928350616314814,1.0,9/24,14.12%,EP300;ANXA4;MTDH;NFKBIA;COMMD7;FOXP3;HDAC3;COMMD6;GSK3B
prerank,estrogen receptor binding (GO:0030331),-0.4351130486504583,-1.3914089181186118,0.0784313725490196,0.4046357718447113,1.0,8/32,11.89%,LEF1;TACC1;ESR1;NCOA1;NSD1;RERG;PADI2;CCDC62
prerank,insulin-like growth factor binding (GO:0005520),0.616014534884013,1.3855893264166494,0.12913385826771653,0.9105689471847844,1.0,2/15,0.77%,ITGB4;IGFBP6
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5056999935925808,1.382547249024628,0.08536585365853659,0.9078810498316555,1.0,7/55,7.49%,SLC7A14;SLC36A3;SLC16A5;SLC16A11;SLC16A2;SLC36A4;SLC3A1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5098358425729197,1.381000990671976,0.10246913580246914,0.8993028450174615,1.0,6/47,7.49%,SLC7A14;SLC36A3;SLC66A1;SLC16A2;SLC36A4;SLC3A1
prerank,phosphatase activity (GO:0016791),0.4890168172022558,1.3806699551678894,0.07962529274004684,0.8854829474757571,1.0,4/73,5.49%,PLPPR2;ATP1A2;DUSP10;DUSP12
prerank,kinase activator activity (GO:0019209),0.5375960258699677,1.3768577641573083,0.1134453781512605,0.8880397896518772,1.0,5/30,4.49%,FGF13;DAXX;WNT11;GPRC5A;EPO
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.44197530263380047,-1.3751132435059514,0.08333333333333333,0.4332953800328364,1.0,10/26,9.95%,SLC6A13;SLC16A12;SLC6A12;SLC16A9;SLC6A6;SLC16A6;SLC16A1;SLC16A4;SLC6A1;SLC16A7
prerank,glucuronosyltransferase activity (GO:0015020),0.5885956141014419,1.3750962543081116,0.12424242424242424,0.8811354996388592,1.0,4/19,9.20%,B4GAT1;LARGE1;CHPF;EXT1
prerank,chloride channel regulator activity (GO:0017081),0.6323641970717683,1.3742106412049515,0.12241653418124006,0.8708275645933321,1.0,2/14,3.67%,CFTR;SGK3
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.6145634333289542,1.367684090751083,0.13249211356466878,0.8863189524637884,1.0,1/15,0.12%,CFTR
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.48204815533049067,-1.367387031866235,0.09696969696969697,0.4409326345859617,1.0,6/18,5.55%,ALDH1A1;ALDH1A2;AKR1B1;ALDH3A2;FAR2;ALDH6A1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.6479514841058718,1.3658996853446728,0.14356435643564355,0.8804673754346704,1.0,1/10,0.66%,B3GALT1
prerank,O-acyltransferase activity (GO:0008374),0.5484121725183349,1.3614223038617776,0.13212795549374132,0.8863626908634402,1.0,10/30,12.71%,MBOAT2;SOAT1;DGAT1;MOGAT3;MOGAT1;SOAT2;GPAM;MBOAT7;LPCAT2;LPCAT3
prerank,sialyltransferase activity (GO:0008373),-0.4754187588824635,-1.3606525020764966,0.09206349206349207,0.4465093829443083,1.0,7/20,7.80%,ST6GALNAC3;ST3GAL1;ST3GAL5;ST8SIA4;ST3GAL3;ST6GALNAC5;ST8SIA6
prerank,proton transmembrane transporter activity (GO:0015078),0.5158208814661384,1.3572367728517314,0.10775295663600526,0.8912940078633923,1.0,18/39,25.25%,ATP6V1B1;COX5A;CTNS;COX8A;UQCRC1;CLCN4;COX7A2L;COX5B;UQCR11;SLC9A1;SLC11A2;UQCRH;ATP6V1B2;COX4I1;COX10;SLC4A11;UQCRFS1;CYB5A
prerank,potassium ion leak channel activity (GO:0022841),-0.5226255781844391,-1.3555731192689402,0.11581920903954802,0.44867960691080283,1.0,8/15,31.71%,KCNK2;KCNK5;KCNK13;KCNK3;KCNK12;KCNK1;KCNK6;KCNK4
prerank,MAP kinase kinase kinase activity (GO:0004709),0.6493649713490445,1.3530260882773002,0.13666666666666666,0.8963025811530769,1.0,5/11,19.78%,MAP3K5;MAP3K4;MAP3K13;MAP3K6;MAP3K1
prerank,sulfotransferase activity (GO:0008146),0.5314267986042951,1.3493346237332182,0.1325136612021858,0.8992263200302428,1.0,5/33,5.25%,UST;SULT1A1;CHST12;SULT2B1;CHST11
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.5179274606708899,1.3441893802835307,0.11583011583011583,0.909207472884089,1.0,17/35,20.21%,FOS;SMARCB1;PIH1D1;TAF1C;ZBTB17;UBTF;SMARCA4;MMP12;DR1;MYC;FOXP1;TBPL1;PARK7;H3-3A;TBP;SNAPC3;KLF10
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5469859537742965,-1.3436836495561824,0.14794520547945206,0.46839307589474055,1.0,7/11,29.11%,CFLAR;CASP9;CASP7;CASP4;CASP2;PYCARD;CASP1
prerank,GDP binding (GO:0019003),0.4821941315950245,1.3415189720422778,0.11057692307692307,0.9079564254759566,1.0,25/63,23.69%,RAB17;MRAS;RAP1B;RAP1A;RAB9B;ARL3;NRAS;KRAS;RHEB;RAB3B;RAB7A;RAB35;RAB5C;HRAS;RAP2C;RAB8B;DIRAS2;RAB9A;RAB27A;RAB10;MIEF1;GNAI3;ARL8B;RAB31;RAB21
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.6504967529896049,1.3406341479814627,0.15599343185550082,0.8987473803198908,1.0,7/10,25.22%,GFUS;DSE;GALE;FUOM;GNE;RPE;GLCE
prerank,voltage-gated potassium channel activity (GO:0005249),-0.3352500709672959,-1.3377227976927801,0.02631578947368421,0.472533944016323,1.0,22/80,22.91%,KCNK2;KCNT2;KCND2;KCNN2;PKD2;KCNQ4;KCNJ2;HCN2;KCNJ12;KCNJ6;KCNJ10;KCNC1;KCNMA1;KCNH5;KCNQ3;HCN1;KCNJ8;KCNJ15;KCNIP2;KCNB2;KCND1;KCNC3
prerank,phospholipase inhibitor activity (GO:0004859),0.6415264779150219,1.3359713703329534,0.18107667210440456,0.9065012959722943,1.0,4/10,15.26%,ANXA4;ANXA5;ANXA2;SNCB
prerank,metallocarboxypeptidase activity (GO:0004181),0.5443181346806123,1.3335470845297523,0.1467764060356653,0.9043979378666906,1.0,6/26,7.99%,CPB1;CPA4;CPA3;AGTPBP1;CPE;AGBL1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.4332733182664934,-1.329833471031587,0.13818181818181818,0.4813803479843239,1.0,7/25,6.98%,POR;FMO1;NOS3;MICAL3;FMO2;CYP26B1;FMO5
prerank,actin binding (GO:0003779),0.4324044828171793,1.3294032329290475,0.06533192834562697,0.9098534758444433,1.0,28/170,8.01%,SORBS1;UTRN;PHACTR1;PAWR;PDLIM5;CALD1;COBL;ABLIM1;PHACTR2;PARVA;DAG1;GSN;MICAL2;SSH3;EPS8L2;CXCR4;CORO7;MLPH;LMOD3;CAPZB;AVIL;TWF1;DMTN;ADD1;FLNB;ANG;MSRB2;MICAL1
prerank,double-stranded RNA binding (GO:0003725),0.46249285555321673,1.329128655354313,0.12075029308323564,0.8986769050691992,1.0,19/70,16.20%,MBNL1;STRBP;VIM;DGCR8;MTDH;TARBP2;MSN;SIDT2;EIF4B;ILF2;FXR1;DUS2;EIF4A1;APTX;ZFR2;TLR3;DHX9;OAS2;ZBP1
prerank,low-density lipoprotein particle binding (GO:0030169),0.5834600049511591,1.3262579069945546,0.17711598746081506,0.8987834780257093,1.0,2/16,1.19%,CDH13;LDLR
prerank,SUMO transferase activity (GO:0019789),0.589198200773161,1.325484955618392,0.17894736842105263,0.8902252969389121,1.0,7/16,14.97%,HDAC4;MUL1;NSMCE2;PIAS1;PIAS3;CBX4;MDM2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.5178687968023126,1.3235478484029986,0.1400560224089636,0.8869931728103526,1.0,7/32,15.97%,EGLN3;KDM4B;EGLN2;KDM4C;RIOX2;TET1;JMJD4
prerank,lipase activator activity (GO:0060229),0.6500509337162225,1.3179001547615181,0.17491749174917492,0.8988694110257961,1.0,1/10,1.40%,CCL5
prerank,sterol binding (GO:0032934),0.47971054890967435,1.3173898529702355,0.11931119311193111,0.8897134544689409,1.0,18/56,14.83%,RORC;SYP;SOAT1;OSBPL9;CAV1;STARD3;SULT2B1;CD81;ERLIN2;INSIG1;NPC1;VDAC2;ERLIN1;SOAT2;OSBPL7;STARD4;VDAC1;OSBPL5
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.5391954924415358,1.317247587629714,0.1404494382022472,0.879153094380163,1.0,3/26,6.61%,B3GALT1;B4GALNT2;CHPF
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5206000654530732,-1.3125182397407,0.14728682170542637,0.5126530104551974,1.0,4/12,5.07%,LTBP1;ENG;ACVRL1;BMPR1B
prerank,deubiquitinase activity (GO:0101005),0.4465659725124541,1.3103913662160034,0.11724137931034483,0.8958950986330249,1.0,27/88,18.64%,USP53;MINDY2;ZC3H12A;USP46;USP29;MINDY3;OTUD1;USP32;USP10;OTUD7B;DESI2;USP19;USP24;USP20;USP39;USP42;USP3;MINDY4;MPND;MYSM1;COPS5;USP28;OTUD6B;USP25;OTULIN;USP21;USP16
prerank,E-box binding (GO:0070888),-0.3835388179513948,-1.309822447373446,0.08620689655172414,0.5098200255011771,1.0,5/34,9.55%,TCF4;ZEB1;MITF;ATOH8;PPARG
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5932831441614563,1.3086172257674666,0.18808777429467086,0.8923043568779134,1.0,7/13,14.38%,SOX9;CSK;EZR;PKIA;GSK3A;GSK3B;PRKAR2A
prerank,hexosyltransferase activity (GO:0016758),0.44026450049440863,1.3077478122903898,0.10579064587973273,0.8850267041414935,1.0,18/101,12.70%,B3GALT1;B4GALNT2;OGT;HEXA;B4GAT1;TMTC1;A4GALT;GCNT2;LARGE1;CHPF;MTAP;EXT1;PIGZ;HEXB;ALG1;CHPF2;MGAT4C;ALG5
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.5750037081260616,1.3056729879200297,0.16043613707165108,0.8826482784945519,1.0,8/17,23.38%,DHCR7;SRD5A3;PECR;BLVRA;TM7SF2;DECR2;MECR;DECR1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.43169412828963016,-1.3050117230560272,0.1441717791411043,0.5116324212616871,1.0,11/21,9.70%,PDE7B;PDE3A;PDE8B;PDE8A;PDE4D;PDE3B;PDE4A;PDE10A;PDE4B;PDE9A;PDE2A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.5524542149028747,-1.304394183880492,0.15789473684210525,0.5037046826578833,1.0,7/10,36.26%,ADARB2;GDA;APOBEC1;CDA;ADA;DCTD;LACC1
prerank,protein tyrosine kinase activity (GO:0004713),-0.3201855086793286,-1.3022055022824703,0.03614457831325301,0.49974330691851393,1.0,32/108,13.47%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;LYN;PTK2;AXL;TIE1;KDR;BAZ1B;PDGFRA;EPHB2;EPHB4;BMX;PKDCC;NTRK2;ERBB4;JAK2;ROR2;FGFR2;KIT;RYK;ABL2;IGF1R;FGFR4;TYK2;FLT4;EPHA5;RET
prerank,cadherin binding (GO:0045296),0.4066717357932572,1.2965502342957906,0.043522267206477734,0.9090754592153634,1.0,59/315,12.26%,CDH1;PHLDB2;CDH13;BAIAP2L1;PLCB3;PDLIM5;CALD1;FMNL2;TJP2;TJP1;AHNAK;PARVA;STXBP6;TMOD3;NIBAN2;PKP4;NDRG1;MPRIP;ARHGAP18;EPS8L2;SH3GLB2;GPRC5A;CTNNA1;EHD1;PPP1R13L;TRIM25;SPTBN2;PFKP;S100A11;CAPZB;PAICS;PKM;TWF1;MRE11;ADD1;HCFC1;TES;CC2D1A;ANXA2;ANK3;FLNB;CHMP4B;GOLGA3;CLIC1;IQGAP1;PI4KA;BAG3;YWHAB;ABI1;EZR;PLEC;FASN;SPTAN1;YWHAZ;ARFIP2;CDH4;ARGLU1;EIF4G2;RPS26
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5033982636341205,-1.2952922338400639,0.16526610644257703,0.5063113095268351,1.0,5/12,21.18%,ENTPD1;CANT1;ENTPD3;ENTPD5;ENTPD6
prerank,phosphatase binding (GO:0019902),0.42817051285615315,1.2950093425976252,0.12181616832779624,0.9048257788924082,1.0,24/105,13.00%,NFATC2;MAP3K5;ANK1;MAGI2;GTF2F1;IKBKE;PPP6R3;AP3B1;CHCHD3;SH3RF2;TSC2;ROS1;PXN;BAD;IQGAP1;LGALS3;CRY2;MTMR3;JAK1;MVP;EIF2AK3;ELL;CARHSP1;ANAPC4
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.41771510636182474,-1.2939351442267846,0.12264150943396226,0.5003420345020113,1.0,11/23,9.70%,PDE7B;PDE3A;PDE8B;PDE8A;PDE4D;PDE3B;PDE4A;PDE10A;PDE4B;PDE9A;PDE2A
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5352944689973309,1.2911930890921615,0.17851959361393324,0.9095475387459274,1.0,4/23,1.60%,PLCB3;CHRM1;CCL5;PLCD3
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.6367625124199798,1.289944632534253,0.19269102990033224,0.894398044381371,1.0,2/10,5.50%,DUSP10;DUSP1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.6367625124199798,1.289944632534253,0.19269102990033224,0.894398044381371,1.0,2/10,5.50%,DUSP10;DUSP1
prerank,5'-3' exonuclease activity (GO:0008409),0.5775006389844246,1.2882152430249074,0.17884914463452567,0.8908438826248432,1.0,6/14,19.43%,FEN1;MRE11;XRN2;DCLRE1C;FAN1;DXO
prerank,general transcription initiation factor binding (GO:0140296),-0.4258350010863819,-1.2865519291389176,0.13395638629283488,0.5095537326364088,1.0,12/25,27.87%,AR;ESR1;TAF1B;RUVBL1;TAF12;THAP7;HHEX;AHR;GTF2A2;YEATS2;DRAP1;TAF1
prerank,protein kinase C activity (GO:0004697),0.572266350317402,1.2847295419561797,0.20303030303030303,0.8951829145509888,1.0,1/14,0.10%,PRKCB
prerank,nuclear receptor coactivator activity (GO:0030374),0.46284175257563986,1.2836072419730675,0.14658385093167703,0.8898977634074032,1.0,14/52,16.74%,PRKCB;CNOT6;PPARGC1A;NCOA3;MED30;ENY2;CALCOCO1;DCAF6;MED12;MED24;ACTN4;ZMIZ2;SFR1;KDM1A
prerank,deoxyribonuclease activity (GO:0004536),0.5911269833186664,1.275706065140026,0.1861198738170347,0.9135446818163296,1.0,9/14,26.93%,MRE11;DNASE1L2;ERCC5;MBD4;DNASE1L1;ERCC4;MAP1S;APEX1;RPS3
prerank,iron ion binding (GO:0005506),0.47555427940735334,1.2753299120521704,0.17691342534504392,0.9053859424501762,1.0,17/48,22.51%,EGLN3;HEPH;ALOX5;EGLN2;FDX1;KDM3A;CDO1;SCD5;ACO2;TET1;HAAO;ISCA2;TYW5;MELTF;PHF2;AOX1;FTO
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.5243900993348671,1.2750234560135871,0.19040697674418605,0.8968005040531576,1.0,9/22,22.87%,MINDY2;IKBKE;OTUD7B;TAB3;IKBKG;TAB2;PRPF8;RNF168;RNF169
prerank,nuclear localization sequence binding (GO:0008139),0.5540823321717018,1.2738443976777,0.20116618075801748,0.8918745671199305,1.0,9/18,17.59%,KPNA7;NFKBIA;TNPO2;KPNA4;BRAP;TNPO1;RANBP6;IPO4;KPNA1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5319232673473646,-1.2715055133039166,0.1875,0.5384113907457988,1.0,6/10,29.11%,CFLAR;CASP9;CASP7;CASP4;CASP2;CASP1
prerank,leucine zipper domain binding (GO:0043522),0.6222985919011279,1.2694935958551026,0.20358306188925082,0.9000271546542344,1.0,2/10,3.81%,PAWR;DAPK3
prerank,myosin II binding (GO:0045159),0.6257004615420343,1.2655862332024717,0.22750424448217318,0.9066088092600367,1.0,5/10,21.30%,GSN;LLGL2;MYL4;SHROOM4;LLGL1
prerank,lipoprotein particle binding (GO:0071813),0.5355096115006166,1.2634597646130046,0.22321428571428573,0.9056925904338335,1.0,2/20,1.19%,CDH13;LDLR
prerank,phosphatidic acid binding (GO:0070300),-0.4403416020237018,-1.2630968522081327,0.19298245614035087,0.5494660275601958,1.0,6/19,10.43%,MARK1;RAPGEF2;PLTP;SMPD3;GSDMD;GRAMD1B
prerank,phospholipase C activity (GO:0004629),0.5134336332283939,1.2566095804021185,0.20916905444126074,0.924214786744816,1.0,4/25,1.60%,PLCB3;CHRM1;CCL5;PLCD3
prerank,alkali metal ion binding (GO:0031420),0.5790986300766074,1.2556041607811956,0.24328593996840442,0.9188168770849331,1.0,2/13,4.16%,ATP1A2;HDAC4
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.6213677961879909,1.2539806661315689,0.22030981067125646,0.9163215428098579,1.0,4/10,19.72%,DAXX;PML;FAN1;IDE
prerank,FMN binding (GO:0010181),-0.5160382033875921,-1.2530107302804419,0.20671834625322996,0.5657678839582282,1.0,2/11,2.44%,POR;NOS3
prerank,ribosome binding (GO:0043022),0.45621703905621985,1.2511709630587362,0.16331658291457288,0.9184841744962301,1.0,24/46,25.52%,CPEB2;YTHDF1;ZC3H12A;EIF6;RPSA;MRPS27;NAA15;CPEB3;NAA10;PYM1;CCDC47;EEF2;TMEM147;YTHDF3;ETF1;GEMIN5;IGHMBP2;EFL1;GTPBP6;MAIP1;C1QBP;EIF2S1;EIF2A;NCLN
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5718553349134271,1.2496996941246425,0.2229299363057325,0.915378265655545,1.0,5/14,5.48%,COL4A3;NGF;TIMP4;TIMP1;TIMP2
prerank,fibroblast growth factor binding (GO:0017134),0.5254553188482275,1.248819345027361,0.20437956204379562,0.9101086582565217,1.0,2/21,1.46%,FGFR1;GPC1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.45356760868675916,-1.2486641974817463,0.16893732970027248,0.5667881620463825,1.0,8/15,18.21%,ALDH1A1;ALDH1A2;ALDH3A2;ALDH4A1;ALDH9A1;ALDH7A1;ALDH2;ALDH3B1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.6011856658760241,1.2473774695718916,0.24121405750798722,0.9073662004773144,1.0,4/11,13.13%,CNGA2;CNGB3;AQP1;CNGB1
prerank,peptidase inhibitor activity (GO:0030414),0.4866971989138398,1.2459387822840957,0.20457604306864063,0.904386026629937,1.0,6/33,7.43%,SLPI;SPINT2;TIMP1;TIMP2;PSMF1;GPC3
prerank,thiol-dependent deubiquitinase (GO:0004843),0.4271325041001029,1.2444889452227814,0.16840882694541232,0.9014333346146921,1.0,25/83,18.64%,USP53;ZC3H12A;USP46;USP29;MINDY3;OTUD1;USP32;USP10;OTUD7B;DESI2;USP19;USP24;USP20;USP39;USP42;USP3;MPND;MYSM1;COPS5;USP28;OTUD6B;USP25;OTULIN;USP21;USP16
prerank,alanine transmembrane transporter activity (GO:0022858),0.5869175258884757,1.2433566462179457,0.23510466988727857,0.8974092727024576,1.0,3/12,11.01%,SLC36A3;SLC36A4;SLC1A4
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4850753883556007,1.2428534313787365,0.2054794520547945,0.8911824065645785,1.0,9/34,8.44%,ARAP1;OGT;ANXA8;PHLDA3;ARAP2;FCHSD2;PLEKHB2;JPH2;IQGAP1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.4522726618697775,-1.242603467975205,0.19327731092436976,0.5732236076306466,1.0,8/15,24.08%,PIK3R1;SOCS5;PIK3R6;PIK3R3;PIK3R5;PIK3R2;SOCS3;CCKBR
prerank,acetylcholine receptor activity (GO:0015464),0.5224016443985655,1.240845216654411,0.21683309557774608,0.8908726375540871,1.0,1/22,0.76%,CHRM1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.2861720595581394,-1.2408352235357347,0.04,0.5686544390112487,1.0,40/147,14.69%,DOCK4;FARP1;PREX2;DENND4A;RAPGEF2;DENND5B;FGD5;VAV3;DENND1A;PLCE1;DOCK10;RASGRF2;ARHGEF28;RASGRP2;SH3BP5;RIC1;EIF2B3;RALGPS1;RABIF;DOCK8;FNIP1;SPATA13;ARHGEF15;RAB3IL1;RGL1;TIAM1;RIC8B;FGD3;WDR41;DENND2C;LAMTOR1;ALS2;ARHGEF2;RCC1;RASGEF1A;DENND4C;CCDC88C;RIC8A;RAPGEF6;EEF1B2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.5240150780335117,-1.2399889165929963,0.22337662337662337,0.5617329852369221,1.0,6/10,31.90%,SETD5;NSD1;NSD3;PRDM9;NSD2;SETD3
prerank,protein kinase regulator activity (GO:0019887),0.41560941662542705,1.2374471202487525,0.15706214689265538,0.8956001115938205,1.0,27/95,19.08%,FGF13;DAXX;PARVA;CDKN1A;WNT11;QARS1;GPRC5A;EPO;ITPRIP;CCND2;ELP4;YWHAB;GPRC5D;SMCR8;CCND1;CCNL2;DUS2;PRKAR2A;WNK1;DNAJC3;PPP1R1B;PRKAG1;HEXIM1;CCNG1;SH3BP5L;TAOK3;CAB39
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5392181987683311,1.2373028324055606,0.23958333333333334,0.8881510980119287,1.0,4/17,6.74%,PITPNM2;ATP10A;PITPNC1;ATP8B2
prerank,mRNA 3'-UTR binding (GO:0003730),0.4270721832646479,1.2370573872286132,0.1822429906542056,0.8813402366268477,1.0,22/79,18.60%,CELF2;PABPC4L;DDX5;CPEB2;ZC3H12A;CELF1;PABPC1L;YBX3;RBMS3;UTP23;CARHSP1;CPEB3;FXR1;RNPS1;DAZAP1;BOLL;AUH;MEX3D;IGF2BP1;IGF2BP2;RBMS2;IGF2BP3
prerank,calcium channel regulator activity (GO:0005246),-0.36637979717732594,-1.2356988520933414,0.17446808510638298,0.5633472777825784,1.0,9/37,12.55%,PRKG1;ITPR1;NRXN1;STIM1;SGK1;STIMATE;CACNG8;REM1;SLC30A1
prerank,phospholipase activator activity (GO:0016004),0.606612696474401,1.2339199322824466,0.24121405750798722,0.8852466731367952,1.0,1/10,1.40%,CCL5
prerank,metalloendopeptidase activity (GO:0004222),0.4290348677951512,1.2335465384155415,0.17090069284064666,0.8788792292424945,1.0,12/76,9.16%,THSD4;ADAMTS14;MMP9;ADAMTS7;ADAMTSL5;ADAM10;ADAM33;ADAMTS20;AFG3L2;ADAMTS1;PITRM1;ADAMTSL4
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5827474219138005,1.232899422341428,0.24044585987261147,0.8736606926471918,1.0,3/11,10.23%,ALDH3A1;DHRS13;AKR1B10
prerank,cell-cell adhesion mediator activity (GO:0098632),0.45785447894802783,1.231950712869585,0.1893644617380026,0.8694688724645601,1.0,7/42,6.89%,BAIAP2L1;PDLIM5;STXBP6;TMOD3;CD200;S100A11;ANXA2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5224356116227139,1.2314684091565997,0.22962962962962963,0.8638052481177756,1.0,5/20,12.30%,ABHD5;DGAT1;MOGAT3;MOGAT1;LPCAT2
prerank,GTPase activator activity (GO:0005096),-0.26610029026086013,-1.230851267714599,0.08333333333333333,0.5667460049460171,1.0,79/313,13.07%,PLCB1;DOCK4;FARP1;ALDH1A1;PREX2;DENND4A;ERRFI1;TBC1D4;ARHGAP28;ADGRB3;ARHGAP24;ARHGAP32;RAPGEF2;DENND5B;FGD5;ARHGAP20;RASGRP3;ASAP1;TBC1D12;CHN2;VAV3;DENND1A;PLCE1;DOCK10;RGS5;RASGRF2;RP2;ARHGEF28;CHN1;RASGRP2;RGS3;SH3BP5;RIC1;EIF2B3;SYDE2;ARHGAP22;RABGAP1L;TBC1D30;RALGPS1;RABIF;DOCK8;FNIP1;MTSS2;RALGAPA2;LRRK2;SPATA13;ARHGEF15;ELMOD2;RAB3IL1;RGL1;TIAM1;RIC8B;GARNL3;TBC1D14;SGSM3;ARRB1;FGD3;WDR41;NPRL3;NCKAP1L;TBC1D5;ARAP3;NF1;ELMOD1;DENND2C;STARD8;STXBP5L;LAMTOR1;PGAM5;ALS2;ARHGEF2;RCC1;TBC1D7;ACAP2;EVI5;RASGEF1A;DENND4C;IQGAP2;CCDC88C
prerank,metallopeptidase activity (GO:0008237),0.41482264255442763,1.2305504954168733,0.1705170517051705,0.8599067238287538,1.0,20/113,13.30%,ADAM12;THSD4;ADAMTS14;MMP9;ADAMTS7;ADAMTSL5;ADAM10;ADAM33;ADAMTS20;AFG3L2;ADAMTS1;PITRM1;ADAMTSL4;PSMD7;ADAM15;MMP12;MPND;MYSM1;COPS5;CHMP1A
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5028593653038239,1.2282957600440931,0.22753623188405797,0.8605075213890067,1.0,4/22,12.55%,CLU;APBB1;AP2A1;MESD
prerank,nuclear export signal receptor activity (GO:0005049),-0.5088971266111054,-1.2277691713547234,0.24054054054054055,0.5664334252963332,1.0,5/11,15.96%,XPO1;EIF4ENIF1;RAN;RANBP17;NUP214
prerank,vinculin binding (GO:0017166),0.5836595638659828,1.2215539005675382,0.245,0.8774171867750381,1.0,4/11,6.81%,UTRN;DAG1;CTNNA1;PXN
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5086418825384903,-1.2189837066839935,0.24675324675324675,0.5792865589844899,1.0,5/11,15.04%,LEF1;MBD2;GATA2;HMGA2;THAP7
prerank,MAP kinase phosphatase activity (GO:0033549),0.5809111338700069,1.2181800889922045,0.24919093851132687,0.8826340873232977,1.0,6/12,27.41%,DUSP10;DUSP1;DUSP3;DUSP16;DUSP29;DUSP8
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.5613201232442427,1.2178278413532113,0.2527131782945736,0.8767709100938457,1.0,5/13,15.89%,FEN1;DNASE1L2;DNASE1L1;ENDOV;FAN1
prerank,TBP-class protein binding (GO:0017025),-0.4250916749585126,-1.2175679798607704,0.1935483870967742,0.5742747785069103,1.0,10/21,27.87%,ESR1;TAF1B;RUVBL1;TAF12;HHEX;AHR;GTF2A2;YEATS2;DRAP1;TAF1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4274294283592746,-1.21712894239806,0.18823529411764706,0.559650643257613,1.0,3/16,0.43%,PTPRM;PTPRG;PTPRB
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4274294283592746,-1.21712894239806,0.18823529411764706,0.559650643257613,1.0,3/16,0.43%,PTPRM;PTPRG;PTPRB
prerank,bHLH transcription factor binding (GO:0043425),-0.4170192181298207,-1.2134600136350462,0.2204968944099379,0.5606009786297527,1.0,3/19,3.75%,FHL2;TCF12;LMO2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5720794534787425,1.2127810162850883,0.255700325732899,0.8878223146598903,1.0,4/12,14.85%,DHRS4;CRYZL1;NQO2;DCXR
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5755066739158884,1.2123326548687987,0.2682926829268293,0.8754430425240055,1.0,5/11,15.09%,BAG1;SIL1;BAG3;HSPBP1;HSPH1
prerank,adenyl nucleotide binding (GO:0030554),0.5755066739158884,1.2123326548687987,0.2682926829268293,0.8754430425240055,1.0,5/11,15.09%,BAG1;SIL1;BAG3;HSPBP1;HSPH1
prerank,solute:proton symporter activity (GO:0015295),0.5334455890299702,1.2102432133581484,0.24732824427480915,0.8762168903649242,1.0,5/16,16.28%,SLC36A3;SLC25A3;CTNS;SLC2A9;SLC11A2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5565600300161251,1.2094240745144187,0.24110032362459546,0.8723085722600766,1.0,2/13,7.87%,SREBF2;EHHADH
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5606558198876302,1.2068456062632285,0.26484751203852325,0.8746214713287165,1.0,8/12,23.70%,NAPSA;SPPL2B;HM13;BACE1;SPPL3;SPPL2A;DDI2;PSEN1
prerank,endonuclease activity (GO:0004519),0.4368870819219195,1.2034755664056982,0.23252858958068615,0.8797695444670888,1.0,12/49,14.04%,ZC3H12A;FEN1;KHNYN;RNASEL;MRE11;ANG;TSNAX;YBEY;LACTB2;ERCC5;MBD4;REXO4
prerank,secondary active transmembrane transporter activity (GO:0015291),0.44104296600964615,1.2008460817933904,0.2484700122399021,0.8824442573701577,1.0,13/51,16.72%,SLCO2A1;ANKH;SLC35D3;MCU;SLC25A3;SLC20A1;SLC16A2;CLCN4;SLC22A8;SLC25A14;SLC35E2B;SLC35E2A;SLC4A4
prerank,N-acyltransferase activity (GO:0016410),-0.37260544030479215,-1.2006830450293748,0.16532258064516128,0.5833545011822169,1.0,9/32,12.87%,TGM2;SAT1;NMT2;CERS4;PLAAT3;NAT10;SMARCE1;CERS5;CERS6
prerank,lipoprotein particle receptor binding (GO:0070325),0.47207977490962894,1.200147957469221,0.25587828492392806,0.8782616822836508,1.0,6/27,18.22%,CLU;APBB1;AP2A1;MESD;RELN;APBB3
prerank,protein kinase activator activity (GO:0030295),0.4194455005024951,1.1980411667085822,0.22195416164053075,0.8792775878672621,1.0,11/60,9.90%,FGF13;DAXX;CDKN1A;WNT11;GPRC5A;EPO;ERBB3;IQGAP1;GPRC5D;MAP2K2;ABI1
prerank,GABA receptor binding (GO:0050811),0.5684558355922925,1.1967856995972883,0.26504065040650404,0.8772418026574182,1.0,1/11,0.56%,PLCL2
prerank,amyloid-beta binding (GO:0001540),0.41078666125975144,1.1964498911510542,0.2152777777777778,0.8720602933232443,1.0,12/79,9.89%,CLU;COL25A1;LDLR;EPHA4;CACNA1A;ITM2C;PFDN1;CRYAB;TGFB2;FZD5;TLR6;APBB1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.42690047705369627,-1.1933857822525527,0.24770642201834864,0.5937997184000651,1.0,3/16,5.43%,SLC13A3;SLC1A5;SLC1A1
prerank,cholesterol binding (GO:0015485),0.44196867019250535,1.1895336467314255,0.24619289340101522,0.8895605627260859,1.0,15/47,14.83%,SYP;SOAT1;CAV1;STARD3;SULT2B1;CD81;ERLIN2;NPC1;VDAC2;ERLIN1;SOAT2;OSBPL7;STARD4;VDAC1;OSBPL5
prerank,phospholipase A2 activity (GO:0004623),0.48958241485940135,1.1895059160007722,0.2668500687757909,0.883208433111447,1.0,2/26,5.51%,PLB1;PLA2G12A
prerank,exoribonuclease activity (GO:0004532),0.5683919151902237,1.1872077551110538,0.2797427652733119,0.8843674812813795,1.0,3/12,8.52%,CNOT6;ZC3H12A;EXOSC3
prerank,neuropeptide hormone activity (GO:0005184),0.5028693032641207,1.1840278971475804,0.2720897615708275,0.8891719888816599,1.0,2/22,2.42%,GAL;PENK
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.5572502816417738,1.180255076446896,0.29204892966360857,0.895669778043845,1.0,6/13,21.56%,SLC66A1;SLC3A1;SLC7A6;SLC7A3;SLC38A7;SLC7A2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.496590304223135,-1.1792101464911227,0.2895377128953771,0.6199009504465979,1.0,3/10,9.75%,PRKAG2;PKIG;PRKAR2B
prerank,endopeptidase activity (GO:0004175),0.371795875421471,1.1777754101834357,0.16481294236602628,0.8977912861546548,1.0,29/257,10.43%,DPP4;THSD4;ADAMTS14;PIK3IP1;MMP9;ADAMTS7;ADAMTSL5;ADAM10;HPN;ADAM33;USP46;USP29;HP;HPR;PRSS12;USP10;PRSS36;GZMM;CTSZ;ADAMTS20;AFG3L2;ADAMTS1;PITRM1;PREP;ADAMTSL4;USP24;KLK1;USP20;USP42
prerank,endopeptidase inhibitor activity (GO:0004866),0.4035402321438691,1.1764064357111585,0.24018475750577367,0.8963955822354219,1.0,13/82,10.37%,COL4A3;SLPI;CRB2;SPINT2;NGF;TIMP4;SERPINC1;TIMP1;TIMP2;ANXA2;PSMF1;SERPINB8;CARD16
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.48187956118956166,1.173919704587323,0.27412587412587414,0.8983925382884599,1.0,6/24,9.97%,IP6K1;PMVK;CMPK1;PPIP5K2;AK5;AK3
prerank,ligand-gated anion channel activity (GO:0099095),0.5148293241484959,1.173733578156296,0.2816691505216095,0.8928089473907826,1.0,1/17,0.12%,CFTR
prerank,protein tyrosine kinase binding (GO:1990782),0.4104852018924333,1.171262945284436,0.2345078979343864,0.8949192537525679,1.0,7/71,4.13%,PITPNM2;ANGPT1;PTPN14;TJP2;EPHA4;PRR7;PITPNM3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.40681679678313754,-1.171198798844097,0.25449101796407186,0.6310118645212401,1.0,11/18,28.57%,PIK3R1;SOCS5;PIK3R6;PIK3R3;PIK3R5;PIK3R2;SOCS3;CCKBR;WDR81;AGAP2;SOCS1
prerank,nuclear receptor binding (GO:0016922),0.39445946440600566,1.1711299194658487,0.21238938053097345,0.8892520552216339,1.0,21/111,14.22%,PRKCB;DAXX;PPARGC1A;NCOA3;DDX5;EP300;LCOR;TGFB1I1;MED30;LATS1;TCF7L2;GAS2L1;BCAS3;KDM3A;SMARCA4;KDM4C;NCOR1;MED12;MED24;NCOR2;FOXP1
prerank,semaphorin receptor binding (GO:0030215),0.4779266854874424,1.1698856520781642,0.2801724137931034,0.88740182773519,1.0,3/23,2.82%,SEMA3D;PLXNB1;SEMA3B
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3714326234422366,1.1698281268796555,0.18106995884773663,0.8816335485223912,1.0,63/248,19.85%,CFTR;RAB17;CLU;DYNC1I1;MRAS;RAP1B;ABCD1;EEF1A1;KIF2A;RAP1A;SHOC1;RHOQ;KIF1C;NRAS;KRAS;RHEB;RAB3B;CDC42;RAB7A;GSPT2;GTPBP10;BMS1;TOR1A;RAB35;GNAO1;AGAP3;KLC1;GNAQ;GNA13;VPS4B;RHOA;RABL3;OPA1;CHD3;RHOU;SEPTIN9;RAB5C;ATL2;RAB1B;HRAS;GNG5;DNM1L;RAB33B;HSP90AA1;GPN1;DHX9;GNA11;ARHGDIB;RAP2C;ARL8A;EEF2;RAB8B;RAP1GAP;DIRAS2;MYO1E;HBS1L;KIF20B;RAB9A;RNF112;RHOT2;ABCB6;MYO18A;RAB27A
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.44333240886045244,-1.1654634607345675,0.2849604221635884,0.6363798807364452,1.0,5/13,9.85%,ALDH1A1;ALDH1A2;ALDH3A2;ALDH4A1;ALDH9A1
prerank,kinase inhibitor activity (GO:0019210),0.4583499461319986,1.1652172055037908,0.27951153324287653,0.8913492505063052,1.0,12/33,18.67%,PARVA;CDKN1A;QARS1;ITPRIP;YWHAB;SMCR8;DUS2;DNAJC3;PPP1R1B;HEXIM1;SH3BP5L;TAOK3
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3420470852158928,-1.1632259367243618,0.2033898305084746,0.6339681481815584,1.0,9/38,12.22%,PLA2G4A;HIP1;DENND1A;SH3PXD2B;DAB2IP;ZFYVE28;PLEKHA4;LANCL2;PLEKHF1
prerank,G protein-coupled receptor activity (GO:0004930),0.37076186174470915,1.1624225313829488,0.1926605504587156,0.8949516480468362,1.0,20/239,10.90%,ADRA1B;AGTR1;GPR4;LPAR1;OPN1SW;LPAR4;CXCR4;PROKR2;ADGRL2;ADGRD1;CCR10;CRHR2;GPR75;GRM2;LGR4;HCRTR1;ADGRG2;GPR63;ADGRG6;TPRA1
prerank,cGMP binding (GO:0030553),0.5566341017297529,1.1614311055235575,0.30337078651685395,0.8922201701552102,1.0,4/11,13.13%,PDE5A;CNGA2;CNGB3;CNGB1
prerank,solute:anion antiporter activity (GO:0140323),-0.442660336994581,-1.1583068521074376,0.2949061662198391,0.638573726827731,1.0,2/14,1.51%,SLC7A11;SLC26A7
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.4483490454855131,-1.1578278141204847,0.2955801104972376,0.6317710918972528,1.0,6/12,16.45%,PIK3CB;PIK3R6;PIK3CD;PIK3R3;PIK3C3;IPMK
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.41538827412534246,1.1577223447474616,0.2721518987341772,0.8989055173283534,1.0,21/57,21.62%,NDUFV1;NDUFB8;COX5A;COX8A;UQCRC1;NDUFB6;NDUFS3;COX7A2L;COX5B;NDUFB7;NDUFV2;NDUFA1;UQCR11;NDUFB4;UQCRH;NDUFB5;NDUFB9;COX4I1;COX10;NDUFA2;NDUFA12
prerank,manganese ion binding (GO:0030145),0.4174096165353217,1.1576788012083934,0.2723926380368098,0.8932109594585543,1.0,6/48,5.83%,FAM20C;MPPED2;FEN1;GALNT1;LARGE1;MGAT1
prerank,methyltransferase activity (GO:0008168),0.42655566004930423,1.1541146789169898,0.265,0.8991408391846721,1.0,19/46,27.59%,CARNMT1;NTMT1;BUD23;GAMT;NNMT;AMT;EEF1AKMT3;MEPCE;PRMT1;N6AMT1;COQ3;ARMT1;TRMT11;MGMT;EHMT1;FTSJ1;LRTOMT;EEF1AKMT2;NDUFAF7
prerank,hyaluronic acid binding (GO:0005540),0.5588651815611518,1.153772316429647,0.3260135135135135,0.8944768536552936,1.0,3/10,8.37%,CD44;IMPG1;STAB2
prerank,omega peptidase activity (GO:0008242),0.39336457072990083,1.1532627658847046,0.27335640138408307,0.8904948856969812,1.0,25/89,18.64%,USP53;ZC3H12A;USP46;USP29;MINDY3;OTUD1;USP32;USP10;OTUD7B;DESI2;USP19;USP24;USP20;USP39;USP42;USP3;MPND;MYSM1;COPS5;USP28;OTUD6B;USP25;OTULIN;USP21;USP16
prerank,poly-pyrimidine tract binding (GO:0008187),0.48128864260831894,1.1506249243325615,0.29555236728837875,0.8935201270937121,1.0,7/23,18.93%,PABPC4L;PABPC1L;RBMS3;DAZAP1;PATL1;RBMS2;PTBP1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.5306954154701523,1.142133578242674,0.3072100313479624,0.9169955413169922,1.0,6/12,21.33%,KDM4D;KDM4B;KDM3A;KDM4C;KDM1A;PHF2
prerank,epidermal growth factor receptor binding (GO:0005154),-0.36791114630383426,-1.141238848616535,0.2578397212543554,0.6657601927485476,1.0,13/25,26.83%,HIP1;TGFA;ERBB4;PLSCR1;LINGO1;GRB2;CNOT9;EGF;ATXN2;TNK2;FAM83B;FER;SNX1
prerank,calcium channel inhibitor activity (GO:0019855),-0.46055749273688196,-1.1396794577386116,0.30848329048843187,0.6616071111975567,1.0,4/11,16.89%,ITPR1;SLC30A1;PACSIN3;FKBP1A
prerank,"DNA binding, bending (GO:0008301)",-0.43898440760562124,-1.139378252041891,0.3018867924528302,0.6545815176624447,1.0,5/14,16.75%,LEF1;SAP30L;HMGA2;HMGB1;HHEX
prerank,endodeoxyribonuclease activity (GO:0004520),0.48761777193458694,1.1388789120785736,0.28810975609756095,0.9219493588485574,1.0,8/20,19.88%,FEN1;MRE11;ERCC5;MBD4;ENDOV;DCLRE1C;RAD50;ERCC4
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.46939658012651203,1.1372518082552874,0.3004484304932735,0.92171815954781,1.0,5/20,9.97%,TJP2;CMPK1;CASK;AK6;AK3
prerank,poly(U) RNA binding (GO:0008266),0.48454643995369273,1.135284228816946,0.31059506531204645,0.9222717556040771,1.0,6/20,17.95%,PABPC4L;PABPC1L;RBMS3;DAZAP1;PATL1;RBMS2
prerank,RNA stem-loop binding (GO:0035613),0.5224594183300663,1.1337373615389055,0.3305785123966942,0.9217048568456474,1.0,4/12,15.36%,ZC3H12A;EPRS1;CPEB3;DHX9
prerank,carboxy-lyase activity (GO:0016831),0.4681610262316781,1.133687983711122,0.311046511627907,0.9162306716124152,1.0,10/23,22.99%,ECHDC1;AZIN1;UMPS;CSAD;PPCDC;PCK2;PISD;GAD1;MLYCD;UXS1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.542990296920918,1.1329776907842233,0.32741935483870965,0.9129627950443421,1.0,2/11,11.96%,SLC25A47;SLC25A45
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.4377149259523756,1.131935630933539,0.3263157894736842,0.910731727091262,1.0,17/34,27.26%,EEF2KMT;DOT1L;SMYD3;EEF1AKMT3;SETDB1;SETD7;ANTKMT;SMYD1;KMT5A;ATPSCKMT;MEN1;KMT2E;N6AMT1;CAMKMT;EHMT1;SMYD2;EEF1AKMT2
prerank,damaged DNA binding (GO:0003684),0.424881797190323,1.1286655153635783,0.30247718383311606,0.915646806280816,1.0,15/44,19.88%,FEN1;EP300;CRY2;SDE2;ERCC5;RPA3;APTX;DCLRE1C;DDB1;PCNA;ERCC2;NBN;SMC6;PNKP;ERCC4
prerank,nuclear import signal receptor activity (GO:0061608),0.5122956806630505,1.1276229290148556,0.34150076569678406,0.9134144481578156,1.0,8/15,20.89%,KPNA7;TNPO2;KPNA4;TNPO1;RANBP6;IPO4;KPNA1;HIKESHI
prerank,tRNA binding (GO:0000049),0.4228771403047478,1.1249905530112942,0.3138500635324015,0.9167150667901351,1.0,22/43,24.51%,EEF1A1;FARS2;ELP5;AARS1;THG1L;MRPS27;PSTK;SARS1;SARS2;TRNT1;TRNAU1AP;CTU1;EIF2AK4;DARS2;TRMT10B;HSD17B10;TYW5;YARS2;IGHMBP2;NSUN6;KARS1;EIF2A
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3974499666329676,1.1202828468985053,0.3030998851894374,0.9268474326629128,1.0,17/75,14.85%,GFUS;ADH7;DHRS4;IMPDH2;HMGCR;ME3;LDHB;EHHADH;PHGDH;PGD;LDHAL6B;AKR1B10;HADHA;HSD17B11;MDH2;HADHB;DCXR
prerank,neuropeptide receptor binding (GO:0071855),0.5142206988638587,1.1186574787530756,0.35949764521193095,0.9266594397088006,1.0,1/14,1.41%,GAL
prerank,PDZ domain binding (GO:0030165),0.40116506457087836,1.1156769440126082,0.29782082324455206,0.9316173901112952,1.0,3/61,2.48%,CXADR;CFTR;CRIM1
prerank,semaphorin receptor activity (GO:0017154),0.5315390765490912,1.1147626705347042,0.34768740031897927,0.9290401313717419,1.0,5/11,15.86%,PLXNB1;PLXNA2;NRP2;PLXNB2;PLXNA3
prerank,histone deacetylase activity (GO:0004407),0.4780233617647195,1.1119082321015203,0.3226744186046512,0.9327981300255395,1.0,4/19,11.18%,HDAC5;HDAC4;HDAC3;MIER2
prerank,phospholipid transfer activity (GO:0120014),0.4607421345931684,1.110291951065461,0.3398496240601504,0.9326032286193495,1.0,3/21,6.46%,PITPNM2;PRELID3B;PITPNC1
prerank,mRNA methyltransferase activity (GO:0008174),-0.4399320083740583,-1.1090952963730345,0.3431952662721893,0.7261288440798084,1.0,3/12,10.84%,METTL8;METTL16;TRMT61B
prerank,protein kinase inhibitor activity (GO:0004860),0.41376084651609907,1.1074439534288951,0.3223350253807107,0.936728989134875,1.0,13/42,18.67%,PARVA;CDKN1A;QARS1;ITPRIP;YWHAB;SMCR8;DUS2;DNAJC3;PPP1R1B;HEXIM1;CAMK2N1;SH3BP5L;TAOK3
prerank,lipase activity (GO:0016298),0.4241226964728096,1.1058196836190861,0.3146496815286624,0.9367676673392485,1.0,4/43,5.06%,PLB1;ABHD5;PITPNM3;ABHD15
prerank,ATPase activator activity (GO:0001671),-0.3805723184714416,-1.1050738618829141,0.27848101265822783,0.7282648103278685,1.0,8/20,24.09%,ATP1B1;DNAJB4;DNAJC19;DNAJA1;DNAJB2;DNAJC1;DNAJB1;AHSA1
prerank,syntaxin-1 binding (GO:0017075),0.4720465131485633,1.1040239357996675,0.3390804597701149,0.9371365219676222,1.0,4/22,8.12%,UNC13C;SYP;DAPK1;STXBP1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.5171270030215495,1.1012691007290727,0.36622073578595316,0.940510281954341,1.0,2/11,10.18%,PPP1R14B;PPP1R11
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.45139986931356496,-1.1009629055899874,0.3475,0.7309532243683325,1.0,3/11,13.77%,ITPR1;MCOLN1;RYR2
prerank,phospholipase activity (GO:0004620),0.38941842080452294,1.1001034542040955,0.32514619883040935,0.9392361820635406,1.0,6/67,7.05%,PLB1;PLCB3;NAPEPLD;PITPNM3;PLA2G12A;PLCL1
prerank,antiporter activity (GO:0015297),0.4668979534950156,1.099441044573424,0.34941520467836257,0.9361851832894978,1.0,8/20,23.01%,SLC35D3;CLCN4;SLC25A14;SLC35E2B;SLC35E2A;ATP1A3;SLC35C2;SLC25A11
prerank,cation transmembrane transporter activity (GO:0008324),0.40393885735754886,1.0971733979346372,0.33456334563345635,0.938204218803571,1.0,18/48,22.51%,SLC36A3;SLC66A1;OCA2;SFXN3;SLC36A4;SFXN1;SLC25A38;SLC1A4;SLC41A1;PKD2L1;SLC6A7;SLC7A3;SLC8B1;SLC38A7;SLC38A6;SLC25A2;SLC7A2;MMGT1
prerank,transforming growth factor beta binding (GO:0050431),0.44817965125597986,1.0962715324918602,0.34388489208633094,0.9362877485489055,1.0,3/23,5.24%,CD109;TWSG1;LTBP4
prerank,RNA polymerase core enzyme binding (GO:0043175),0.435022044496158,1.0961319245070125,0.3622795115332429,0.9316383171179878,1.0,9/33,16.65%,NCOA3;ESRRB;ELP4;RPRD2;WDR43;ERCC5;DHX9;ELP2;SPTY2D1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.4393867047906066,-1.0951504844535283,0.3672922252010724,0.7373661256627002,1.0,6/12,19.79%,TENT5A;PAPOLA;PAPOLG;TENT5D;TENT2;PAPOLB
prerank,death receptor activity (GO:0005035),0.5320117210260668,1.0942995476430204,0.36245954692556637,0.9323821751007867,1.0,3/11,8.88%,EDA2R;TNFRSF10B;TNFRSF1A
prerank,CoA hydrolase activity (GO:0016289),0.4871050784087402,1.0933954925403664,0.37631184407796103,0.9301471750358425,1.0,2/16,2.69%,ACOT8;ABCD1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3407067258824954,-1.0931180537097949,0.29133858267716534,0.7349614377828114,1.0,4/29,5.43%,SLC13A3;SLC26A7;SLC1A5;SLC1A1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.46386381015777906,1.0911430977338081,0.3834048640915594,0.9324005409663567,1.0,4/22,10.08%,DUSP10;DUSP12;DUSP1;MTMR3
prerank,histone acetyltransferase activity (GO:0004402),0.42990972757176005,1.0907760909632498,0.34132581100141046,0.928719592464216,1.0,4/30,6.62%,NCOA3;EP300;NAA40;KAT6B
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.4569754542377153,-1.090325412570071,0.3542234332425068,0.7343323184214138,1.0,7/10,41.10%,DPYSL5;CAD;OPLAH;CRMP1;DPYS;DPEP1;DPYSL4
prerank,protein kinase binding (GO:0019901),0.34087575073048754,1.0900141918129118,0.25576730190571717,0.9262280782349894,1.0,117/479,18.20%,PRKCB;UTRN;ANK2;DAXX;PDLIM5;TJP2;TRIB2;EPHA4;CDKN1A;GRK5;ADAM10;EMP2;CAV1;NBEAL2;MAVS;HDAC5;EEF1A1;QARS1;PRR7;FOXO3;RELB;AP2A2;DUSP10;CAVIN2;HSPB1;PPP1R15A;PIH1D1;DUSP1;CAV2;RNF138;BCL2L1;FOXM1;SPRED3;SOX9;SHC1;PFKFB2;CSK;MSN;MAPK7;TRIM21;CCND2;SYN1;ILK;BAD;LATS1;ADCY6;SRCIN1;CDC42;FBXO5;TCF7L2;PKD1;IQGAP1;PARD6B;FZD5;PTPN6;ACSL3;OXSR1;LRBA;CDK5RAP1;DACT2;ACTB;SMCR8;CCND1;EZR;ZC3HC1;NELL2;EXOC2;SLC12A4;JTB;MVP;PKIA;RHOA;YWHAZ;AP2A1;PTN;PPP1CB;MAPKAP1;BCAR1;PTPN2;PPM1D;KCNA5;MAP3K13;GSK3A;VDAC1;TNIP1;SHC2;IRAK1;GSK3B;PRKAR2A;WNK1;CCDC88A;DNAJC3;TNNI3;HSP90AA1;RB1CC1;ITGB2;PRKCSH;FAM83H;EEF2;AP1B1;ABL1;CRK;PRKAG1;ARHGAP33;NSF;SUFU;CDKN2D;MAPKAPK2;CDC25B;CHEK2;MTCP1;DUSP3;CDH5;PTPN11;USF1;CAMK2N1;ATF2
prerank,cytokine receptor activity (GO:0004896),0.37295459785070884,1.08997596862983,0.3414351851851852,0.921484435271667,1.0,10/83,6.03%,CD44;CRLF1;CCR4;IL17RE;IL17RA;IL3RA;ACKR2;ACKR4;GFRA3;CCRL2
prerank,lysophospholipase activity (GO:0004622),0.46620392109537206,1.0845449444956687,0.3722627737226277,0.9332664456310507,1.0,1/20,0.17%,PLB1
prerank,retinoid binding (GO:0005501),-0.36461977911940346,-1.0841662231337046,0.3425925925925926,0.7426865094058701,1.0,3/22,4.96%,ALDH1A2;NR2F2;CYP26B1
prerank,heme binding (GO:0020037),-0.2863019097114516,-1.0809980104447445,0.3105590062111801,0.742698170263427,1.0,14/65,10.29%,GUCY1B1;NOS3;PTGIS;FLVCR2;NOX4;CYP26B1;CYP1B1;PTGS2;PGRMC2;HEBP1;JAK2;COX15;RSAD1;SDHC
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.40417124882884314,1.0791194612619819,0.35370611183355005,0.9451543059385582,1.0,5/38,8.55%,SLPI;SPINT2;SERPINC1;ANXA2;SERPINB8
prerank,voltage-gated anion channel activity (GO:0008308),0.4779199646769593,1.0785737391574106,0.3630862329803328,0.9420091075148481,1.0,6/15,15.44%,VDAC2;CLCN4;ANO6;VDAC1;GPR89B;GPR89A
prerank,phosphatase activator activity (GO:0019211),0.48913725792726714,1.0779495650509578,0.3778801843317972,0.9390660008690573,1.0,2/14,5.06%,GTF2F1;PPP1R15A
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.509618657883892,1.0761225302016737,0.3782467532467532,0.9400456402340001,1.0,4/11,14.15%,NAA40;NAA15;NAA20;NAA10
prerank,steroid hydroxylase activity (GO:0008395),-0.39307252102978807,-1.0725894567507497,0.3292307692307692,0.7567239895958547,1.0,6/16,28.60%,CYP7B1;CYP1B1;CYP2A6;CYP2S1;CYP27A1;CYP46A1
prerank,ribonuclease activity (GO:0004540),0.3815909582925671,1.07162564576114,0.37344913151364767,0.9494527827498672,1.0,10/56,10.51%,CNOT6;ZC3H12A;KHNYN;RNASEL;ANG;TSNAX;EXOSC3;YBEY;RNASE3;LACTB2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.4189913452549619,-1.0649946338218739,0.38309859154929576,0.7684278000283568,1.0,7/13,21.92%,TARBP1;METTL1;TRMT10A;TRMT5;THUMPD2;TRMT1L;TRMT10C
prerank,ligand-gated calcium channel activity (GO:0099604),-0.36522713210138,-1.064800623611425,0.35403726708074534,0.760837009390499,1.0,4/19,7.75%,ITPR1;GRIN2A;GRIN2B;MCOLN1
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.358276449692477,-1.064326424548992,0.3516819571865443,0.754190641631043,1.0,5/20,12.55%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,guanyl ribonucleotide binding (GO:0032561),0.3417418153907743,1.0637774455669722,0.3746130030959752,0.9690020701218034,1.0,42/196,16.98%,RAB17;PDE5A;MPPED2;MRAS;RAP1B;EEF1A1;RAP1A;RAB9B;ARL4A;CNGA2;ARL3;RHOQ;NRAS;KRAS;EIF2B2;RHEB;GLUD1;CNGB3;RAB3B;CDC42;RAB7A;ARHGEF5;GTPBP10;THG1L;BMS1;RAB35;RHOA;ARFIP2;RABL3;CNGB1;ARF4;RHOU;TUBB2B;RAB5C;ATL2;RAB1B;HRAS;RAP2C;ARL8A;RAB8B;ADSS2;DIRAS2
prerank,chemoattractant activity (GO:0042056),0.4336891320293263,1.0632149000181004,0.37052341597796146,0.9659921671992071,1.0,5/26,8.83%,CCL5;GDNF;BMP4;LGALS3;VEGFB
prerank,titin binding (GO:0031432),0.4866916412883288,1.0627723381081966,0.3803680981595092,0.9624260819785795,1.0,1/13,1.08%,ACTN2
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.3900706052018276,-1.0627527361140972,0.3937677053824363,0.7504412411798271,1.0,8/15,38.01%,P2RY14;P2RY1;P2RY12;PTAFR;GPR34;P2RX3;P2RX5;P2RX6
prerank,monocarboxylic acid binding (GO:0033293),0.4570084248102793,1.0609382518879196,0.3987823439878234,0.9633492120655436,1.0,1/18,0.89%,NAPEPLD
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.3531731640836068,-1.0606805420543595,0.3674698795180723,0.7480418140529632,1.0,8/21,38.01%,GRIK2;GLRB;CHRNB1;CHRNA4;CHRNB2;P2RX3;P2RX5;P2RX6
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.5019516686165689,1.0588320893532837,0.4130781499202552,0.9649082650325347,1.0,1/12,0.79%,CYFIP2
prerank,phosphate ion binding (GO:0042301),-0.4401752290778988,-1.0582628957355802,0.37626262626262624,0.7467786289031326,1.0,4/10,21.18%,RPH3A;PDE2A;PNP;ADSS1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.362381127505621,-1.0565656281584725,0.36245954692556637,0.7438498879191594,1.0,14/21,52.77%,GRM5;GRM1;CHRNB1;ANXA9;CHRNA4;CHRNB2;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3;DRD5;CHRNA1
prerank,carbohydrate kinase activity (GO:0019200),0.496932326816599,1.05557576318615,0.40901771336553944,0.97007623069481,1.0,4/11,16.85%,NAGK;HK1;GALK2;GNE
prerank,LRR domain binding (GO:0030275),0.4844094219353244,1.0548983445442932,0.39939024390243905,0.9671892201698967,1.0,4/14,14.35%,PAWR;DAPK3;LRRFIP2;ZXDC
prerank,sequence-specific mRNA binding (GO:1990825),-0.44038807805109625,-1.0542399992585558,0.4152744630071599,0.7423044541496233,1.0,6/10,27.32%,DHFR;SHFL;LARP6;TYMS;FMR1;RBM24
prerank,glutamate receptor binding (GO:0035254),-0.36924658272803146,-1.0523339245566359,0.3888888888888889,0.7399900910789511,1.0,4/17,4.78%,HIP1;GNAS;SHANK3;SHISA6
prerank,RNA polymerase II complex binding (GO:0000993),0.4166652642977683,1.0523269844275753,0.4128065395095368,0.9702760181575275,1.0,8/32,15.55%,NCOA3;ESRRB;ELP4;RPRD2;WDR43;ERCC5;DHX9;ELP2
prerank,lysine N-methyltransferase activity (GO:0016278),0.4480946427856708,1.050525506966829,0.4124629080118694,0.9707588280393726,1.0,9/20,27.26%,EEF2KMT;EEF1AKMT3;SETD7;ANTKMT;KMT5A;ATPSCKMT;EHMT1;SMYD2;EEF1AKMT2
prerank,glycerophospholipid flippase activity (GO:0140333),0.49945305821694785,1.0500363684416691,0.4276422764227642,0.9674602487264606,1.0,2/11,6.74%,ATP10A;ATP8B2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.4951961434261042,1.0495556042636525,0.441747572815534,0.9641164431956524,1.0,4/12,19.64%,FOS;TBPL1;H3-3A;TBP
prerank,histone methyltransferase activity (GO:0042054),0.4127015921559517,1.0481092387157638,0.4151967435549525,0.9640656400908199,1.0,15/32,25.77%,NTMT1;DOT1L;SMYD3;SETDB1;PRMT1;PRMT2;SETD7;SMYD1;KMT5A;MEN1;KMT2E;KMT2C;N6AMT1;EHMT1;SMYD2
prerank,CCR chemokine receptor binding (GO:0048020),0.4157286069642147,1.0478314049715622,0.38472222222222224,0.96035010153695,1.0,2/28,6.03%,CCL5;CCRL2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.3628527874956066,1.0451545309345474,0.3950762016412661,0.9638277441525483,1.0,17/72,12.19%,ACTN2;STXBP6;VILL;ANXA8;GSN;AMER3;PHLDA3;AMER2;AVIL;TWF1;ANXA2;KRIT1;JPH2;RAB35;SNX18;GSDME;MAPKAP1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4327247365959814,1.0445818817136463,0.44216691068814057,0.9610325355454552,1.0,5/24,6.27%,MKNK2;PTK2B;DAPK1;PHKA2;CAMKK1
prerank,active ion transmembrane transporter activity (GO:0022853),0.399860047437609,1.0444740068368301,0.4119170984455959,0.9567910663669636,1.0,8/37,11.64%,SLCO2A1;ATP13A3;COX5A;COX8A;UQCRC1;COX7A2L;COX5B;SLC22A8
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.503036599799254,1.044356143484596,0.43812709030100333,0.9526409340008974,1.0,5/11,16.96%,RBX1;UBR5;UBE4A;PRPF19;STUB1
prerank,gated channel activity (GO:0022836),0.46993653344081027,1.0424795498376833,0.41883116883116883,0.9536565985212615,1.0,6/14,21.13%,TMC6;TMC2;PACC1;TMEM63B;TMEM266;TMC4
prerank,protein phosphatase inhibitor activity (GO:0004864),0.41184521426306225,1.0413831914301175,0.4177215189873418,0.9524174228212311,1.0,7/26,15.21%,PPP1R14B;LGALS3;LMTK2;PPP1R11;PTN;SET;PPP1R1B
prerank,microtubule binding (GO:0008017),0.3311200529728498,1.0411078639108857,0.41597510373443985,0.9488115735017714,1.0,48/222,19.23%,FGF13;MAPRE2;RP1;DYNC1I1;FMN1;NDRG1;NDEL1;KIF2A;KIF13A;GJB6;REEP3;MAP6;ARL3;KIF1C;PSRC1;EML2;KIF1B;MAP4;CLIP4;KRIT1;CETN3;CCDC181;CHP1;GAS2L1;HOOK1;HDGFL3;EZR;PAFAH1B1;MARK4;ABRAXAS1;OPA1;TPGS1;GAPDH;CCDC88A;DNM1L;MAP1LC3B;REEP4;CAMSAP1;KIF17;RAE1;NUMA1;RMDN3;HDAC6;SUN2;FHDC1;KIF20B;HOOK3;TUBGCP5
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.37464150307252464,1.0397099053656533,0.4057788944723618,0.9483691621029956,1.0,16/49,23.02%,MINDY2;IKBKE;OTUD7B;PSMD4;TAB3;AGAP3;ABRAXAS1;TNIP1;ZFAND6;IKBKG;HDAC6;TAB2;PRPF8;RNF168;RNF169;UBQLN2
prerank,acylglycerol lipase activity (GO:0047372),-0.4198518967595209,-1.0394201927405533,0.39800995024875624,0.7654612858322247,1.0,5/11,17.14%,ABHD3;MGLL;LIPE;ABHD12;ABHD2
prerank,nuclease activity (GO:0004518),0.377513412068608,1.039238083495306,0.3973105134474328,0.9454006148257387,1.0,13/52,17.39%,ZC3H12A;FEN1;RNASEL;MRE11;ANG;XRN2;DNASE1L2;RNASE3;ERCC5;DNASE1L1;REXO4;RNASE4;RNASE7
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.47895345863760896,1.038110109111894,0.41896024464831805,0.9442855340983554,1.0,4/13,15.53%,SH3BP4;ITGB1BP1;CCDC88A;ARHGDIB
prerank,calcium-release channel activity (GO:0015278),0.45938294921642936,1.0359823314785706,0.42701863354037267,0.9461094270542404,1.0,5/17,13.39%,ITPR2;TPCN1;ITPR3;RASA3;TRPM2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.34471128702062515,-1.035604041231463,0.3758169934640523,0.7676041992094712,1.0,5/23,8.03%,HIP1;SH3PXD2B;CLVS2;SNX14;PLEKHA4
prerank,adenylate cyclase binding (GO:0008179),-0.42038387612840394,-1.0355651238961958,0.42355889724310775,0.7603799493294393,1.0,2/10,7.10%,ADCY5;CAP2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.4217092012512181,-1.035165902672977,0.44235924932975873,0.7542224885006007,1.0,6/12,19.18%,PIK3R1;SH2B3;GAB2;BLNK;SH2B2;TRADD
prerank,potassium channel regulator activity (GO:0015459),-0.2827110606920469,-1.033487724354048,0.35185185185185186,0.7516227102428449,1.0,10/49,16.58%,DPP10;SGK1;ABCC9;KCNIP4;WNK2;KCNIP3;KCNIP1;DPP6;KCNMB4;SLC5A3
prerank,snRNA binding (GO:0017069),0.3868539956547169,1.0330179286475687,0.40583554376657827,0.9504081490679828,1.0,12/42,22.55%,LSM10;SNRNP70;LARP7;LSM4;DDX39B;SF3B3;MEPCE;HEXIM1;PRPF8;TUT1;GEMIN5;CDK9
prerank,voltage-gated ion channel activity (GO:0005244),-0.3893998316302876,-1.032323978290506,0.43137254901960786,0.7476452857426056,1.0,4/14,6.87%,KCND2;CACNA1E;PKD2;VDAC3
prerank,syntaxin binding (GO:0019905),0.3722358146511315,1.0296175726421264,0.42788461538461536,0.9562227072186263,1.0,19/61,17.72%,UNC13C;CACNA1A;SYP;BLOC1S6;DAPK1;STXBP1;VPS54;VPS11;PTPN2;NAPA;NAPB;VPS18;VPS52;SYT6;STX16;SYT12;ABL1;NSF;VAMP1
prerank,Notch binding (GO:0005112),-0.34685574225257626,-1.0295956214439113,0.3839541547277937,0.7473787996650049,1.0,6/22,13.22%,JAG1;MEGF10;DTX1;JAG2;NOTCH4;CCN3
prerank,endoribonuclease activity (GO:0004521),0.39859294585517985,1.0289516533724106,0.4269503546099291,0.9538177659846001,1.0,7/32,14.16%,ZC3H12A;KHNYN;RNASEL;TSNAX;YBEY;LACTB2;ENDOV
prerank,ribosomal large subunit binding (GO:0043023),0.4900671587333254,1.0287434295047573,0.42598684210526316,0.9501696903119742,1.0,3/11,9.92%,CPEB2;EIF6;LTN1
prerank,beta-tubulin binding (GO:0048487),0.4002799955819332,1.027527595296488,0.42718446601941745,0.9494842890808229,1.0,2/31,3.68%,FGF13;GJB6
prerank,H4 histone acetyltransferase activity (GO:0010485),0.5028761033425108,1.027296629429705,0.4431239388794567,0.9457861629049298,1.0,5/10,21.81%,EP300;NAA40;ATF2;USP22;HAT1
prerank,leak channel activity (GO:0022840),-0.36950439949601527,-1.0269541476881652,0.4176470588235294,0.7470622620505964,1.0,3/18,8.24%,KCNK2;KCNK5;PANX1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.31833819344305536,1.0268476870843979,0.398,0.9429642661612676,1.0,117/732,14.26%,NFATC2;ZBTB7C;KLF5;NR3C2;THRB;FOXN3;TBR1;TFAP2C;KLF4;PBX3;PBX1;ZIC4;KLF3;DMRT2;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;FOXP4;KLF12;HDAC5;ZFHX4;ZNF692;MXD4;CC2D1B;FOXO3;FOS;RELB;MGA;FOXC2;SP5;GLIS2;ZNF219;KLF16;HDAC4;NFE2L2;NR6A1;ZBTB16;NFE2L1;NACC1;POU2F3;FOXD2;PRRX2;ESRRB;RARG;RFX7;IRF3;NKX2-8;PATZ1;JUND;OVOL2;CREB1;ZIK1;ZBTB17;RXRB;HOXA5;ZIC2;SOX9;NRF1;FOXD1;ZBTB7B;CC2D1A;MEF2D;KLF7;STAT4;ZNF418;ZFHX3;ZNF471;SIX1;TCF7L2;MAZ;POU3F1;JUN;POU5F2;GRHL2;FOXP3;ZIC1;NR2C1;DNMT3A;PRDM15;NFE2L3;ZNF467;ZNF205;NFIB;NFYC;NFIC;CREB3L4;CREB3;SP2;MYT1;CALCOCO1;MAFG;HOXB5;MEF2B;KDM6A;MAFK;ZNF148;SP1;ZBTB42;MED8;FOXK1;ZSCAN20;TFEB;MYBL1;GATA3;ZFP30;RREB1;NFIA;MYC;ZFP1;MEF2C;ZFP92;FOXP1;PAX3;SARS1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.39698538047325865,1.026700024074887,0.4198895027624309,0.935229666500196,1.0,12/34,21.62%,NDUFV1;NDUFB8;NDUFB6;NDUFS3;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFB5;NDUFB9;NDUFA2;NDUFA12
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.39698538047325865,1.026700024074887,0.4198895027624309,0.935229666500196,1.0,12/34,21.62%,NDUFV1;NDUFB8;NDUFB6;NDUFS3;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFB5;NDUFB9;NDUFA2;NDUFA12
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.4246458658454837,-1.0253906040459866,0.4320388349514563,0.7441582575698358,1.0,3/10,21.42%,NOX4;NCF2;CYBB
prerank,hydro-lyase activity (GO:0016836),0.38552449746101086,1.023019731027025,0.41589403973509936,0.9416668917107907,1.0,13/41,20.93%,ECHDC1;UROS;EHHADH;ENO2;HACD4;HADHA;ACO2;AUH;HADHB;ECHS1;PARK7;APIP;ACO1
prerank,acetylation-dependent protein binding (GO:0140033),0.4421104985238111,1.021360983699799,0.4446064139941691,0.9380074433453983,1.0,7/20,18.26%,MLLT3;KMT2A;BRD7;DPF2;SMARCA4;BRDT;BRD9
prerank,lysine-acetylated histone binding (GO:0070577),0.4421104985238111,1.021360983699799,0.4446064139941691,0.9380074433453983,1.0,7/20,18.26%,MLLT3;KMT2A;BRD7;DPF2;SMARCA4;BRDT;BRD9
prerank,retinoid X receptor binding (GO:0046965),-0.42197246400225746,-1.0210360954515527,0.422279792746114,0.7484051081560142,1.0,6/11,27.07%,TACC1;NSD1;PPARG;NR4A2;NRIP1;MED25
prerank,Hsp90 protein binding (GO:0051879),-0.3053913715675496,-1.020127576108919,0.4166666666666667,0.7441066637685891,1.0,7/33,9.03%,PACRG;HIF1A;KDR;TSC1;SLC12A2;NPAS2;HSF1
prerank,diacylglycerol kinase activity (GO:0004143),-0.4095723063406436,-1.0193196245147005,0.41414141414141414,0.7396011211561916,1.0,7/11,23.18%,DGKH;DGKB;DGKI;DGKG;DGKZ;DGKQ;DGKK
prerank,ion channel inhibitor activity (GO:0008200),0.390484944273213,1.0161167860846088,0.43915343915343913,0.9486221461630993,1.0,7/35,15.32%,CFTR;MCUB;VTI1B;RASA1;NEDD4;WNK1;TNNI3
prerank,exonuclease activity (GO:0004527),0.38047590245869745,1.0160188187787427,0.4716981132075472,0.9448495336416237,1.0,13/46,20.42%,CNOT6;ZC3H12A;FEN1;MRE11;EXOSC3;XRN2;POLG;REXO4;DCLRE1C;FAN1;RAD50;DXO;APEX2
prerank,RNA binding (GO:0003723),0.31447482812112604,1.0158645370369066,0.415,0.9412745604935984,1.0,324/1321,20.23%,MBNL1;MSI2;NUDT4;CELF2;NSA2;PPARGC1A;STRBP;AHNAK;VIM;LSM10;PABPC4L;SAMD4A;GTF2F1;DDX5;CPEB2;YTHDF1;ZC3H12A;SRSF2;GRWD1;SLPI;CELF1;SAMD4B;PABPC1L;EEF1A1;DGCR8;PEF1;EPRS1;CDC42EP4;DIAPH1;RBFOX2;CMSS1;CTNNA1;NOP2;ACIN1;PCDH20;MRPL37;MRPL2;PES1;YBX3;RBM19;PPAN;BUD23;ADK;HSPB1;TRIM25;DMGDH;FARS2;MTDH;UTP11;SON;KHNYN;FDPS;SNRNP70;CCDC9;TARBP2;SNRPB;UNK;RPS4X;EIF3L;SLTM;USP10;KIF1C;RBMS3;POLR2A;PKM;MRPS7;MOV10;SRRM2;RNASEL;SUCLG1;ADD1;TES;PSMD4;MSN;ANXA2;EIF4A3;MAP4;SLIRP;UTP23;SMG7;FLNB;SSRP1;RBM20;MAK16;SIDT2;DHX32;PRRC2C;NKAP;UNC50;ANG;KRR1;RPSA;RALY;POP4;STXBP1;TSNAX;LARP7;LSM4;MAZ;LGALS3;ABCF1;L1TD1;EXOSC3;JUN;UBTF;POP1;DDX39B;ELP5;XRN2;HNRNPH2;RBM8A;RPL31;EIF4B;MYO5A;RPL22;SUMO2;GSPT2;ERI3;AGFG1;GTPBP10;MOV10L1;WDR33;PHF5A;AARS1;THG1L;DBR1;MRPS23;ILF2;NIP7;EZR;LUC7L3;BMS1;RRP12;MTREX;DHX57;MRPS27;LACTB2;SRPK2;WDR36;KHDC4;DDX55;PLEC;HABP4;R3HDM2;WDR43;SRRM4;FASN;TBRG4;ZMAT3;ZCCHC24;RPL28;ANKRD17;PWP2;CSNK1E;MDH2;SRSF7;YWHAZ;SF3A2;SRBD1;DDX47;RBM46;ZCCHC8;SYNCRIP;WDR6;EIF4G2;NAA15;PSTK;POLDIP3;RPS26;RBM42;MRPL9;HNRNPUL1;RPP21;FAM133B;CCDC9B;SRPK1;GPATCH1;RBM10;TUT7;GOLGB1;CPEB3;CHD3;GAR1;FRG1;IBA57;PINX1;FXR1;CSTF1;LGALS1;RNPS1;NOC4L;DAZAP1;YARS1;PNN;R3HDM1;HARS2;TPD52L2;NOL6;TNPO1;RPL10A;FNDC3A;RRP9;SRSF9;REXO4;DCP1A;ENDOV;LTA4H;SRRT;EIF4G1;SARS1;SARS2;DUS2;RRBP1;RPF1;UPF3B;HADHB;MRPS15;EIF4A1;TRNT1;ALDOA;RBM18;APTX;DDX18;ZFR2;GRSF1;EIF5B;PYM1;UTP14A;RBM47;TLR3;UTP4;MBNL2;HSP90AA1;DHX9;TRNAU1AP;ISY1;FBRSL1;RPL14;LUC7L2;SELENOH;ACTN4;OAS2;IMP4;PABPN1;IMMT;CCDC47;EIF3B;FLNA;CWC15;FSCN1;DUSP11;MEPCE;CDC5L;CANX;MEX3D;UBE2N;ZBP1;IGF2BP1;RBPMS2;MRPS28;MRPS35;DYNC1H1;MAGOHB;MAGOH;ATXN2L;ARHGEF1;EEF2;RBM28;KDM1A;CTU1;PRR3;EIF1;UBC;RPS27A;HEXIM1;ASS1;IGF2BP2;PRPF40B;EIF2AK4;PRMT1;ZYX;RAE1;PRPF6;FARSA;CLUH;PATL1;ALDH18A1;EIF4A2;SEC23IP;RBMS2;PDCD11;SRSF1;YTHDF3;PARK7;PPP1R10;UBAP2L;ROCK2;IGF2BP3;IMP3;HNRNPA3;TRUB2;UBFD1;PTBP1;SNUPN;RPL6;SRSF5;DARS2;NUCKS1;DXO;TRMT10B;ANKHD1;PCBP2;CDK11B;MYO18A;HDGF;CSTF3;GCN1;DDX20;RPS28;MAPT;WBP4;SF3A3;ETF1;HSD17B10
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.3783957976301425,-1.013423720704498,0.46511627906976744,0.7472074599451608,1.0,1/15,0.46%,PLA2G4A
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3211611016866358,1.0125940152516253,0.470648815653965,0.9462503591605073,1.0,63/269,18.41%,CLU;DAXX;PPARGC1A;TRIB2;CDKN1A;SMAD6;FHIT;IKBKE;CXCR4;PRR7;BAG1;ERLIN2;NFKBIA;PATZ1;ELOB;POLR2A;DDRGK1;MUL1;ERBB3;UQCRC1;SLC22A18;FZD5;RBX1;JUN;PML;SUMO2;SUMO3;UBE2B;APBB1;JAK1;ACTG1;HSPBP1;YWHAZ;UBXN7;NPLOC4;GSK3B;PRKAR2A;WASHC1;DNM1L;MDM2;MAP1LC3B;SYT11;HSP90AA1;CCDC50;RNF31;IKBKG;HM13;UBE2N;TPI1;UBE2J1;UBC;RPS27A;VCL;SMAD5;STUB1;SMC6;CHEK2;HDAC6;USP25;STAM;PSMD1;TSG101;TRIM37
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.31352849843991903,1.0122972974452185,0.458,0.9431457547940892,1.0,117/731,14.26%,NFATC2;ZBTB7C;KLF5;NR3C2;THRB;TBR1;TFAP2C;KLF4;PBX3;PBX1;ZIC4;KLF3;DMRT2;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;FOXP4;KLF12;HDAC5;ZFHX4;ZNF692;MXD4;CC2D1B;FOXO3;FOS;RELB;MGA;FOXC2;SP5;GLIS2;ZNF219;KLF16;HDAC4;NFE2L2;NR6A1;ZBTB16;NFE2L1;NACC1;POU2F3;FOXD2;PRRX2;ESRRB;RARG;RFX7;IRF3;NKX2-8;PATZ1;JUND;OVOL2;CREB1;ZIK1;ZBTB17;RXRB;HOXA5;ZIC2;SOX9;NRF1;FOXD1;ZBTB7B;CC2D1A;MEF2D;KLF7;STAT4;ZNF418;ZFHX3;ZNF471;SIX1;TCF7L2;MAZ;POU3F1;JUN;POU5F2;GRHL2;FOXP3;ZIC1;NR2C1;DNMT3A;PRDM15;NFE2L3;ZNF467;TWIST1;ZNF205;NFIB;NFYC;NFIC;CREB3L4;CREB3;SP2;MYT1;CALCOCO1;MAFG;HOXB5;MEF2B;KDM6A;MAFK;ZNF148;SP1;ZBTB42;MED8;FOXK1;ZSCAN20;TFEB;MYBL1;GATA3;ZFP30;RREB1;NFIA;MYC;ZFP1;MEF2C;ZFP92;FOXP1;PAX3;SARS1
prerank,microtubule motor activity (GO:0003777),0.3725995483792693,1.0121469276466477,0.4313222079589217,0.9395852848763927,1.0,6/51,6.87%,DYNC1I1;KIF2A;DYNLRB1;KIF13A;KIF1C;KIF1B
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.3916219591996012,-1.0120800093546547,0.4568245125348189,0.744383995322209,1.0,4/13,9.46%,PIP5K1B;PIP4K2A;PIK3CB;PIK3CD
prerank,transferrin receptor binding (GO:1990459),0.4884376844264707,1.0112573247086407,0.4470588235294118,0.9381621640254354,1.0,7/10,27.63%,CD81;CHUK;IKBKG;IKBKB;SNX2;HFE;SNX4
prerank,FAD binding (GO:0071949),0.42293713099083985,1.0103330081715418,0.46264367816091956,0.9368506461757174,1.0,5/24,8.85%,MICAL2;CYB5R3;NQO2;MICAL1;CRY2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.39627455310778803,1.0098540290029625,0.462787550744249,0.9343332224044378,1.0,8/33,15.55%,NCOA3;ESRRB;ELP4;RPRD2;WDR43;ERCC5;DHX9;ELP2
prerank,small GTPase binding (GO:0031267),0.326913117963685,1.0080137258521769,0.4822546972860125,0.9356120249993032,1.0,38/169,15.76%,RNF152;SRGAP2;NDRG1;AKAP13;CAV1;CDC42EP4;EHD1;DAPK3;MLPH;CDC42EP5;UNC13D;YBX3;TSC2;SH3BP4;RAB11FIP3;DOCK7;GCC2;DVL3;EXOC4;IQGAP1;MYO5A;DMXL2;MYO1C;RAF1;GGA1;EXOC2;SGSM2;ARFIP2;MAPKAP1;WASF1;EXOC8;CHML;OCRL;ULK1;DNM1L;USP6NL;ARHGDIB;FLNA
prerank,poly(A) binding (GO:0008143),0.42245794949961146,1.008003928452567,0.45809248554913296,0.9317946071715908,1.0,4/21,6.91%,PABPC4L;PABPC1L;RBMS3;EIF4A3
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.41395712154942893,-1.0078345985445951,0.4651741293532338,0.7486108661915465,1.0,6/11,10.78%,ITPR1;TRPC3;TRPC4;RPH3A;TRPC6;TRPC5
prerank,actin monomer binding (GO:0003785),0.4313442179152404,1.006442657207991,0.4858757062146893,0.932133125299935,1.0,6/22,16.73%,COBL;LMOD3;TWF1;MYL4;ABL1;PFN2
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3852125166586702,1.0060503665225318,0.4394736842105263,0.9294032891336143,1.0,3/35,1.79%,PLCB3;NAPEPLD;MPPED2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.46808112377152755,1.0043546763712747,0.4624183006535948,0.9297974313313855,1.0,3/10,11.01%,KDM4B;KDM4C;RIOX2
prerank,BMP binding (GO:0036122),-0.408353024542445,-1.0029934725724796,0.43617021276595747,0.7541819347860866,1.0,2/11,1.88%,ENG;GREM2
prerank,receptor tyrosine kinase binding (GO:0030971),0.36137872752898237,1.0029586291653927,0.4598997493734336,0.9297482177612062,1.0,6/56,7.98%,PITPNM2;ANGPT1;PTPN14;PITPNM3;SHC1;FIZ1
prerank,protein serine/threonine kinase activity (GO:0004674),0.31436985845876225,1.0008766807017697,0.4863773965691221,0.931267950579408,1.0,83/334,20.09%,PRKCB;MAP3K8;PRKAA2;LIMK2;FAM20C;NRBP2;MAP3K5;GRK5;TSSK6;TSSK4;IKBKE;NEK7;CDK10;CDK6;MKNK2;PTK2B;SGK3;DAPK3;DAPK1;CDKL2;CDK4;CAMKK1;STK39;SIK3;MAPK15;MAPK7;CDK16;MAP3K4;ILK;LATS1;PLK3;DYRK1B;STK16;MAPK9;AURKC;OXSR1;BCR;TRIO;LMTK2;CASK;RAF1;SRPK2;CDKL4;GRK2;PKMYT1;CSNK1E;EIF2AK3;TGFBR2;MARK4;SRPK1;CDK2;MAP3K13;GSK3A;IRAK1;GSK3B;CHUK;ULK1;WNK1;CDC42BPA;PLK2;TESK1;ATR;AAK1;MAP3K6;PAK6;TTK;MAPK6;PRKCZ;EIF2AK4;MAPKAPK2;CHEK2;BMPR1A;PRKCQ;STK24;ROCK2;TAOK3;STK38L;IRAK4;PRKD2;CDK11B;MAP3K1;CAMK2B;PIK3R4
prerank,sodium channel regulator activity (GO:0017080),0.3872969351439849,0.9987526540192276,0.4411764705882353,0.9329717594143283,1.0,2/37,3.67%,FGF13;SGK3
prerank,actinin binding (GO:0042805),0.4198658510397104,0.9966089368721552,0.4896449704142012,0.934761681439384,1.0,6/21,12.82%,PDLIM5;DAG1;CSRP3;MYOT;PKD2L1;KCNA5
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3756225186724887,0.9963109677917246,0.45525291828793774,0.93181640611571,1.0,2/38,2.30%,SORBS1;MAGI2
prerank,mRNA binding (GO:0003729),0.3141107366398833,0.9962057784788222,0.4774590163934426,0.9284037038524997,1.0,61/249,19.82%,CELF2;PABPC4L;SAMD4A;DDX5;CPEB2;YTHDF1;ZC3H12A;SLPI;CELF1;SAMD4B;PABPC1L;RBFOX2;YBX3;KHNYN;SNRNP70;UNK;RBMS3;PKM;MRPS7;SRRM2;EIF4A3;UTP23;RBM20;RBM8A;SHMT1;LUC7L3;SRRM4;SRBD1;RBM46;SYNCRIP;EIF4G2;RPS26;CARHSP1;CPEB3;FXR1;RNPS1;DAZAP1;BOLL;AUH;DCP1A;EIF4G1;UPF3B;EIF4A1;GRSF1;RBM47;DHX9;LUC7L2;IGF2BP1;RBPMS2;IGF2BP2;CLUH;RBMS2;SRSF1;YTHDF3;PARK7;IGF2BP3;PTBP1;SRSF5;DXO;PCBP2;CSTF3
prerank,double-stranded DNA binding (GO:0003690),0.30986459841809016,0.9937713509566233,0.523,0.9307739377648785,1.0,113/531,21.33%,NFATC2;KLF5;NR3C2;THRB;TFAP2C;KLF4;PBX1;ZIC4;KLF3;ELF3;SREBF2;RORC;GLI3;HOXA4;HIVEP1;KLF12;FEN1;FOXO3;FOS;CGGBP1;FOXC2;GLIS2;KLF16;NR6A1;POU2F3;FOXD2;PRRX2;ESRRB;RARG;RFX7;IRF3;NKX2-8;JUND;OVOL2;CREB1;RXRB;MRE11;HOXA5;SOX9;ZBTB7B;MEF2D;CENPS;SIX1;POU3F1;JUN;FOXP3;ZIC1;NR2C1;HDGFL3;NFIB;NFIC;CREB3L4;CREB3;SP2;MAFG;HOXB5;MEF2B;SP1;FOXK1;TFEB;GATA3;ERCC5;ZNF177;ZFP1;REXO4;MEF2C;FOXP1;PAX3;IRF2;APTX;MBNL2;DHX9;KLF6;E2F1;HMBOX1;ZBP1;CAMTA2;ABL1;HSF2;POU4F1;SMAD5;DMRTA1;USF1;RAD50;ATF2;PARK7;MEOX2;RARA;NFKB2;ZBTB26;TEAD1;NUCKS1;ZBTB7A;PNKP;HOXA9;HDGF;SREBF1;KLF2;NFAT5;MAPT;ZBTB32;HOXA1;KLF10;UBP1;SOX4;IRF6;ARNT;TERF2;YY1;ELF1;MTF1;YBX1;GABPA
prerank,gamma-tubulin binding (GO:0043015),0.4173415071440996,0.9933784279580238,0.4702467343976778,0.9281226177142391,1.0,7/21,19.23%,NDRG1;DIXDC1;RAB11FIP5;MARK4;BLOC1S2;GIT1;TUBGCP5
prerank,tubulin binding (GO:0015631),0.3119216620618878,0.9933122549523665,0.5101626016260162,0.9246198242380468,1.0,62/295,19.23%,FGF13;MAPRE2;RP1;DYNC1I1;FMN1;DAG1;NDRG1;NDEL1;DIXDC1;KIF2A;KIF13A;GJB6;REEP3;MAP6;ARL3;AGTPBP1;KIF1C;PSRC1;EML2;KIF1B;MAP4;KRIT1;AGBL1;GPAA1;CETN3;CCDC181;CHP1;GAS2L1;HOOK1;HDGFL3;EZR;BCAS3;PAFAH1B1;RAB11FIP5;EFHC2;MARK4;ABRAXAS1;BLOC1S2;OPA1;TPGS1;GAPDH;ALDOA;CCDC88A;WASHC1;DNM1L;MAP1LC3B;REEP4;ARL8A;CAMSAP1;KIF17;RAE1;GIT1;NUMA1;RMDN3;HDAC6;RITA1;SUN2;FHDC1;KIF20B;TBCE;HOOK3;TUBGCP5
prerank,metalloexopeptidase activity (GO:0008235),0.36503966518413844,0.992780707317562,0.4654320987654321,0.922332748544815,1.0,6/51,7.99%,CPB1;CPA4;CPA3;AGTPBP1;CPE;AGBL1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.48647749390621103,0.9921886633978694,0.4837662337662338,0.9202497627682273,1.0,4/10,27.28%,FEN1;DCLRE1C;APEX1;POLD1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.4131086806565013,-0.990851783745209,0.47368421052631576,0.7781981696217802,1.0,6/10,23.72%,STAMBPL1;OTUD5;TNFAIP3;ATXN3;CYLD;YOD1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3084185895370661,0.9903564787396522,0.5295295295295295,0.9212718848267726,1.0,99/597,16.93%,BNC2;NFATC2;KLF5;NR3C2;THRB;TFAP2C;KLF4;PBX1;ZIC4;KLF3;ELF3;SREBF2;RORC;SMAD6;GLI3;HOXA4;HIVEP1;GABPB1;GABPB2;KLF12;GRWD1;HDAC5;FOXO3;FOS;FOXC2;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;POU2F3;FOXD2;PRRX2;BEND3;ESRRB;RARG;RFX7;IRF3;NKX2-8;JUND;OVOL2;CREB1;RXRB;HOXA5;SOX9;ZBTB7B;MEF2D;SIX1;TCF7L2;POU3F1;JUN;CRY2;FOXP3;BRD7;ZIC1;NR2C1;ARID4A;NFIB;NFYC;NFIC;CREB3L4;CREB3;ZW10;SP2;NCOR1;CALCOCO1;MAFG;HOXB5;MEF2B;MAFK;SP1;FOXK1;TFEB;CHD3;GATA3;ZNF177;MBD4;MLH3;ZFP1;MEF2C;FOXP1;PAX3;IRF2;ATMIN;MBNL2;DHX9;KLF6;CREB3L2;MCM8;E2F1;HMBOX1;MCM7;ABL1;HINFP;RNF10;HSF2;MCM6;POU4F1;SMAD5
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.4392632322769461,0.9891605505969624,0.4781297134238311,0.9172158507913271,1.0,11/16,30.73%,ATP6V1D;ATP6V0D1;ATP5F1B;ATP6V1B2;ATP6V0B;ATP6V0E1;ATP6V0E2;ATP6V0D2;TCIRG1;ATP6V0C;ATP6V0A2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.4392632322769461,0.9891605505969624,0.4781297134238311,0.9172158507913271,1.0,11/16,30.73%,ATP6V1D;ATP6V0D1;ATP5F1B;ATP6V1B2;ATP6V0B;ATP6V0E1;ATP6V0E2;ATP6V0D2;TCIRG1;ATP6V0C;ATP6V0A2
prerank,I-SMAD binding (GO:0070411),0.4440295958581905,0.9871798156300378,0.4801980198019802,0.9189677733784462,1.0,2/13,7.32%,SMAD6;TGFB1I1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.4335066892065365,0.986263592549846,0.5111111111111111,0.9176150304274305,1.0,2/17,2.69%,ACOT8;ABCD1
prerank,ubiquitin protein ligase binding (GO:0031625),0.3127957486985699,0.9851430964905569,0.5231719876416066,0.9168945501746599,1.0,59/254,18.41%,CLU;DAXX;PPARGC1A;TRIB2;CDKN1A;SMAD6;FHIT;IKBKE;CXCR4;BAG1;ERLIN2;NFKBIA;PATZ1;ELOB;POLR2A;MUL1;ERBB3;UQCRC1;SLC22A18;FZD5;RBX1;JUN;PML;SUMO2;UBE2B;APBB1;JAK1;ACTG1;HSPBP1;YWHAZ;UBXN7;NPLOC4;GSK3B;PRKAR2A;WASHC1;DNM1L;MDM2;MAP1LC3B;SYT11;HSP90AA1;CCDC50;RNF31;IKBKG;HM13;UBE2N;TPI1;UBE2J1;UBC;RPS27A;VCL;SMAD5;STUB1;SMC6;CHEK2;HDAC6;USP25;PSMD1;TSG101;TRIM37
prerank,calcium ion binding (GO:0005509),0.3103729334815494,0.9839056663757006,0.540241448692153,0.916530897819857,1.0,41/323,11.96%,CDH1;PITPNM2;DSG2;CDH13;ITPR2;ANXA3;STIM2;ANXA8;ANXA8L1;GSN;S100A6;S100A10;OTOF;PITPNM3;ANXA4;LTBP4;FBLN1;S100A11;ANXA5;ANXA2;CALR3;MICU1;DSC3;DSC2;HPGDS;CETN3;IQGAP1;CHP1;PCLO;PCDHA4;DNASE1L2;NDUFAB1;ITPR3;TRPM4;MMP12;S100A1;CALU;PKD2L1;PLSCR3;CDH4;LETM1
prerank,SH3 domain binding (GO:0017124),0.3525715250443461,0.9818571321611888,0.49347568208778175,0.9181234601984086,1.0,10/62,10.76%,ADAM12;ENAH;ESPN;MAPK15;AFAP1;AFAP1L1;MICAL1;ABI1;AKAP5;ADAM15
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.4192062204195647,-0.9809669799761527,0.5153061224489796,0.7964967748166296,1.0,3/10,8.32%,SLC6A13;SLC6A12;SLC6A1
prerank,adrenergic receptor binding (GO:0031690),-0.3611580106163327,-0.9808840818797292,0.4691358024691358,0.7901054636579433,1.0,3/16,1.69%,RAPGEF2;GNAS;PDE4D
prerank,protein homodimerization activity (GO:0042803),0.3040194236422381,0.9808837288600233,0.5775775775775776,0.9171392114313546,1.0,113/589,18.61%,CUBN;DPP4;FGFR1;NECTIN3;SRGAP2;CCL5;MAP3K5;PDGFC;ADAM10;FOXP2;S100A6;GDF15;ABCD1;STARD3;DGCR8;TIMM10;EPRS1;S100A10;DAPK3;GDNF;BLOC1S6;CARNMT1;NR6A1;ZBTB16;HSPB1;HARS1;TARBP2;S100A11;CRYAB;TSC2;IRF3;RAB11FIP3;CAV2;BCL2L1;HSPB8;ADD1;NRF1;ZBTB7B;GLB1;NQO2;PSMF1;NADK2;TRIM21;TGFB2;ANG;GALE;CHMP4A;CHMP4B;HPGDS;PML;TMEM192;KMT2A;FOXP3;EXT1;SHMT1;ATP5IF1;HOOK1;NFS1;PSMD7;CR2;PON3;S100A1;PDK2;VPS4B;RABL3;SP1;PHETA2;PAXX;ERCC5;CHMP1A;FXR1;MAP3K13;SLC39A13;FLRT3;SYT6;IRAK1;PHETA1;CHUK;SARS1;BNIP3L;CCDC88A;NAGA;DNTTIP1;DNM1L;SDCBP2;HSP90AA1;ABCB9;ACTN4;SPPL2B;GSTM2;IKBKG;FLNA;HM13;RBPMS2;TPI1;TBC1D22A;TPD52;RAP1GAP;STUB1;SLC8B1;FICD;SPPL3;CHEK2;PDCD6IP;BMPR1A;USF1;TSG101;PDLIM4;PDXK;PARK7;TRIM37;HMGCS1;SPPL2A
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.2919412234815612,-0.9784452324951317,0.4671814671814672,0.7895358384122677,1.0,10/34,18.43%,STK3;IGF2;STRADA;ETAA1;IRGM;ALS2;FAM20A;DBF4;INCENP;MAP2K1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.32165351641865164,-0.9779522077913378,0.4816053511705686,0.7843278490731465,1.0,5/25,9.16%,ZC3HAV1;ART3;PARP14;TNKS;PARP8
prerank,amino acid binding (GO:0016597),-0.3009264507658631,-0.9745123807985583,0.5,0.7864193864846788,1.0,19/31,36.06%,NOS3;GRM7;GRIN2B;GLRA1;GLRA3;GLRA2;SRR;GLRB;CASTOR1;THNSL2;CAD;GRIN3A;AARS2;SHMT2;GRIN1;GCLC;GLDC;GNMT;NOS2
prerank,histone demethylase activity (GO:0032452),0.3865801380245139,0.9716639022825073,0.48480662983425415,0.9361446889359235,1.0,7/27,12.31%,KDM4D;KDM4B;KDM5C;KDM3A;KDM4C;RIOX2;KDM6A
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4025769678570839,0.9708198238357357,0.4810126582278481,0.931364775730421,1.0,6/21,13.26%,CDK10;CDK6;CDKL2;CDK4;CDKL4;CDK2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4025769678570839,0.9708198238357357,0.4810126582278481,0.931364775730421,1.0,6/21,13.26%,CDK10;CDK6;CDKL2;CDK4;CDKL4;CDK2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.39606538775236183,-0.970630856336837,0.5148247978436657,0.7891537871124824,1.0,4/11,15.69%,SLC35B3;LRRC8A;SLC25A25;SLC25A23
prerank,MAP-kinase scaffold activity (GO:0005078),-0.39521060858469853,-0.9673503151954325,0.4949748743718593,0.7903351242547005,1.0,2/11,0.55%,SH3RF1;KSR1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.3811906787484136,-0.9655476667697153,0.5121951219512195,0.7884309887044237,1.0,5/12,20.67%,SLC35B3;LRRC8A;SLC25A25;SLC25A23;SLC25A5
prerank,cytochrome-c oxidase activity (GO:0004129),0.4289647390386228,0.9639482282539574,0.4915514592933948,0.9448199799643454,1.0,4/15,10.61%,COX5A;COX8A;COX7A2L;COX5B
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.29834126620780477,0.9628687759382023,0.619,0.9439062833190753,1.0,125/831,14.26%,NFATC2;ZBTB7C;KLF5;NR3C2;THRB;TBR1;TFAP2C;KLF4;PBX3;PBX1;ZIC4;KLF3;TFAP2D;DMRT2;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;FOXP4;KLF12;ZNF436;HDAC5;ZFHX4;ZNF692;MXD4;CC2D1B;FOXO3;FOS;RELB;MGA;FOXC2;SP5;GLIS2;ZNF219;KLF16;HDAC4;NFE2L2;ZBTB8A;NR6A1;ZBTB16;NFE2L1;NACC1;POU2F3;FOXD2;PRRX2;ESRRB;RARG;RFX7;IRF3;NKX2-8;PATZ1;JUND;OVOL2;ZBTB46;CREB1;ZIK1;FOXM1;ZBTB17;RXRB;HOXA5;ZIC2;SOX9;NRF1;FOXD1;ZBTB7B;CC2D1A;MEF2D;KLF7;STAT4;ZNF418;ZFHX3;ZNF471;CIC;SIX1;TCF7L2;MAZ;POU3F1;JUN;POU5F2;ZFP57;GRHL2;FOXP3;ZIC1;NR2C1;DNMT3A;PRDM15;NFE2L3;ZNF467;TWIST1;ZNF205;NFIB;NFYC;NFIC;CREB3L4;CREB3;SP2;MYT1;CALCOCO1;MAFG;HOXB5;MEF2B;KDM6A;MAFK;ZNF148;SP1;ZBTB42;MED8;FOXK1;ZSCAN20;TFEB;MYBL1;GATA3;ZFP30;RREB1;ZNF177;NFIA;MYC;ZFP1;MEF2C;ZFP92;FOXP1;PAX3;SARS1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.31054355309980636,0.9611246989719335,0.565625,0.944730150910338,1.0,34/181,14.12%,KLF4;PPARGC1A;NCOA3;HDAC5;EP300;FOS;HDAC4;NFE2L2;ANXA4;WWP2;HSPB1;MTDH;SMARCB1;NFKBIA;CREB1;DDRGK1;COMMD7;FIZ1;TCF7L2;JUN;FOXP3;ACTB;HDAC3;BCAS3;COMMD6;SMARCA4;NCOR1;MIER2;SP1;PIAS1;PIAS3;MKKS;NCOR2;GSK3B
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.42869064266886914,0.9581821683387608,0.5204855842185129,0.9483210758290828,1.0,4/15,8.10%,VEPH1;PHLDA3;RUBCNL;JPH2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.39402783330222674,0.9580609628671375,0.5203938115330521,0.938309577910173,1.0,1/22,0.76%,CHRM1
prerank,serotonin receptor activity (GO:0099589),0.39402783330222674,0.9580609628671375,0.5203938115330521,0.938309577910173,1.0,1/22,0.76%,CHRM1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.39402783330222674,0.9580609628671375,0.5203938115330521,0.938309577910173,1.0,1/22,0.76%,CHRM1
prerank,rRNA binding (GO:0019843),0.35743710913938737,0.9558145979598308,0.5270618556701031,0.9402514428998857,1.0,7/42,15.79%,PPAN;MRPS7;UTP23;ANG;MRPS27;MDM2;MRPS18C
prerank,neurexin family protein binding (GO:0042043),0.46277806583282743,0.9555862791972591,0.5222602739726028,0.9374253681925593,1.0,2/10,7.26%,SYTL4;CPE
prerank,death receptor binding (GO:0005123),0.4276938783284386,0.9546258144476183,0.5372670807453416,0.9364320981796634,1.0,3/15,11.24%,EDA;NGF;FEM1B
prerank,thyroid hormone receptor binding (GO:0046966),0.38306597967031997,0.9532546803435974,0.5234806629834254,0.9363186799847046,1.0,6/28,13.22%,NCOA3;MED30;GAS2L1;NCOR1;MED12;MED24
prerank,RNA cap binding (GO:0000339),0.42545317862879883,0.9525007220174414,0.5329153605015674,0.9349140159215027,1.0,1/16,0.79%,CYFIP2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.4172121473870505,0.949842285558097,0.5438335809806835,0.9378698353907462,1.0,1/18,3.48%,HSD17B14
prerank,pyrophosphatase activity (GO:0016462),-0.2580470235906533,-0.94948651658963,0.553072625698324,0.8209564168187339,1.0,20/50,22.90%,ENTPD1;ENPP1;ALPL;PPA1;ITPA;ENPP3;LHPP;PRUNE1;PPA2;PRUNE2;ATCAY;DOLPP1;NUDT1;ENTPD3;DHX29;ENTPD5;CILP;ENTPD6;FITM2;NUDT16
prerank,protein heterodimerization activity (GO:0046982),0.30542012775138966,0.948980019670509,0.581151832460733,0.9365577299421171,1.0,25/178,14.21%,ADRA1B;AGTR1;HEXA;ATP1A2;PEF1;PGLYRP3;PPP2CA;BUD23;BCL2L1;ADD1;PSMF1;MICU1;ERBB3;EXT1;TLR6;KCNB1;PAFAH1B1;SAE1;TLR4;GABBR2;FXR1;TUBB2B;IRAK1;MEF2C;CHUK
prerank,GTPase binding (GO:0051020),0.30477088203716074,0.9489357027007391,0.5842812823164426,0.9333864270827903,1.0,41/194,15.76%,RNF152;SRGAP2;NDRG1;AKAP13;CAV1;EPRS1;CDC42EP4;EHD1;DAPK3;MLPH;CDC42EP5;UNC13D;YBX3;TSC2;SH3BP4;RAB11FIP3;DOCK7;GCC2;DVL3;EXOC4;IQGAP1;MYO5A;DMXL2;MYO1C;RAF1;GGA1;EXOC2;SGSM2;ARFIP2;MAPKAP1;WASF1;RASA1;EXOC8;CHML;OCRL;ULK1;DNM1L;USP6NL;HSP90AA1;ARHGDIB;FLNA
prerank,dynactin binding (GO:0034452),0.4369717899193506,0.947229711118587,0.5056,0.9343461178504309,1.0,4/12,20.05%,PAFAH1B1;GSK3B;HOOK3;MAPT
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.29814564063012383,0.9445451983197569,0.5955056179775281,0.9373393087377636,1.0,47/232,17.31%,RNF152;TRIM60;RNF43;RNF220;TRIM59;SH3RF2;WWP2;RNF5;TRIM25;TRIM44;RNF138;MUL1;TRIM21;CBLL1;TRIM41;CDC42;RBX1;TRIM11;TRIM26;RNF121;LTN1;PPP1R11;COP1;SIAH3;VPS11;NSMCE2;RNF126;PIAS1;DTX3;PIAS3;PELI1;CBX4;BRAP;VPS18;UBR5;NEDD4;MDM2;BFAR;MSL2;PDZRN3;DTX2;PRPF19;RNF10;STUB1;UBE2D3;SIAH1;XIAP
prerank,protein phosphatase binding (GO:0019903),0.3143058153751925,0.9439331003638798,0.5731573157315731,0.9355538337772537,1.0,21/117,11.85%,MAP3K5;ANK1;GTF2F1;IKBKE;PPP6R3;AP3B1;SH3RF2;PPP1R15A;ROS1;PXN;SMG7;BAD;IQGAP1;LGALS3;PPP1R16A;MTMR3;PPP1R11;AKAP5;JAK1;MVP;EIF2AK3
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.46377415350313217,0.9431094272657197,0.5435139573070608,0.9341582599980263,1.0,1/10,0.71%,SLCO2A1
prerank,sequence-specific DNA binding (GO:0043565),0.293647489373728,0.9424140619660417,0.6726726726726727,0.9325445558776937,1.0,73/590,13.30%,NFATC2;KLF5;NR3C2;THRB;TFAP2C;KLF4;PPARGC1A;PBX1;ZIC4;KLF3;ELF3;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;KLF12;FOXO3;FOS;FOXC2;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;POU2F3;FOXD2;PRRX2;ESRRB;RARG;RFX7;IRF3;SLTM;NKX2-8;JUND;OVOL2;CREB1;RXRB;HOXA5;SOX9;FOXD1;ZBTB7B;MEF2D;SMG7;UPF3A;SIX1;TCF7L2;POU3F1;JUN;CXXC4;KMT2A;GRHL2;FOXP3;ZIC1;NR2C1;NFIB;NFIC;CREB3L4;CREB3;SP2;MMP12;CALCOCO1;MAFG;HOXB5;MEF2B;MAFK;ZNF148;SP1;FOXK1;TFEB;GATA3;ZNF177
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.26311040551876824,-0.9404582303440983,0.5373134328358209,0.836273788143274,1.0,12/44,21.60%,MECOM;SETD5;PRDM16;NSD1;EZH2;RBBP5;NSD3;WDR5;SETDB2;PRDM9;WDR82;SUV39H2
prerank,tau protein binding (GO:0048156),0.35563354243005313,0.9377883865037329,0.5340909090909091,0.9398673186759383,1.0,12/40,18.58%,CLU;EP300;PPP2CA;ACTB;MARK4;GSK3A;GSK3B;PPP2CB;HSP90AA1;STUB1;HDAC6;ROCK2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3093515750912306,0.9376563098550957,0.5802997858672377,0.9369460196245896,1.0,24/134,15.34%,CFTR;SLCO2A1;SLC36A3;SLC35D3;SLC16A11;SLC66A1;OCA2;CTNS;SFXN3;SLC36A4;SLC3A1;SLC2A8;SLC25A1;SFXN1;SLC25A38;SLC1A4;PDPN;SLC25A21;SLC25A17;SLC26A4;SLC6A7;SLC19A2;SLC25A12;SLC7A3
prerank,ligand-gated cation channel activity (GO:0099094),-0.23638918040956042,-0.9319677709845893,0.6382978723404256,0.8501787467512587,1.0,15/75,14.41%,GRIK2;KCNN2;GRIN2A;GRIA3;GRIA2;KCNJ2;GRIN2B;GRIK3;MCOLN1;GRIK4;GRIK1;KCNJ12;CCDC51;KCNJ6;KCNJ10
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.28975137210036045,-0.9307153383643494,0.6156716417910447,0.8466082775108495,1.0,7/30,12.55%,SLC30A10;SLC39A12;SLC40A1;SLC39A8;SLC39A10;TTYH1;SLC30A1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.2980009764579933,0.9304337431914405,0.5901132852729145,0.9499627246556966,1.0,36/188,16.75%,BNC2;KLF4;PBX1;SMAD6;GABPB1;GABPB2;HDAC5;FOXO3;FOS;FOXC2;GLIS2;HDAC4;NFE2L2;JUND;SIX1;TCF7L2;JUN;CRY2;BRD7;ARID4A;NFYC;NCOR1;CALCOCO1;MAFK;SP1;FOXK1;TFEB;CHD3;GATA3;MEF2C;ATMIN;DHX9;CREB3L2;HINFP;RNF10;LIN54
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.45545911921840143,0.9303790157508456,0.5509868421052632,0.9468703167584369,1.0,3/10,17.33%,CDKN1A;HEXIM1;CDKN2D
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.42491936346848763,0.9299773315157323,0.537984496124031,0.944541934143419,1.0,3/13,7.10%,GDF15;BMP5;BMP4
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.39273640005325855,0.9298851904000014,0.5647743813682679,0.9415395844001558,1.0,3/22,5.85%,CPEB2;ZC3H12A;RBMS3
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4153645888158354,0.929778989930309,0.5555555555555556,0.9385709996768897,1.0,4/16,17.66%,ALOX5;TDO2;CDO1;HAAO
prerank,anion channel activity (GO:0005253),0.33223550666149376,0.9272593302385157,0.5653235653235653,0.9410898357196613,1.0,12/61,15.44%,CFTR;ANO7;VDAC2;CLIC1;CLCN4;SLC1A4;ANO6;VDAC1;ANO3;CLCC1;GPR89B;GPR89A
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.41336088022851064,0.925716665280219,0.543939393939394,0.9414328855733668,1.0,3/14,17.97%,CAPN2;CAPNS1;CAPN15
prerank,histone deacetylase binding (GO:0042826),0.31102581822666536,0.9244963584097208,0.5947187141216992,0.9408696096059492,1.0,21/88,18.10%,GLI3;HDAC5;HDAC4;NACC1;LCOR;MEF2D;FOXP3;YWHAB;CCND1;HDAC3;SP2;NCOR1;MIER2;MEF2B;SP1;NCOR2;MEF2C;HSP90AA1;CAMTA2;HDAC6;USF1
prerank,motor activity (GO:0003774),0.331115739550334,0.9244177958421916,0.5577639751552795,0.93787301869907,1.0,6/60,6.87%,DYNC1I1;KIF2A;DYNLRB1;KIF13A;KIF1C;KIF1B
prerank,BMP receptor binding (GO:0070700),0.4249238127476316,0.9237349419165447,0.5361635220125787,0.9363113069067872,1.0,3/12,7.10%,GDF15;BMP5;BMP4
prerank,ATP binding (GO:0005524),0.2919556201734721,0.9235789265390706,0.6531440162271805,0.9336171790786267,1.0,84/266,22.89%,PRAG1;MAP3K5;TSSK6;TSSK4;ABCD1;ATP1A2;CDK6;MKNK2;DAPK3;DAPK1;HARS1;PFKP;CARS2;TWF1;PMVK;EIF2B2;SIK3;EIF4A3;SYN1;LATS1;PPIP5K2;HSPA4;ABCF1;OXSR1;HSPA14;LMTK2;MOV10L1;ABCA2;AARS1;THG1L;AK6;MTREX;SRPK2;PDK2;MARK4;SRPK1;OLA1;TARS1;VPS4A;EIF4G1;SARS2;WNK1;TRNT1;CDC42BPA;HSP90AA1;DHX9;ABCB9;OAS2;PEX6;MAP3K6;ABL1;PEAK1;MCM6;PRKAG1;CLP1;PI4K2A;FICD;SYN3;BMPR1A;PDXK;STK38L;DARS2;PNKP;ABCB6;CDK11B;IDE;MYO18A;TBCK;CDC42BPG;YARS2;ATP1A1;ATP1A3;WNK4;N4BP2;ABCF3;HSPA13;CDC42BPB;SMC4;LONP1;ACLY;MKNK1;IGHMBP2;PRPS1L1;PRPS1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.3040842167257975,-0.9218968985097084,0.552901023890785,0.861345071746987,1.0,10/24,25.61%,KCNN2;ABCC9;KCNJ2;KCNJ12;KCNJ6;KCNJ10;KCNJ8;KCNJ15;KCNJ3;KCNK1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.31868684852925555,0.9218512333036863,0.5692307692307692,0.9342919579262156,1.0,23/71,18.02%,PTPN14;EYA2;PTPRU;PTPRD;DUSP1;PTPRF;PTPN9;PTPRA;EYA1;PTPN6;MTMR3;ACP1;PTPRE;PTPN2;PGP;PTP4A3;DUSP11;PTPN13;PTPDC1;CDC25B;PTP4A2;DUSP3;PTPN11
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.25020885660470993,-0.9216732063252521,0.6565217391304348,0.8554212000394871,1.0,7/55,8.24%,SLC24A3;ITPR1;TRPC3;ATP2A2;PKD2;SLC24A2;PANX1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.4296534296935023,0.9195887930710026,0.5657237936772047,0.9361237861211386,1.0,1/12,1.00%,CNOT6
prerank,myosin binding (GO:0017022),0.3354715917734992,0.9167324586409341,0.572851805728518,0.9395722037405483,1.0,10/55,13.51%,CALD1;GSN;CXCR4;MLPH;NCKIPSD;RAB3B;LMTK2;LLGL2;RHOA;ARFGEF1
prerank,translation initiation factor activity (GO:0003743),0.35346625637466683,0.9157612191161234,0.580602883355177,0.9385682906876917,1.0,13/36,17.85%,EIF3L;EIF2B2;EIF3K;EIF4G2;COPS5;EIF3M;EIF4G1;EIF4A1;EIF5B;EIF3B;EIF1;EIF2B4;EIF4A2
prerank,SH2 domain binding (GO:0042169),-0.28051256015268694,-0.9145401001587043,0.6037735849056604,0.8657038090340031,1.0,11/31,18.07%,AFAP1L2;SH3PXD2B;PTK2;PAG1;JAK2;BLNK;RACK1;RUFY1;SKAP1;SH2B2;INPPL1
prerank,retinoic acid receptor binding (GO:0042974),-0.33012756016683736,-0.9142992554667869,0.546448087431694,0.8598279563333724,1.0,3/17,9.55%,TACC1;NSD1;PPARG
prerank,alpha-actinin binding (GO:0051393),0.3735096959912094,0.9142403517806527,0.5632022471910112,0.9387080604978902,1.0,10/24,18.50%,PDLIM5;DAG1;MYOT;PKD2L1;KCNA5;PDLIM7;NRAP;PDLIM3;PDLIM4;RARA
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3107387293797566,0.9140594384463829,0.5945330296127562,0.9360910183173252,1.0,16/91,10.99%,ACTN2;STXBP6;VILL;ANXA8;GSN;AMER3;PHLDA3;AMER2;AVIL;TWF1;ANXA2;KRIT1;JPH2;RAB35;SNX18;GSDME
prerank,ubiquitin protein ligase activity (GO:0061630),0.28764943282776034,0.9120716104394799,0.6390593047034765,0.9372482489401471,1.0,44/228,17.31%,RNF152;TRIM60;RNF43;RNF220;TRIM59;SH3RF2;WWP2;RNF5;TRIM25;TRIM44;RNF138;MUL1;TRIM21;CBLL1;TRIM41;CDC42;RBX1;TRIM11;TRIM26;RNF121;LTN1;PPP1R11;COP1;SIAH3;VPS11;RNF126;DTX3;PELI1;BRAP;VPS18;UBR5;UBE4A;NEDD4;MDM2;BFAR;MSL2;PDZRN3;DTX2;PRPF19;RNF10;STUB1;UBE2D3;SIAH1;XIAP
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.317889322155161,0.9109528773128464,0.6063829787234043,0.9364707086290113,1.0,13/69,14.15%,SOAT1;EP300;DGAT1;MOGAT3;ZDHHC12;MOGAT1;KAT6B;SOAT2;CERS2;MBOAT7;NAA15;LPCAT3;NAA10
prerank,GTPase activity (GO:0003924),0.2930357898757026,0.9104790039290012,0.6666666666666666,0.9344762285523366,1.0,41/192,16.98%,RAB17;MRAS;RAP1B;EEF1A1;RAP1A;RHOQ;NRAS;KRAS;RHEB;RAB3B;CDC42;RAB7A;GSPT2;GTPBP10;BMS1;RAB35;GNAO1;AGAP3;GNAQ;GNA13;RHOA;RABL3;OPA1;RHOU;SEPTIN9;RAB5C;ATL2;RAB1B;HRAS;GNG5;DNM1L;RAB33B;GPN1;GNA11;ARHGDIB;RAP2C;ARL8A;EEF2;RAB8B;RAP1GAP;DIRAS2
prerank,mannose binding (GO:0005537),-0.3556136573587691,-0.9100059810381631,0.5625,0.8637180998672133,1.0,2/12,12.21%,LMAN2L;LMAN2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3178056596604604,0.9085341530883538,0.600459242250287,0.9355859477071797,1.0,13/74,10.81%,FAM20C;ADK;PIK3C2B;AGK;PKM;DCAKD;NT5C3A;TRPT1;NADK2;NADK;PI4KA;HK1;DGKA
prerank,chemokine receptor binding (GO:0042379),0.34611487656980433,0.9085336553766737,0.5685210312075983,0.9325968552224924,1.0,2/35,6.03%,CCL5;CCRL2
prerank,snoRNA binding (GO:0030515),0.3568632303836707,0.9017682392578054,0.5860215053763441,0.9438513911335397,1.0,5/30,15.66%,NUDT4;BMS1;GAR1;RRP9;IMP4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.2895150129340054,-0.9017571367437797,0.5874587458745875,0.8762421008487512,1.0,6/24,12.22%,PLA2G4A;DAB2IP;PLEKHA8;GSDMD;LANCL2;PLEKHF1
prerank,microtubule plus-end binding (GO:0051010),0.38170598240597164,0.9013739649402039,0.5852601156069365,0.9416656526591035,1.0,3/20,10.51%,MAPRE2;CLIP4;PAFAH1B1
prerank,ATPase regulator activity (GO:0060590),-0.26170413542051835,-0.9003705066231977,0.6528925619834711,0.8729628923243796,1.0,16/38,24.09%,TSC1;ATP1B1;DNAJB4;FNIP1;DNAJC19;DNAJA1;FNIP2;DNAJB2;BAG4;BAG5;BRSK2;GRPEL1;DNAJC1;BAG2;DNAJB1;AHSA1
prerank,cation channel activity (GO:0005261),0.3004892561733502,0.8999546753262557,0.6267123287671232,0.9416022532074283,1.0,17/94,14.46%,TRPM3;NALCN;TRPM8;MCU;CALHM5;ABCC8;ANXA2;PKD1;TRPM6;TRPM4;AQP1;PKD2L1;ANO6;HVCN1;TRPM2;CACNB2;TMEM175
prerank,phosphotyrosine residue binding (GO:0001784),-0.26278662124653185,-0.8980837804497434,0.6778242677824268,0.8720044078292286,1.0,10/37,13.28%,PIK3R1;NCK2;CRKL;SHE;ABL2;PTPN3;BCAR3;GRB2;PIK3R3;SHF
prerank,metal ion binding (GO:0046872),0.281985152624613,0.8976226271505395,0.7837837837837838,0.9435907637476032,1.0,57/477,11.96%,CDH1;PITPNM2;DSG2;CDH13;ITPR2;ANXA3;STIM2;MAP3K5;TSSK6;TSSK4;ANXA8;ANXA8L1;GSN;S100A6;FEN1;EYA2;S100A10;OTOF;PITPNM3;IDH3G;ANXA4;LTBP4;FBLN1;S100A11;ANXA5;RHEB;SIK3;NT5C3A;ANXA2;CALR3;DCTPP1;MICU1;DSC3;DSC2;LATS1;HPGDS;CETN3;IQGAP1;CHP1;OXSR1;PCLO;TRIM26;MOV10L1;PCDHA4;THG1L;DNASE1L2;NDUFAB1;SRPK2;ITPR3;TRPM4;MMP12;S100A1;CALU;PKD2L1;PLSCR3;CDH4;LETM1
prerank,mechanosensitive ion channel activity (GO:0008381),0.41538986507290526,0.8956519072823044,0.5658536585365853,0.9447136146069703,1.0,4/12,21.13%,TMC6;TMC2;TMEM63B;TMC4
prerank,ATPase binding (GO:0051117),0.3124651737016061,0.8943876423113557,0.6122448979591837,0.9443004397512791,1.0,13/71,14.72%,ANK2;ANK1;PEX26;BBC3;CAV1;PIH1D1;CHMP4A;ATP5IF1;EZR;S100A1;TOR1AIP1;DNAJC10;ATP6V1E1
prerank,kinase binding (GO:0019900),0.2807615644206015,0.8942131740890965,0.7696969696969697,0.9417204226157116,1.0,97/434,18.32%,MYOM2;UTRN;ANK2;DAXX;PIK3IP1;CDKN1A;ADAM10;EMP2;GSN;CAV1;NBEAL2;MAVS;EEF1A1;QARS1;FOXO3;RELB;AP2A2;HSPB1;PPP1R15A;PIH1D1;CAV2;RNF138;BCL2L1;POLR2A;FOXM1;SPRED3;SHC1;PFKFB2;MSN;TRIM21;CCND2;SYN1;ILK;BAD;LATS1;ADCY6;SRCIN1;CDC42;FBXO5;TCF7L2;PKD1;IQGAP1;FZD5;PTPN6;CHP1;ACSL3;OXSR1;LRBA;CDK5RAP1;ACTB;SMCR8;CCND1;ZC3HC1;CARD16;EXOC2;SLC12A4;JTB;MVP;RHOA;YWHAZ;AP2A1;PTN;PPP1CB;MAPKAP1;BCAR1;PTPN2;KCNA5;MAP3K13;VDAC1;SHC2;IRAK1;GSK3B;WNK1;DNAJC3;TNNI3;RB1CC1;FLNA;ITGB2;FAM83H;EEF2;AP1B1;CRK;PRKAG1;STUB1;ARHGAP33;NSF;SUFU;CDKN2D;CDC25B;CHEK2;MTCP1;DUSP3;PTPN11;USF1;CAMK2N1;ATF2;PARK7
prerank,mRNA 5'-UTR binding (GO:0048027),0.3655522659038081,0.8911038826968726,0.6071428571428571,0.9450043797194206,1.0,11/24,28.75%,UTP23;SHMT1;SYNCRIP;IGF2BP1;IGF2BP2;IGF2BP3;RPL41;RPL26;CCT5;DDX3X;LARP1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.353488985120408,0.8907859661556516,0.6071428571428571,0.9427138903864254,1.0,9/27,19.05%,POLR2A;POLR3B;POLR1D;POLR1C;POLR1F;MED21;POLR2C;POLR3H;POLR2E
prerank,protein phosphatase 1 binding (GO:0008157),0.37080192489424235,0.889970075688944,0.5878877400295421,0.9414103159457923,1.0,4/21,10.18%,SH3RF2;PPP1R15A;PPP1R16A;PPP1R11
prerank,tRNA methyltransferase activity (GO:0008175),-0.3227286374618643,-0.8888976649687922,0.5969696969696969,0.8871914146148768,1.0,8/16,24.92%,TARBP1;TRMT5;THUMPD2;TRMT9B;TRMT44;ALKBH8;TYW3;BCDIN3D
prerank,ion channel activity (GO:0005216),0.3071449186721855,0.8879927537926355,0.6486486486486487,0.9426545574020858,1.0,15/80,15.84%,TRPM3;NALCN;TRPM8;TMC6;MCUB;CALHM5;GRID1;TMC2;TRPM6;TRPM4;PKD2L1;CNGB1;TRPM2;TMEM63B;TMEM120A
prerank,Tat protein binding (GO:0030957),0.4298880505997217,0.8879429543414321,0.60580204778157,0.9398461529123702,1.0,3/10,10.85%,SMARCB1;ACTB;SMARCA4
prerank,U6 snRNA binding (GO:0017070),0.4039619631605969,0.8871803007910157,0.6016260162601627,0.9385419539457829,1.0,5/14,21.46%,LARP7;LSM4;DDX39B;PRPF8;TUT1
prerank,tau-protein kinase activity (GO:0050321),-0.30260850995849997,-0.8844295942062412,0.6461038961038961,0.8911778151422637,1.0,4/20,7.58%,MARK1;BRSK1;PRKAA1;ROCK1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.33451092013244377,-0.8837596565417198,0.6005154639175257,0.8864470133718804,1.0,3/14,12.28%,NOD1;MAL;RACK1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.36609969801241765,-0.8831326702058834,0.6176470588235294,0.8816768060108019,1.0,4/10,15.12%,PIK3CB;PIK3CD;PIK3R3;PIK3C3
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4105210053502351,0.8823102126790088,0.6221864951768489,0.945524150552436,1.0,5/14,20.93%,SDHB;ACO2;CIAO3;ISCA2;ACO1
prerank,phosphatidylinositol binding (GO:0035091),0.3003942837116363,0.8822202993014734,0.6350114416475973,0.942793503234921,1.0,16/91,14.94%,PITPNM2;ITPR2;PIGU;SNX8;PITPNC1;RUBCNL;WDFY3;GPAA1;RUBCN;BCAS3;ITPR3;SNX12;ESYT2;EXOC8;CCDC88A;SNX16
prerank,muscle alpha-actinin binding (GO:0051371),0.3953619906030019,0.8807096750809987,0.5918674698795181,0.942801942144618,1.0,7/15,20.89%,PDLIM5;PKD2L1;PDLIM7;NRAP;PDLIM3;PDLIM4;MYPN
prerank,transcription cis-regulatory region binding (GO:0000976),0.27665415153797907,0.8792799691804121,0.7937937937937938,0.9428526454018749,1.0,64/406,15.96%,BNC2;FOXN3;TFAP2C;KLF4;PBX1;TFAP2D;SMAD6;GLI3;GABPB1;GABPB2;ZNF436;HDAC5;FOXO3;FOS;FOXC2;GLIS2;HDAC4;NFE2L2;ZBTB8A;ESRRB;JUND;ZBTB46;FOXM1;ZBTB17;RXRB;SOX9;ZBTB7B;MEF2D;CIC;SIX1;TCF7L2;JUN;CRY2;XRN2;ZFP57;GRHL2;BRD7;TWIST1;ARID4A;NFYC;CREB3;MMP12;NCOR1;CALCOCO1;DR1;MAFK;SP1;FOXK1;TFEB;CHD3;GATA3;RREB1;ZNF177;MYC;MEF2C;FOXP1;IRF2;ATMIN;RFXAP;ZFP3;CREB3L2;ACTN4;E2F1;CDC5L
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.34983085936899105,0.8792481797635768,0.6109589041095891,0.9400915366895923,1.0,9/27,19.05%,POLR2A;POLR3B;POLR1D;POLR1C;POLR1F;MED21;POLR2C;POLR3H;POLR2E
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.42251004381480256,0.8785550763766163,0.6028708133971292,0.9387230429892277,1.0,8/12,26.82%,SDHB;FDX1;ISCA1;CIAPIN1;ISCA2;AOX1;CISD2;CISD1
prerank,microtubule minus-end binding (GO:0051011),-0.3298958095838342,-0.8782561203376876,0.6598984771573604,0.8863173692263118,1.0,7/13,28.94%,TUBGCP2;MACF1;CAMSAP2;HAUS4;HAUS7;TUBGCP3;CAMSAP3
prerank,poly-purine tract binding (GO:0070717),0.35468283875480533,0.8781788090546,0.6274509803921569,0.936724768477647,1.0,4/27,6.91%,PABPC4L;PABPC1L;RBMS3;EIF4A3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2852750049298644,0.8777591449861313,0.7148891235480465,0.9347026236359027,1.0,28/173,14.22%,TFAP2C;SREBF2;RORC;FOXP2;FOXP4;KLF12;ZNF436;ZNF692;FOXO3;ZNF219;ZBTB16;NACC1;PATZ1;OVOL2;ZBTB17;CC2D1A;ZFHX3;JUN;ZFP57;FOXP3;SP2;MAFK;ZNF148;FOXK1;GATA3;ZNF177;MYC;FOXP1
prerank,endopeptidase activator activity (GO:0061133),-0.3661323435668982,-0.8775418575137303,0.6191780821917808,0.8816832615954021,1.0,5/10,32.88%,PSME1;APH1B;VSIR;PSME2;NLRC4
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.344785849354701,0.8771842573581484,0.6177285318559557,0.9330706839849596,1.0,7/32,14.01%,SLC36A3;SFXN3;SLC36A4;SFXN1;SLC25A38;SLC1A4;SLC6A7
prerank,CXCR chemokine receptor binding (GO:0045236),-0.35597390017464486,-0.8771482253442124,0.597911227154047,0.8764577594178997,1.0,1/11,2.87%,CXCL12
prerank,MHC class II protein complex binding (GO:0023026),0.4114842595889274,0.8752144140371135,0.6016,0.9344763908209627,1.0,3/11,15.33%,CD81;PKM;HSP90AA1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.410721125320897,0.8751808154786478,0.6063492063492063,0.9317833771639867,1.0,2/12,7.67%,ARSI;ARSB
prerank,NADP binding (GO:0050661),0.34010108134631756,0.8745321437328237,0.6185430463576159,0.9303250597983701,1.0,5/32,8.36%,DHCR7;HMGCR;ME3;CRYZL1;PGD
prerank,adenyl ribonucleotide binding (GO:0032559),0.2758145215372046,0.874434909708872,0.7565922920892495,0.927780813867856,1.0,90/291,23.00%,PRAG1;MAP3K5;MPPED2;TSSK6;TSSK4;ABCD1;ATP1A2;CDK6;MKNK2;DAPK3;DAPK1;HMGCR;HARS1;PFKP;CARS2;TWF1;PMVK;EIF2B2;SIK3;EIF4A3;GLUD1;SYN1;LATS1;PPIP5K2;HSPA4;ABCF1;OXSR1;HSPA14;LMTK2;MOV10L1;ABCA2;AARS1;THG1L;AK6;MTREX;SRPK2;PDK2;MARK4;SRPK1;OLA1;TARS1;VPS4A;EIF4G1;SARS2;WNK1;TRNT1;CDC42BPA;HSP90AA1;DHX9;ABCB9;OAS2;PEX6;MAP3K6;ABL1;PEAK1;MCM6;PRKAG1;CLP1;PI4K2A;FICD;SYN3;BMPR1A;PDXK;SLC19A1;STK38L;DARS2;PNKP;ABCB6;CDK11B;IDE;MYO18A;TBCK;CDC42BPG;YARS2;MIEF1;ATP1A1;ATP1A3;WNK4;N4BP2;ABCF3;HSPA13;CDC42BPB;SMC4;LONP1;ACLY;MKNK1;IGHMBP2;PRPS1L1;PRPS1;APRT
prerank,AMP binding (GO:0016208),0.4130222781804037,0.8722955463154213,0.6152597402597403,0.9291415368616556,1.0,2/11,5.23%,MPPED2;PFKP
prerank,cysteine-type peptidase activity (GO:0008234),0.3001666323689599,0.8717235765196356,0.6431137724550898,0.9274522436722806,1.0,27/73,24.56%,TINAGL1;USP46;USP29;USP10;CTSZ;OTUD7B;CAPN2;USP24;USP20;USP42;SFRP1;USP28;CTSH;ATG4B;USP25;OTULIN;USP21;USP16;CTSK;USP2;USP11;BLMH;CASP3;ATG4D;USP13;USP34;CTSF
prerank,fatty acid synthase activity (GO:0004312),0.417559592630166,0.8705296949838718,0.6138279932546374,0.9271173272745298,1.0,2/10,8.00%,ELOVL1;ELOVL6
prerank,filamin binding (GO:0031005),0.4244349177087199,0.8679643451676935,0.632890365448505,0.9291340103291984,1.0,1/11,1.62%,NEBL
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2715499693422027,0.8663466217542687,0.8166332665330661,0.9293847558430547,1.0,122/431,22.89%,PRAG1;MAP3K5;TSSK6;TSSK4;MRAS;RAP1B;ABCD1;ATP1A2;EEF1A1;CDK6;RAP1A;MKNK2;ARL4A;DAPK3;DAPK1;ARL3;HARS1;RHOQ;PFKP;CARS2;TWF1;PMVK;NRAS;KRAS;EIF2B2;RHEB;SIK3;EIF4A3;GLUD1;SYN1;LATS1;PPIP5K2;CDC42;HSPA4;RAB7A;ABCF1;OXSR1;HSPA14;ARHGEF5;LMTK2;GTPBP10;MOV10L1;ABCA2;AARS1;THG1L;AK6;BMS1;MTREX;RAB35;SRPK2;PDK2;RHOA;ARFIP2;RABL3;MARK4;SRPK1;OLA1;TARS1;VPS4A;ARF4;RHOU;TUBB2B;EIF4G1;SARS2;ATL2;WNK1;RAB1B;TRNT1;HRAS;CDC42BPA;HSP90AA1;DHX9;ABCB9;OAS2;RAP2C;ARL8A;PEX6;MAP3K6;ABL1;PEAK1;MCM6;ADSS2;PRKAG1;CLP1;DIRAS2;PI4K2A;FICD;SYN3;BMPR1A;PDXK;STK38L;RAB9A;RNF112;RHOT2;DARS2;PNKP;ABCB6;CDK11B;IDE;MYO18A;RAB27A;RAB10;TBCK;CDC42BPG;YARS2;ATP1A1;ATP1A3;RHOC;WNK4;RABL6;N4BP2;ABCF3;HSPA13;CDC42BPB;SMC4;LONP1;ACLY;MKNK1;IGHMBP2;ARL8B;PRPS1L1;PRPS1
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.2933606928158201,0.8656115850799759,0.6786922209695603,0.9281769229756505,1.0,14/100,8.46%,ARAP1;OGT;VEPH1;ANXA8;PHLDA3;ARAP2;FCHSD2;PLEKHB2;RUBCNL;GOLPH3;ZFYVE19;JPH2;IQGAP1;RUBCN
prerank,nucleotidyltransferase activity (GO:0016779),0.3650635561318663,0.865054982973028,0.6482861400894188,0.9265032983799177,1.0,5/19,12.89%,MOCS3;REV1;TENT4A;THG1L;TUT7
prerank,sodium channel activity (GO:0005272),0.33780960078706,0.8634981986434891,0.6294820717131474,0.9266990937688074,1.0,2/37,1.22%,ASIC5;SCN3A
prerank,transcription coactivator binding (GO:0001223),0.36719874224266064,0.8634833721148323,0.6406015037593985,0.924076292098535,1.0,2/20,6.22%,THRB;ZBTB17
prerank,protein tyrosine kinase activator activity (GO:0030296),0.37309699601691226,0.8628563213235863,0.6285289747399703,0.922603140676904,1.0,4/19,9.90%,CCL5;EFNA5;ERBB3;ABI1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3428027617267038,0.8617876295495733,0.6407766990291263,0.9220190012974481,1.0,6/28,14.16%,FEN1;POP4;POP1;DBR1;RPP21;ENDOV
prerank,cyclic nucleotide binding (GO:0030551),0.36013404586457687,0.8617288142930797,0.6294706723891274,0.9194831009275429,1.0,3/21,7.48%,PDE5A;CNGA2;CNGB3
prerank,ephrin receptor binding (GO:0046875),0.36602306456379846,0.8609891732125426,0.6412884333821376,0.9181375641744608,1.0,6/21,16.76%,EFNB2;EFNA5;SHC1;EFNA4;ABL1;CRK
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.40573600388171066,0.8585150600000455,0.6655844155844156,0.9200688694302586,1.0,2/12,5.55%,CDK6;CDK4
prerank,chemokine activity (GO:0008009),0.33125834744282373,0.8555675554274896,0.6523489932885906,0.9228317310005335,1.0,1/31,1.40%,CCL5
prerank,high voltage-gated calcium channel activity (GO:0008331),0.41539682274851497,0.8552362635377201,0.6357504215851602,0.9207857120732231,1.0,2/10,3.49%,CACNA1A;CACNB3
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.35748602502579535,0.8489074419013455,0.6506024096385542,0.9296445402536039,1.0,5/21,14.40%,REV1;POLK;POLG;POLE4;POLH
prerank,vitamin D receptor binding (GO:0042809),0.38057654736647795,0.8477131759128012,0.6411042944785276,0.9291890338429962,1.0,3/14,13.22%,MED30;MED12;MED24
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.30091387967409117,-0.8470869560233152,0.6997084548104956,0.9339696596972774,1.0,8/16,35.36%,SLC44A2;SLC44A1;SLC5A7;SLC22A2;SLC25A26;SLC22A3;SLC22A5;SLC29A4
prerank,histone methyltransferase binding (GO:1990226),0.40661727400236714,0.8451572926434238,0.6591639871382636,0.931285386396851,1.0,2/11,5.89%,PHF1;LCOR
prerank,magnesium ion binding (GO:0000287),0.2812186908490517,0.8450829388111352,0.7408602150537634,0.928821860308233,1.0,28/135,17.07%,MAP3K5;TSSK6;TSSK4;FEN1;EYA2;IDH3G;RHEB;SIK3;NT5C3A;DCTPP1;LATS1;HPGDS;OXSR1;MOV10L1;THG1L;SRPK2;PLSCR3;SRPK1;OPA1;ENDOV;PGP;CDC42BPA;FAN1;IDH3A;MAP3K6;ABL1;PI4K2A;YDJC
prerank,adenylyltransferase activity (GO:0070566),-0.29201901704115485,-0.8437512516142892,0.6962025316455697,0.9341465130199099,1.0,6/21,19.79%,GPHN;PAPOLA;PAPOLG;SELENOO;TENT2;PAPOLB
prerank,clathrin adaptor activity (GO:0035615),-0.3154006261405091,-0.843167929842554,0.6829971181556196,0.929038870076935,1.0,3/15,7.34%,HIP1;DAB2;AP2B1
prerank,cation:chloride symporter activity (GO:0015377),0.4084430385733366,0.8430773387891333,0.652317880794702,0.9297688462578593,1.0,3/10,16.68%,SLC12A8;SLC12A4;SLC12A6
prerank,peptidase activator activity (GO:0016504),0.3531707729952839,0.8421953784686069,0.6801152737752162,0.928715712531633,1.0,2/22,5.11%,CAV1;PCOLCE2
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3358495656458068,0.8419602662460526,0.6465638148667602,0.9266048322217239,1.0,11/29,22.86%,DUSP10;DUSP1;MAPK7;PPM1D;TNIP1;ABL1;PRMT1;MAPKAPK2;CDK5RAP3;DUSP16;TPR
prerank,ribonuclease P RNA binding (GO:0033204),0.4072947900451277,0.8416154068900329,0.6478632478632479,0.9246814386984302,1.0,3/10,12.55%,POP4;POP1;RPP21
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2630162743977647,0.8410062359584932,0.8385469223007064,0.9231906056825583,1.0,91/346,23.12%,RNF152;TRIM60;FBXW8;RNF43;RNF220;TRIM59;SH3RF2;WWP2;RNF5;TRIM25;TRIM44;RNF138;KLHL21;MUL1;TRIM21;CBLL1;TRIM41;MAGEL2;CDC42;UBE2G2;RMND5B;RBX1;RNF146;PML;TRIM11;TRIM26;RNF121;TRIM47;UBE2B;LTN1;RNF182;PPP1R11;COP1;SIAH3;UBE2Q1;KLHL13;VPS11;RNF141;RNF126;MIB2;RNF123;DTX3;ANAPC4;PELI1;BRAP;VPS18;UBR5;NEDD4;MDM2;UBE2H;BFAR;RNF31;MAEA;MSL2;UBE2N;PDZRN3;DTX2;PRPF19;RNF10;UBE2J1;STUB1;UBE2D3;SIAH1;XIAP;TRIM37;RNF112;UBE2Z;RNF41;FBXO9;RNF130;UBE3C;RMND5A;CHFR;ZFP91;UBE2E1;SMURF2;ARIH2;TRAF3IP2;TRIM5;RNF168;CUL2;FBXW2;RCHY1;RNF213;RNF150;NSMCE1;BIRC3;RNF14;CDC23;UBR4;TRIM3
prerank,NAD+ binding (GO:0070403),-0.3375033764521609,-0.8404268662232377,0.650137741046832,0.9284746331322147,1.0,3/12,16.36%,ZC3HAV1;HPGD;SIRT2
prerank,chloride channel activity (GO:0005254),0.30416258785831063,0.8391138875826659,0.6915544675642595,0.9239241637769348,1.0,9/59,15.64%,CFTR;ANO7;CLIC1;CLCN4;SLC1A4;ANO6;ANO3;CLCC1;PACC1
prerank,acid-thiol ligase activity (GO:0016878),-0.31989318954042745,-0.8380949365967428,0.6997167138810199,0.9272580180022119,1.0,3/13,10.63%,ACSS3;ACSL1;ACSS1
prerank,GTPase regulator activity (GO:0030695),0.26690144080529554,0.8349096910259943,0.799791449426486,0.9286025812402163,1.0,44/212,15.20%,ARHGAP42;SRGAP2;ARAP1;RANBP3L;CPEB2;ASAP2;SIPA1L1;ARHGAP18;WNT11;GRTP1;TBC1D16;ADAP1;DLC1;IPO7;TSC2;SH3BP4;ARHGAP29;ARHGAP10;KRIT1;IQGAP1;RALGDS;JUN;OPHN1;BCR;LLGL2;SGSM2;GNAQ;TBC1D1;DOCK1;RASA1;ASAP3;ARHGEF10L;RGS6;ARFGEF1;OCRL;ARHGAP31;PREB;SEC23A;ITGB1BP1;FLCN;CCDC88A;DNM1L;ARHGAP27;USP6NL
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.34802806147714166,-0.8343679178638669,0.6989795918367347,0.9287787722981214,1.0,2/11,5.75%,SGMS1;PTDSS1
prerank,DNA-binding transcription factor binding (GO:0140297),0.26826365569248145,0.8335489279272876,0.783195020746888,0.9283552901492216,1.0,34/189,14.13%,KLF4;HDAC5;EP300;FOS;CGGBP1;DAPK3;HDAC4;NFE2L2;WWP2;HSPB1;MTDH;CREB1;ZBTB17;HCFC1;DDRGK1;MEF2D;FIZ1;TCF7L2;JUN;TWIST1;TLE2;PTMA;NCOR1;MIER2;TLE4;YWHAZ;SP1;PIAS1;PIAS3;MKKS;MYC;TLE5;GSK3B;MEF2C
prerank,ADP binding (GO:0043531),-0.27262799676412547,-0.832369399012645,0.7227722772277227,0.9266156788791976,1.0,2/25,2.09%,PRKAG2;ME1
prerank,DNA polymerase activity (GO:0034061),0.34511905642816676,0.8291701096488474,0.6809453471196455,0.9334814065026111,1.0,5/22,14.40%,REV1;POLK;POLG;POLE4;POLH
prerank,transcription coregulator binding (GO:0001221),0.2961827535681632,0.8284917762312214,0.7078507078507078,0.9321355957380222,1.0,5/50,6.22%,THRB;ZBTB16;PHF1;LCOR;ZBTB17
prerank,transforming growth factor beta receptor binding (GO:0005160),0.35176342822401974,0.8259163331011424,0.6656626506024096,0.9339834652230584,1.0,4/18,14.52%,SMAD6;TGFB2;TGFBR2;TGFBR3
prerank,growth factor activity (GO:0008083),-0.20575269914354355,-0.8247033926829953,0.8819444444444444,0.9349437344740624,1.0,7/74,8.54%,TGFA;JAG1;NRG3;VEGFC;FGF2;IGF2;JAG2
prerank,telomerase RNA binding (GO:0070034),0.34263081822466174,0.8241745880634656,0.6947674418604651,0.9344798074670261,1.0,4/22,13.25%,SNRPB;SMG7;GAR1;PINX1
prerank,CoA-ligase activity (GO:0016405),-0.3119903810307468,-0.8220862402499116,0.7272727272727273,0.9338531361401394,1.0,4/14,16.95%,ACSS3;ACSL1;ACSS1;ACSBG1
prerank,calcium channel activity (GO:0005262),0.2804422544960763,0.8185581679351142,0.7302325581395349,0.9418080669950903,1.0,14/84,13.49%,STIM2;CACNA2D3;CACNA1A;TRPM8;MCU;CACNB3;CACNA2D4;ANXA2;TMC2;PKD1;TRPM4;PKD2L1;TRPM2;CACNB2
prerank,DNA binding (GO:0003677),0.2525075764397144,0.816801257761637,0.95,0.9421042802782061,1.0,165/694,22.56%,NFATC2;THRB;TFAP2C;PPARGC1A;PBX1;ZIC4;FOXP2;NUPR1;ZC3H12A;KLF12;FEN1;SLPI;EP300;MLH1;FOXO3;CGGBP1;FOXC2;ZNF219;SHOC1;HDAC4;NFE2L2;NR6A1;ZMYM6;ZBTB16;POLR2H;SMARCB1;NABP2;POU2F3;FOXD2;ESRRB;RARG;IRF3;SLTM;NKX2-8;PHF1;PATZ1;RNF138;POLR2A;SYCP2;MRE11;HOXA5;ZIC2;SOX9;FOXD1;CENPS;ANG;TSNAX;SIX1;TCF7L2;POU3F1;JUN;CRY2;SDE2;GRHL2;FOXP3;TRIM26;NR2C1;DNMT3A;HDGFL3;ILF2;DNASE1L2;POLG;ARID4A;NFIB;NFYC;CR2;SMARCA4;MMP12;ARID3B;CALCOCO1;GTF3C3;JRKL;MAFK;ZNF148;SP1;ZMYM4;HMGN1;CHD3;GATA3;ERCC5;MBD4;POLR3C;MYC;DNASE1L1;RPA3;REXO4;ENDOV;PAX3;SRRT;IRF2;APTX;DNTTIP1;DHX9;TET1;DCLRE1C;MCM8;ZGPAT;E2F1;HMBOX1;FAN1;CDC5L;DDB1;PCNA;ZBP1;CAMTA2;MCM7;ABL1;GTF3C2;SPTY2D1;ERCC2;HINFP;MCM6;POU4F1;NBN;BCLAF3;SMC6;GTF3C5;USF1;TSG101;RAD50;PARK7;MEOX2;TRIM16;RFC1;PLAGL2;ZKSCAN3;RPL6;TEAD1;NUCKS1;ZBTB7A;PNKP;APP;JCHAIN;PCBP2;HDGF;ERCC4;SREBF1;KLF2;MAPT;SNAPC3;ZBTB32;HOXA1;IKZF1;NABP1;IRF6;ZNF513;TWNK;ARNT;ZNF8;ACR;YY1;MTF1;YBX1;TAF6;ZBTB49;MCM4;GTF3C4;LONP1;SFPQ;PGR;POLR3F;MEN1;IGHMBP2;CDK9;RPL7
prerank,store-operated calcium channel activity (GO:0015279),0.3951275752609356,0.8143492246221478,0.6683501683501684,0.9436230362794346,1.0,1/10,1.26%,STIM2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.30203769910023837,0.8141588395120474,0.7426751592356687,0.9414099289115666,1.0,11/49,15.30%,ANXA3;ANXA8;ANXA4;ANXA5;ANXA2;PCLO;CPNE2;ESYT2;SYT6;SYT11;SYT12
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.3692035911934407,0.8123500334427862,0.6693037974683544,0.9419223637375078,1.0,5/14,21.75%,POP4;POP1;RPP21;TSEN2;RPP40
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.25833714665723245,0.8106000946583543,0.8466257668711656,0.9422971483335619,1.0,46/254,16.87%,KLF5;TFAP2C;KLF4;ELF3;FOXO3;FOXC2;GLIS2;ZBTB16;POU2F3;FOXD2;ESRRB;IRF3;NKX2-8;CREB1;ZBTB17;RXRB;HOXA5;SOX9;NRF1;KLF7;SIX1;JUN;GRHL2;PRDM15;NFIB;NFYC;NFIC;CREB3;MEF2B;SP1;SMARCD2;MYBL1;GATA3;RREB1;NFIA;MYC;MEF2C;IRF2;ATMIN;MDM2;RFXAP;KLF6;CDC5L;HINFP;HSF2;POU4F1
prerank,glutathione transferase activity (GO:0004364),0.33135892642456366,0.8094847184454546,0.7130559540889526,0.9416012678621754,1.0,5/23,15.68%,MGST3;GSTO1;HPGDS;GSTK1;GSTM2
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.25151062378942285,-0.808075986738224,0.7695035460992907,0.9537633786361758,1.0,5/31,5.16%,KCNK5;ABCC9;SLC12A2;PKD2;KCNQ4
prerank,signal sequence binding (GO:0005048),0.3121360601830142,0.8076455064462256,0.716931216931217,0.9422354660489681,1.0,10/35,17.59%,KPNA7;NFKBIA;TNPO2;KPNA4;TOMM20;BRAP;TNPO1;RANBP6;IPO4;KPNA1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.3626623150642291,0.8050255869745948,0.689922480620155,0.9441183717771121,1.0,1/14,3.00%,ADH7
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3236191247122186,-0.8035057135583477,0.7481840193704601,0.955733563815888,1.0,4/12,26.65%,SLC2A1;SLC5A3;SLC2A3;SLC2A4
prerank,MAP kinase activity (GO:0004707),-0.30285524319086693,-0.8026096889656168,0.7594594594594595,0.9512643461320416,1.0,2/14,4.23%,MAPK4;MAPK10
prerank,ribosomal small subunit binding (GO:0043024),0.3444463019424183,0.8016715011996696,0.6900958466453674,0.9469731224307144,1.0,2/17,9.03%,CPEB2;EIF4B
prerank,WW domain binding (GO:0050699),0.3260262291821727,0.8002792407450301,0.7140845070422536,0.9466874513009095,1.0,7/26,20.60%,ENAH;WBP1;TCEAL5;TCEAL8;KIF20B;PMEPA1;TRAF4
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2765834498470077,0.7989574723600894,0.7683741648106904,0.9464970257589711,1.0,7/85,10.86%,PLB1;ABHD5;ABHD15;PLA2G12A;PAFAH2;AARS1;PON3
prerank,voltage-gated calcium channel activity (GO:0005245),0.3085528112209612,0.7985787743378446,0.7211155378486056,0.9446659775991519,1.0,5/37,7.79%,CACNA2D3;CACNA1A;CACNB3;CACNA2D4;TMC2
prerank,hexosaminidase activity (GO:0015929),0.36587456543807007,0.7968361922289429,0.71499176276771,0.9449196276716625,1.0,4/12,16.66%,HEXA;HEXB;NAGA;HEXD
prerank,glucose transmembrane transporter activity (GO:0005355),-0.28788857402220874,-0.7916250156323236,0.7562326869806094,0.9642203507502602,1.0,5/17,26.65%,SLC2A1;SLC5A3;SLC5A11;SLC2A3;SLC2A4
prerank,endopeptidase regulator activity (GO:0061135),0.2990004376280581,0.7911901720406449,0.7548387096774194,0.9515881165988079,1.0,4/40,9.64%,SLPI;SPINT2;PSMF1;ABCA2
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.3275844994625227,0.7909519496699914,0.7211267605633803,0.9495029491351976,1.0,13/22,30.73%,ATP6V1D;ATP6V1E1;ATP6V0D1;ATP5F1B;ATP6V1B2;ATP6V0B;ATP6V0E1;ATP2C1;ATP6V0E2;ATP6V0D2;TCIRG1;ATP6V0C;ATP6V0A2
prerank,Toll-like receptor binding (GO:0035325),-0.333299107679922,-0.7894001792235793,0.732824427480916,0.9619303828030885,1.0,3/11,13.65%,DAB2IP;TIRAP;UNC93B1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2912853090060859,0.7881178664116918,0.7528373266078184,0.9513128771608665,1.0,22/54,30.01%,HDAC5;PDF;HDAC4;HDAC3;NIT1;MIER2;NTAQ1;VNN1;HDAC6;NADSYN1;ACR;SIRT4;SIRT7;NGLY1;HDAC8;PM20D1;NTAN1;SUDS3;ASRGL1;ASAH1;HDAC11;HINT3
prerank,translation elongation factor activity (GO:0003746),0.35034583515511364,0.786999407161874,0.7154213036565977,0.9506724722636329,1.0,1/14,2.92%,EEF1A1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3442680375363659,0.786931972151289,0.7211093990755008,0.9483652845578687,1.0,4/17,16.96%,CMPK1;AK5;AK3;CLP1
prerank,3'-5' exonuclease activity (GO:0008408),0.296156501264227,0.7864582714072208,0.7427122940430925,0.9466974415605858,1.0,6/45,10.39%,CNOT6;MRE11;EXOSC3;XRN2;ERI3;POLG
prerank,ribonuclease P activity (GO:0004526),0.374691639270882,0.7861243101367282,0.6976351351351351,0.9448472718806076,1.0,3/11,12.55%,POP4;POP1;RPP21
prerank,metal ion transmembrane transporter activity (GO:0046873),0.30957032442528865,0.7786966532851072,0.7444444444444445,0.9536839117422143,1.0,6/27,16.28%,ITPR2;TMEM165;AQP1;SLC41A1;ATP2B4;SLC11A2
prerank,GTPase inhibitor activity (GO:0005095),0.3491280753323952,0.7778118383936782,0.7230046948356808,0.9525899342572598,1.0,2/13,8.44%,CPEB2;IQGAP1
prerank,cytokine receptor binding (GO:0005126),0.2655460580130262,0.7765664844377917,0.7908878504672897,0.9521277345793707,1.0,10/83,11.74%,CRLF1;CCL5;CLCF1;EPO;CCRL2;PXDN;TGFB2;VEGFB;JAK1;SOCS2
prerank,gap junction channel activity (GO:0005243),0.3154238571929736,0.7742077898781187,0.7399425287356322,0.953330263590204,1.0,2/22,4.93%,GJB6;GJC2
prerank,wide pore channel activity (GO:0022829),0.31148724275918493,0.7738202384287662,0.738944365192582,0.951509300348119,1.0,2/23,4.93%,GJB6;GJC2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.2831249883005726,0.7734252311515707,0.7939024390243903,0.949730067262793,1.0,13/53,15.34%,SLC36A3;SLC66A1;OCA2;CTNS;SLC36A4;SLC3A1;SFXN1;SLC25A38;SLC7A6;SLC1A4;SLC6A7;SLC25A12;SLC7A3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.3514066101309782,0.7728495917289112,0.7469512195121951,0.9482197361158583,1.0,4/14,15.02%,PYCR3;ALDH1L2;NOXRED1;ALDH1L1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.29517733899184695,0.7721329157336431,0.7472826086956522,0.9468541041582788,1.0,11/35,25.92%,NT5C3A;LCMT2;TRPT1;TRIT1;AARS1;DUS2;GATB;DUS3L;FTO;TARS2;FTSJ1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.2445472834243968,-0.7721302839607619,0.825,0.9845360611552442,1.0,11/27,27.57%,RNF144A;TRAF6;RNF144B;DCUN1D3;PPARA;DCUN1D2;RNF180;SIAH2;FOXL2;DCUN1D4;RNF19B
prerank,GTP binding (GO:0005525),0.24784590175446825,0.7639666213001953,0.8645833333333334,0.9565616061996277,1.0,32/172,16.98%,MRAS;RAP1B;EEF1A1;RAP1A;ARL4A;ARL3;RHOQ;NRAS;KRAS;EIF2B2;RHEB;GLUD1;CDC42;RAB7A;ARHGEF5;GTPBP10;THG1L;BMS1;RAB35;RHOA;ARFIP2;RABL3;ARF4;RHOU;TUBB2B;ATL2;RAB1B;HRAS;RAP2C;ARL8A;ADSS2;DIRAS2
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.31304844925850944,-0.7633097950404213,0.7583547557840618,0.9925799038403431,1.0,7/11,52.77%,CHRNB1;CHRNA4;CHRNB2;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.36845140504200236,0.7618661812792575,0.7549668874172185,0.9572066649536923,1.0,3/10,14.15%,NAA15;NAA20;NAA10
prerank,single-stranded DNA binding (GO:0003697),0.2583107962107308,0.7618151100521839,0.8428246013667426,0.9549180883192793,1.0,28/93,22.49%,MLH1;SHOC1;POLR2H;NABP2;RNF138;CRY2;ERCC5;POLR3C;RPA3;REXO4;APTX;DHX9;MCM8;MCM7;MCM6;POU4F1;SMC6;PARK7;NUCKS1;JCHAIN;PCBP2;ERCC4;MAPT;NABP1;TWNK;MCM4;LONP1;IGHMBP2
prerank,single-stranded RNA binding (GO:0003727),0.2784675266353312,0.7588410652013049,0.7872062663185379,0.9570058608840649,1.0,8/43,15.36%,STRBP;L1TD1;EIF4B;LACTB2;FXR1;ENDOV;ZFR2;DHX9
prerank,peptidoglycan binding (GO:0042834),0.36982142291389014,0.7581923995767074,0.7523961661341853,0.9556600225094514,1.0,4/10,19.63%,PGLYRP3;HK1;RNASE7;JCHAIN
prerank,single-stranded DNA helicase activity (GO:0017116),-0.2661148183379203,-0.7535649360681326,0.8422619047619048,1.0,1.0,12/19,36.69%,WRNIP1;RFC3;HELQ;RAD51;RFC4;RFC2;RFC5;HELB;DSCC1;DNA2;CHTF18;PIF1
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.27039173219910695,-0.753481989703203,0.7662721893491125,0.9949336435056899,1.0,5/15,15.12%,PIK3CB;PIK3CD;PIK3R3;PI4K2B;PIK3C3
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3488490442468658,0.752700978878045,0.7572815533980582,0.9610424556536679,1.0,2/13,12.30%,ABHD5;LPCAT2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3084521875900368,0.7492072197761012,0.7684797768479776,0.9635825803726957,1.0,3/25,4.04%,ANXA8;PHLDA3;FCHSD2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.30658945852039554,-0.7486831354138623,0.7916666666666666,0.9959061265776458,1.0,4/11,25.56%,PRMT3;PRMT9;PRMT6;CARM1
prerank,pseudouridine synthase activity (GO:0009982),-0.29490694190141337,-0.7485998479302451,0.7534626038781164,0.9900522015067942,1.0,3/13,14.68%,PUS7;DKC1;RPUSD4
prerank,nucleosomal DNA binding (GO:0031492),0.31829809843397167,0.7485150043431585,0.7690014903129657,0.9621645116236097,1.0,7/21,18.54%,SMARCB1;ACTB;SMARCA4;SMARCD2;GATAD2B;SMARCC1;H3-3A
prerank,aspartic-type peptidase activity (GO:0070001),0.3519907041823928,0.7483872816417771,0.7374213836477987,0.9599729866957717,1.0,4/10,23.70%,NAPSA;BACE1;DDI2;PSEN1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.30505073648733233,0.7477755034554401,0.7889518413597734,0.9584757611258495,1.0,3/24,9.43%,GLUL;ZDHHC12;GOLGA7
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.3250522325819823,0.7459559475887925,0.7692307692307693,0.9562681384364776,1.0,6/16,22.77%,ANO8;ANO7;ANO6;ANO3;TTYH3;ANO10
prerank,intracellular chloride channel activity (GO:0061778),0.3250522325819823,0.7459559475887925,0.7692307692307693,0.9562681384364776,1.0,6/16,22.77%,ANO8;ANO7;ANO6;ANO3;TTYH3;ANO10
prerank,galactosyltransferase activity (GO:0008378),0.35222890105293614,0.7437275056131533,0.7688442211055276,0.9570078216589282,1.0,1/11,3.79%,A4GALT
prerank,ion gated channel activity (GO:0022839),0.3043501934246059,0.7434832761202926,0.7787234042553192,0.9550455523027028,1.0,8/24,19.06%,ANO8;ANO7;TRPM4;PKD2L1;ANO6;ANO3;TMEM63B;TTYH3
prerank,cardiolipin binding (GO:1901612),0.3529613200214851,0.740237924333924,0.7560137457044673,0.9574261811228753,1.0,3/10,18.80%,GSDME;OPA1;STOML2
prerank,transition metal ion binding (GO:0046914),0.23026254641047764,0.7397354699719447,0.9607645875251509,0.9557792436538894,1.0,90/397,22.59%,NAPEPLD;FAM20C;KLF4;MMP9;GPC1;MPPED2;FEN1;ADH7;TIMM10;ADAM33;EPRS1;GALNT1;HDAC4;LARGE1;TIMP1;RNF5;HEPH;ALOX5;TIMP2;DUSP12;MGAT1;TES;KDM5C;NQO2;KLF7;ANG;TAB3;MSRB2;CHORDC1;CXXC4;FDX1;KMT2A;PITRM1;SHMT1;PHF5A;ZNF205;LACTB2;KDM3A;SOD2;KDM4C;MMP12;MYT1;PLSCR3;SCD5;ACO2;NPEPPS;CHD3;TARS1;CHMP1A;SEC23A;LTA4H;MDM2;SNCB;TET1;SLC11A2;ABL1;SIAH1;ZFYVE1;TAB2;PDXK;PARK7;PCK2;USP16;RNF112;APIP;ENPP5;SEC24B;IDE;TIMM9;ISCA2;LVRN;ZBTB32;RASSF1;ZNF8;QPCTL;ACR;TYW5;ZCCHC4;QPCT;MELTF;PHF2;ADPRM;XPNPEP1;ARIH2;KMT2B;DPF3;AOX1;SEC24D;RCHY1;CCS
prerank,DNA secondary structure binding (GO:0000217),0.2941437980708553,0.7376378952998428,0.7986301369863014,0.9565321394776779,1.0,10/31,23.82%,RECQL4;KMT2A;ERCC5;MEF2C;ABL1;LIN54;MAPT;YY1;MEN1;FANCM
prerank,cysteine-type endopeptidase activity (GO:0004197),0.2538179071484731,0.7374620534672326,0.8411764705882353,0.9544776338511729,1.0,24/78,25.30%,USP46;USP29;USP10;CTSZ;CAPN2;GPAA1;CAPNS1;USP24;USP20;USP42;SFRP1;USP28;CTSH;USP25;CAPN15;USP16;CTSK;USP2;USP11;CASP3;USP13;USP34;CTSF;CASP8
prerank,solute:sodium symporter activity (GO:0015370),-0.23685426534398069,-0.7357073707081812,0.8807017543859649,1.0,1.0,6/27,23.75%,SLC4A10;SLC5A3;SLC5A11;SLC4A8;SLC5A7;SLC5A6
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.29162387620397023,0.7345570070282399,0.8186813186813187,0.9561536829497037,1.0,4/33,9.40%,CNOT6;EXOSC3;XRN2;ERI3
prerank,carboxylic acid binding (GO:0031406),0.2766274459201924,0.7339785724438586,0.819371727748691,0.9546038303762368,1.0,4/38,9.26%,RTN4R;SESN2;GLUD1;SHMT1
prerank,methyl-CpG binding (GO:0008327),-0.24484191805927075,-0.7309693869045366,0.8701298701298701,1.0,1.0,5/22,16.03%,MBD2;MECP2;TET3;ZBTB21;MBD3
prerank,CARD domain binding (GO:0050700),-0.27846682762582087,-0.7305388918626109,0.8306010928961749,0.996971325417259,1.0,4/14,14.40%,NOD1;CARD10;IRGM;CASP4
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.2873991285872746,-0.7289190896134035,0.821522309711286,0.993220312630346,1.0,2/12,5.16%,VEGFC;DAB2IP
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.28434424439805966,0.7280968790905075,0.8139841688654353,0.9602092413465527,1.0,4/34,9.40%,CNOT6;EXOSC3;XRN2;ERI3
prerank,symporter activity (GO:0015293),-0.2963293143966621,-0.7230686133987237,0.8103896103896104,0.9947219407976667,1.0,3/10,23.75%,MFSD2A;SLC5A5;SLC5A6
prerank,hormone activity (GO:0005179),0.26704787896719906,0.7225428049319329,0.8309002433090025,0.965249186988436,1.0,2/54,2.42%,GAL;PENK
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.24824985067469033,-0.722358396983385,0.8652694610778443,0.9898397887634036,1.0,2/21,5.36%,KL;FGF2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.275495789920094,-0.7212220123350108,0.8356164383561644,0.9854445782257806,1.0,4/14,24.31%,KCNJ2;KCNJ8;KCNIP2;KCNJ3
prerank,methylation-dependent protein binding (GO:0140034),-0.19291763528224415,-0.7205532445150671,0.9736842105263158,0.9805677465537486,1.0,12/57,16.31%,KDM7A;CHD8;SUZ12;PYGO1;RBBP5;ING2;MSL3;NCAPG2;MTF2;WDR5;THAP7;ZMYND11
prerank,telomeric DNA binding (GO:0042162),0.28127003070522183,0.7198839295279411,0.8381344307270233,0.9663628028956374,1.0,15/32,31.47%,SMG7;UPF3A;HMBOX1;KDM1A;RAD50;TERF2;ZBTB48;TINF2;APEX1;TERT;XRCC5;TERF1;TERF2IP;TELO2;NCL
prerank,myosin V binding (GO:0031489),-0.2582521303528344,-0.7174414508249009,0.8426966292134831,0.9786567000525005,1.0,4/15,18.92%,RAB11B;RAB39B;RAB3D;RAB3C
prerank,acetyltransferase activity (GO:0016407),0.2789000916157484,0.7170742421802658,0.8143053645116919,0.9676593614840592,1.0,5/31,14.15%,EP300;KAT6B;PAFAH2;NAA15;NAA10
prerank,voltage-gated sodium channel activity (GO:0005248),0.3020818854444062,0.714881129544016,0.7893982808022922,0.9681471755144487,1.0,1/22,1.22%,SCN3A
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.22353949104592905,-0.7134211152037995,0.9032258064516129,0.9778481495224493,1.0,8/29,18.95%,PRKAG2;PKIG;CIT;PRKAR2B;INCA1;SPRED1;PRKAR1B;CIB1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.25307787084189387,0.7132485904997214,0.8772782503037667,0.967862378577369,1.0,10/60,12.75%,PPM1L;PPP2CA;PPM1B;DUSP1;UBLCP1;PP2D1;PPM1A;MTMR3;PPP1CB;PPM1D
prerank,DNA polymerase binding (GO:0070182),0.3064104999442165,0.7126920252308715,0.8248062015503876,0.9662310914083742,1.0,6/18,22.22%,NABP2;SMARCA4;HSP90AA1;PCNA;PTGES3;LONP1
prerank,3'-5' DNA helicase activity (GO:0043138),0.31536586300115116,0.7112702468275616,0.7667682926829268,0.965793630893318,1.0,7/16,26.18%,RECQL4;DHX9;MCM7;MCM6;FANCM;FBH1;MCM2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.2416140196767376,-0.7104548529610871,0.8731117824773413,0.975809164739925,1.0,8/20,23.72%,OTULINL;SENP2;SENP5;OTUB1;USP7;EIF3F;OTUD5;YOD1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.3365919215749341,0.7100041033453249,0.8110367892976589,0.9650466561953673,1.0,6/11,29.16%,NABP2;RAD50;TERF2;RPA2;TERF1;TERF2IP
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.24931575319948282,0.7077078022543111,0.8852071005917159,0.9654119341673959,1.0,4/73,9.02%,SORCS2;CRHR2;LGR4;HCRTR1
prerank,transcription corepressor binding (GO:0001222),0.27911222864031904,0.7064259966236148,0.8489736070381232,0.9647109676018546,1.0,12/27,26.48%,ZBTB16;PHF1;LCOR;HDAC3;HDAC6;ZBTB7A;HDGF;USP11;PER1;PER2;EHMT1;WIZ
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.2627335813052639,-0.7058628561765568,0.8474114441416893,0.9756363455472102,1.0,4/16,12.29%,MTMR14;MTM1;MTMR7;MTMR2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.318928182251511,0.7041656284440795,0.794912559618442,0.9653662505398005,1.0,4/15,22.45%,ABHD5;LPCAT2;ABHD4;GPAT3
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.28696811274341055,-0.7021495592095864,0.8346883468834688,0.9743296979625875,1.0,8/11,53.57%,KCNJ8;KCNJ3;KCND3;KCNE5;KCNQ1;KCNJ5;KCNE2;KCNE3
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.2636208050116425,0.7008153180142338,0.8705128205128205,0.9673384401996713,1.0,7/42,17.33%,CDKN1A;CCND2;CCND1;CCNL2;HEXIM1;CCNG1;CDKN2D
prerank,voltage-gated chloride channel activity (GO:0005247),0.3373145606907816,0.6979255563914735,0.8186274509803921,0.9684971570665192,1.0,2/10,12.18%,CLCN4;ANO6
prerank,DNA replication origin binding (GO:0003688),0.2841218080716725,0.6961375329287273,0.8349928876244666,0.9684146422884797,1.0,9/23,26.18%,GRWD1;DHX9;MCM8;MCM7;MCM6;ORC2;MCM4;ORC3;MCM2
prerank,ubiquitin binding (GO:0043130),0.24328462356858568,0.6960709561820683,0.8886255924170616,0.9662529879525241,1.0,24/73,25.81%,CXCR4;HSPB1;NSFL1C;MARK4;UBXN7;NPLOC4;NEDD4;MDM2;RNF31;IKBKG;UBE2N;RAE1;USP25;TSG101;ILRUN;USP16;FBXW7;RNF168;DDI2;UBXN2A;USP13;NUP62;FBXO7;UBAP1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.2539824453968788,0.693552699008326,0.8742216687422167,0.967034192541382,1.0,14/49,24.05%,MPPED2;ATP1A2;DUSP10;DUSP12;PPP1CB;PGP;PLCXD3;DUSP11;DUSP3;DUSP16;ACP2;ACP6;APEX1;ARMT1
prerank,copper ion binding (GO:0005507),0.2579722106840838,0.6931188582899923,0.8822768434670116,0.9653683380212864,1.0,4/42,7.82%,GPC1;HEPH;ANG;SUMF1
prerank,histone acetyltransferase binding (GO:0035035),0.2906716264107476,0.6922971583271557,0.8352941176470589,0.9641872065006245,1.0,5/21,19.36%,GLI3;FOXP3;BCAS3;PCNA;ZBTB7A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.32825512856170025,0.690917723632998,0.8125,0.9635373648802625,1.0,1/11,6.77%,DDAH2
prerank,phosphatidylglycerol binding (GO:1901611),0.3111524552369397,0.6901008014963192,0.8056013179571664,0.962315983089313,1.0,4/13,18.80%,PITPNC1;GSDME;OPA1;STOML2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.2722443361878012,0.6870934506066564,0.8513513513513513,0.9637742509459618,1.0,3/28,9.36%,PRKAA2;AURKC;MAP2K2
prerank,N-acetyltransferase activity (GO:0008080),0.294843902838443,0.6830934432297586,0.8458083832335329,0.966022983867106,1.0,3/19,14.15%,EP300;AANAT;NAA10
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.2665399198071279,-0.6793956424353407,0.8759894459102903,0.9915337030391445,1.0,4/14,12.29%,MTMR14;MTM1;MTMR7;MTMR2
prerank,calcium activated cation channel activity (GO:0005227),0.2950067761915952,0.6741296229715453,0.8578274760383386,0.9734734182861409,1.0,7/17,22.77%,TRPM4;PKD2L1;ANO6;TMEM63B;KCNMB2;KCNMB3;ANO10
prerank,pyridoxal phosphate binding (GO:0030170),0.28659654122089373,0.6720220129089399,0.8402877697841726,0.9735676139014434,1.0,9/20,30.77%,ABAT;SHMT1;PDXK;PYGB;PYGM;PLPBP;PNPO;OAT;PSAT1
prerank,channel activity (GO:0015267),-0.1940983717625737,-0.6713607617204376,0.9598214285714286,0.9934232033864334,1.0,12/41,27.99%,BCL2;PANX1;AQP11;AQP4;BAX;KCNK3;MPV17;CHRNB1;TRPA1;SLC14A1;TMEM120B;PANX2
prerank,protein phosphatase activator activity (GO:0072542),0.31130164972368857,0.6706262514031232,0.8341013824884793,0.9728518085226191,1.0,6/13,30.69%,PPP1R15A;PPP2R5E;CALM2;PHACTR4;CALM1;PPP2R5C
prerank,calcium-activated potassium channel activity (GO:0015269),-0.2707242717807013,-0.6698245546673087,0.8682926829268293,0.9891150515092609,1.0,3/11,15.54%,KCNN2;KCNMA1;KCNMB4
prerank,ubiquitin-dependent protein binding (GO:0140036),0.32572467438546304,0.6662350120660616,0.8557377049180328,0.9750668050244415,1.0,6/10,33.08%,FAN1;IDE;ANKRD13D;ANKRD13B;USP15;LAPTM5
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.25255152153600574,-0.6628084149862129,0.900804289544236,0.9896331992940752,1.0,4/14,23.15%,SLC26A7;SLC26A6;SLC26A8;SLC26A2
prerank,protein phosphatase regulator activity (GO:0019888),0.23872222841707072,0.6602544972211085,0.9168704156479217,0.9789973894242817,1.0,14/53,19.62%,PPP6R3;RCAN1;PPP1R15A;PPP2R2D;LGALS3;LMTK2;PPP1R16A;PTN;SET;PPP1R1B;IGBP1;PPP2R2C;PPP2R5E;RCAN2
prerank,palmitoyltransferase activity (GO:0016409),0.26220162138906183,0.6596571700059327,0.9013698630136986,0.9774079033404139,1.0,3/28,9.43%,GLUL;ZDHHC12;GOLGA7
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.30121550391304996,0.6594592768634823,0.8793650793650793,0.9754664044602074,1.0,2/14,9.97%,CMPK1;AK5
prerank,SUMO binding (GO:0032183),-0.25793118714179686,-0.6573241730130713,0.8994845360824743,0.9889861208934909,1.0,3/13,11.87%,SERBP1;RNF4;SIMC1
prerank,triglyceride lipase activity (GO:0004806),0.28211482731800097,0.6573046880989978,0.8853410740203193,0.9753072274369764,1.0,1/20,3.19%,ABHD5
prerank,kinase activity (GO:0016301),0.22211196079995582,0.6540454205893254,0.9560439560439561,0.9761925324263582,1.0,19/109,14.37%,EPHA4;PIK3C2B;IP6K1;AGK;PMVK;DCAKD;STK39;MAPK15;NADK2;NADK;PPIP5K2;PI4KA;CKMT1A;DGKA;PKMYT1;PSTK;IRAK1;GSK3B;DOLK
prerank,phosphatase inhibitor activity (GO:0019212),0.2719567929983209,0.6496200151392946,0.8717948717948718,0.9783532017851788,1.0,5/20,15.21%,LGALS3;LMTK2;PTN;SET;PPP1R1B
prerank,MHC class I protein binding (GO:0042288),-0.251072051418562,-0.6457285952773163,0.9030612244897959,0.9927090922104469,1.0,2/13,11.76%,TAP2;ATP5F1A
prerank,water transmembrane transporter activity (GO:0005372),0.3034565778660217,0.6445574869067139,0.8744038155802861,0.9809657221329723,1.0,2/11,12.50%,AQP1;PDPN
prerank,pentosyltransferase activity (GO:0016763),0.24409402742710334,0.644204472546333,0.91005291005291,0.9791626926203987,1.0,8/36,18.30%,LARGE1;PARP3;UPP2;UMPS;PARP6;TNKS2;UPP1;PARP2
prerank,anion:anion antiporter activity (GO:0015301),0.28023529645120543,0.6413554639492157,0.880248833592535,0.9796183655832867,1.0,6/17,25.49%,SLC4A2;SLC26A4;SLC25A4;SLC19A1;SLC25A11;SLC4A3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.25380480395321603,0.6364787224992888,0.9020979020979021,0.9816413155162698,1.0,6/28,21.16%,EDA;FEM1B;PIDD1;TRIM37;TRAF4;TMBIM1
prerank,transaminase activity (GO:0008483),0.2983838868292086,0.6310780981724406,0.8651685393258427,0.9842173063772799,1.0,2/11,16.24%,ABAT;BCAT2
prerank,mannosyltransferase activity (GO:0000030),0.2606400908415105,0.6304000387617903,0.8791044776119403,0.9826619425742977,1.0,4/21,13.96%,TMTC1;PIGZ;ALG1;ALG12
prerank,1-phosphatidylinositol binding (GO:0005545),0.28164727097520814,0.6278311980541048,0.890282131661442,0.9826029911134987,1.0,6/15,25.82%,WDFY3;ZFYVE1;SESTD1;WDFY1;SNX10;EEA1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.23515536555608468,0.6263267154783256,0.9373368146214099,0.9817372588459361,1.0,5/40,11.23%,CARNMT1;GAMT;NNMT;DNMT3A;THUMPD3
prerank,methylated histone binding (GO:0035064),-0.16464762747738032,-0.6247701289232613,1.0,1.0,1.0,12/62,16.31%,KDM7A;CHD8;SUZ12;PYGO1;RBBP5;ING2;MSL3;NCAPG2;MTF2;WDR5;THAP7;ZMYND11
prerank,cAMP response element binding (GO:0035497),0.3018921630348851,0.6237103202762833,0.8512396694214877,0.9817496505845111,1.0,4/10,18.20%,CREB1;JUN;CREB3L2;ATF2
prerank,hormone receptor binding (GO:0051427),-0.23625810587044466,-0.6234390044720493,0.9076517150395779,0.9974629693693543,1.0,3/14,13.80%,JAK2;TYK2;PTHLH
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.19523995958025556,-0.6210507673197736,0.9612403100775194,0.9939078788175052,1.0,13/29,29.59%,ACER2;GAA;GALC;GBA2;HPSE2;NEU1;CTBS;NEU3;HYAL2;ENGASE;OVGP1;HPSE;ACER3
prerank,voltage-gated cation channel activity (GO:0022843),0.20975475502644347,0.6204112274528301,0.9674887892376681,0.9823156415127559,1.0,12/97,13.99%,CACNA2D3;CACNA1A;CACNB3;PTK2B;CACNA2D4;TMC2;KCNA4;KCNB1;KCNA5;HVCN1;CACNB2;KCNQ5
prerank,NADPH binding (GO:0070402),0.2790547199288208,0.6187608708439968,0.8922345483359746,0.9814991188972761,1.0,2/13,14.28%,HMGCR;DUS2
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.26484973864550415,0.6185627317330818,0.9252873563218391,0.9795535350261584,1.0,8/21,26.76%,EZR;AKAP5;WASF1;ARFGEF1;AKAP8;PRKACA;AKAP1;WASF3
prerank,RNA methyltransferase activity (GO:0008173),-0.21201348879574589,-0.6166591771836196,0.9453376205787781,0.9913382725874783,1.0,6/19,24.92%,METTL8;TRMT5;TRMT9B;TYW3;MRM2;BCDIN3D
prerank,anion transmembrane transporter activity (GO:0008509),0.2943262825146,0.6163351790813267,0.8988580750407831,0.9792173368860226,1.0,1/12,2.52%,SLC4A2
prerank,RNA polymerase binding (GO:0070063),0.26098040284449825,0.6140894157647652,0.8964992389649924,0.9788526768267569,1.0,4/18,15.68%,STOM;NEDD4;DHX9;PABPN1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.2267082838028553,0.6131389093302395,0.947560975609756,0.9774495130395888,1.0,11/53,18.40%,MICAL2;CYB5R3;NQO2;ACADL;MICAL1;CRY2;ILVBL;SQLE;PPOX;KDM1A;PRODH
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.24150414560838757,0.611075330107982,0.928169014084507,0.976956193359111,1.0,10/34,21.44%,UBE2G2;UBE2B;UBE2Q1;UBE2H;UBE2N;UBE2J1;UBE2F;UBE2D3;UBE2Z;UBE2E1
prerank,zinc ion binding (GO:0008270),0.19171004747204787,0.6108094137427306,0.9959183673469387,0.9750770504821045,1.0,60/293,21.89%,NAPEPLD;KLF4;MMP9;ADH7;TIMM10;ADAM33;EPRS1;HDAC4;TIMP1;RNF5;TIMP2;DUSP12;TES;KDM5C;NQO2;KLF7;TAB3;MSRB2;CHORDC1;CXXC4;KMT2A;PITRM1;SHMT1;PHF5A;ZNF205;LACTB2;KDM4C;MMP12;MYT1;NPEPPS;CHD3;TARS1;CHMP1A;SEC23A;LTA4H;MDM2;TET1;SIAH1;ZFYVE1;TAB2;PDXK;USP16;RNF112;APIP;ENPP5;SEC24B;IDE;TIMM9;LVRN;ZBTB32;RASSF1;ZNF8;QPCTL;ACR;ZCCHC4;QPCT;PHF2;ARIH2;KMT2B;DPF3
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.2440955646973793,-0.6077847359208494,0.9425587467362925,0.9911052302519553,1.0,2/12,12.28%,NOD1;RACK1
prerank,four-way junction DNA binding (GO:0000400),-0.21392745254014797,-0.6076519117962795,0.9376770538243626,0.9860057760800158,1.0,4/17,18.04%,RAD51D;HMGB1;BLM;XRCC2
prerank,regulatory RNA binding (GO:0061980),0.2303435303479696,0.6072460441834872,0.9409395973154362,0.9755840638613724,1.0,5/38,15.36%,ZC3H12A;TARBP2;RBM10;TUT7;DHX9
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.2650901620965889,0.6038647710689498,0.9178082191780822,0.9760065135659026,1.0,1/18,2.56%,TNFAIP8
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.24308961025185039,0.6011445095759776,0.9360795454545454,0.9757987708631654,1.0,4/27,13.86%,ANKH;SLC22A8;SLC25A14;SLC26A4
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.24065156603108856,-0.595793038153397,0.9486486486486486,0.9867884073846278,1.0,5/11,28.32%,HMGA2;APLF;NEIL3;NTHL1;ALKBH1
prerank,thioesterase binding (GO:0031996),-0.23904842751548505,-0.5956896544312853,0.9360613810741688,0.9817276612427738,1.0,4/11,21.63%,TRAF6;ARF6;TRAF1;HAUS7
prerank,ephrin receptor activity (GO:0005003),0.25962239182436053,0.5923070637241807,0.9194029850746268,0.9776558653095339,1.0,3/17,13.17%,EPHA4;EPHA3;EFNA4
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.25962239182436053,0.5923070637241807,0.9194029850746268,0.9776558653095339,1.0,3/17,13.17%,EPHA4;EPHA3;EFNA4
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2315921608198327,0.5907150662280425,0.9455511288180611,0.9766266439567509,1.0,15/33,30.99%,RNF5;DCUN1D5;SIAH3;DCUN1D1;SIAH1;PARK7;ARIH2;RNF14;UBE3D;RPS3;RNF19A;UBA2;TOLLIP;ARIH1;PRKN
prerank,protein phosphorylated amino acid binding (GO:0045309),0.22001859102988938,0.5842373893427145,0.9566326530612245,0.9785041321528495,1.0,10/42,18.07%,SHB;SHC1;PTPN6;YWHAB;RASA1;NEDD4;ABL1;CRK;PTPN11;YES1
prerank,MHC protein binding (GO:0042287),0.23841859539493176,0.5721179669683728,0.9445277361319341,0.9832575668260815,1.0,3/20,16.43%,CD81;ABCB9;ATP5F1B
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2274551119153606,0.5701008312386994,0.9439775910364145,0.9823584484838861,1.0,9/31,21.44%,UBE2G2;UBE2B;UBE2Q1;UBE2H;UBE2N;UBE2J1;UBE2D3;UBE2Z;UBE2E1
prerank,alpha-tubulin binding (GO:0043014),0.21968392210685928,0.5677714018816263,0.9554655870445344,0.9815004803409223,1.0,15/31,30.44%,EFHC2;WASHC1;ARL8A;HDAC6;TBCE;CDK5R1;TRPV4;ARL8B;FYN;RACGAP1;SNCA;TBCEL;TAOK1;EFHC1;ARL4C
prerank,peptide hormone receptor binding (GO:0051428),-0.22666499278136965,-0.5631607672973651,0.9543147208121827,0.9908922559284259,1.0,11/11,77.36%,PTHLH;CCK;UCN2;GPHB5;GHRH;GPHA2;UCN3;PSMC5;GNRH1;VIP;ADCYAP1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.21358338103700353,-0.5597401479435282,0.9663865546218487,0.9872404183882177,1.0,4/14,24.12%,NOX4;NCF2;CYBB;AIFM1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.22255991737397818,-0.5582745838553324,0.9675675675675676,0.9827477767702771,1.0,3/12,20.41%,TRAF6;BABAM2;TRAF1
prerank,O-methyltransferase activity (GO:0008171),0.26469351668499425,0.5534967293924041,0.9408866995073891,0.986537384006768,1.0,4/10,26.09%,MEPCE;COQ3;CMTR2;LRTOMT
prerank,ubiquitin-specific protease binding (GO:1990381),0.23739553399495467,0.5505841905862968,0.9489164086687306,0.9858915898152951,1.0,3/19,18.32%,LCOR;RHBDD2;PARK7
prerank,aminopeptidase activity (GO:0004177),0.2213930786240752,0.5464781691389734,0.956338028169014,0.9855912740199626,1.0,9/26,22.50%,NPEPPS;LTA4H;CTSH;MMP14;LVRN;METAP1D;XPNPEP1;RNPEPL1;BLMH
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.215246389052131,0.5461830596165337,0.9773333333333334,0.9836723951204678,1.0,7/35,18.07%,PTK2B;CSK;STYK1;TXK;ABL1;PEAK1;YES1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.1993759078995733,-0.5441838083039336,0.9852941176470589,0.982699451375787,1.0,4/15,21.25%,RBBP5;WDR5;PRDM9;WDR82
prerank,delayed rectifier potassium channel activity (GO:0005251),0.20997700308964817,0.5394915216027523,0.9676113360323887,0.9844082351333169,1.0,4/32,13.99%,KCNA4;KCNB1;KCNA5;KCNQ5
prerank,kinesin binding (GO:0019894),0.21101788594583726,0.5187582192514922,0.9776847977684798,0.9901261777000103,1.0,12/27,30.45%,KIF1B;ACTB;TOR1A;CROCC;AP1AR;KLC2;TTBK2;MAPK8IP1;SNCA;MAPK8IP2;AP1G1;SPAG9
prerank,metalloaminopeptidase activity (GO:0070006),0.22836300610575547,0.5113499168135036,0.9672386895475819,0.9905323806211715,1.0,6/16,21.45%,NPEPPS;LTA4H;MMP14;LVRN;XPNPEP1;RNPEPL1
prerank,P-type ion transporter activity (GO:0015662),-0.2043903349708146,-0.5043661315016541,0.9947916666666666,0.9882937788779717,1.0,6/12,37.55%,ATP2A2;ATP2B3;ATP7B;ATP2C2;ATP2B2;ATP2A1
prerank,miRNA binding (GO:0035198),0.19698803860751615,0.4970440952590711,0.9844851904090268,0.9926435982184847,1.0,3/30,12.89%,ZC3H12A;RBM10;TUT7
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.1861778935671157,0.46716056721822313,0.9901269393511989,0.9971959179245756,1.0,4/30,19.14%,TNFAIP8;CARD16;XIAP;UBE2Z
prerank,N-methyltransferase activity (GO:0008170),0.17394993393150296,0.40347426265664577,0.9969924812030075,1.0,1.0,7/20,26.11%,NNMT;PRMT1;ZCCHC4;FDXACB1;N6AMT1;TRMT11;METTL5
prerank,carbohydrate:cation symporter activity (GO:0005402),0.16577741510263022,0.34890888565582523,1.0,1.0,1.0,11/11,83.43%,SLC2A9;SLC2A10;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC17A5;SLC23A2;SLC23A1;SLC5A11;SLC5A3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.1547857722972787,0.3475346862235391,0.9984939759036144,1.0,1.0,1/16,6.37%,MACROD1
prerank,phospholipase binding (GO:0043274),0.15140088902768079,0.3270191948306033,1.0,0.9998118425871038,1.0,5/13,31.26%,PAFAH1B1;FYN;PDPK1;PRKN;SYK
